Paper Digest: COVID-19 Related Patents
In response to the COVID-19 pandemic, Paper Digest Team extracted all patents related to COVID-19 on our radar. These results are sorted by relevance & date.
If you do not want to miss interesting academic papers, you are welcome to sign up our daily paper digest service to get updates on new papers published in your area every day. You are also welcome to follow us on Twitter and Linkedin to get updated with new conference digests.
Paper Digest Team
New York City, New York, 10017
team@paperdigest.org
TABLE 1: Paper Digest: COVID-19 Related Patents
| Title | Applicant/Assignee | Filing Date | Publish Date | Grant Date | |
|---|---|---|---|---|---|
| 1 | Method and System for Exposing Hidden or Masked Antigenic Sites of Viral Specimens Present in Biosamples Using a Home-Based COVID-19 Rapid Lateral Flow Immunoassay Test Summary Related Patents View Save Abstract: A disease detection system including a platform or cartridge to perform testing using a rapid lateral flow chromatographic immunoassay (LFIA) test intended for the qualitative … |
PRINCETON BIOCHEMICALS | 2025-08-28 | 2025-12-25 | |
| 2 | VARIANT STRAIN-BASED CORONAVIRUS VACCINES Summary Related Patents View Save Abstract: The disclosure provides coronavirus mRNA vaccines, including vaccines directed against spike proteins of one or more variant strains of SARS-CoV-2, as well as methods of using the … |
MODERNATX | 2025-08-08 | 2025-12-04 | |
| 3 | RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the … |
GIGAGEN | 2025-07-31 | 2026-01-15 | |
| 4 | Effect of YEL002 on Conditions and Diseases Summary Related Patents View Save Abstract: A preparation comprising the YEL002 compound as an active ingredient for the prevention or treatment of one or more diseases, and methods of using such preparations. The … |
RADMIT | 2025-07-27 | 2026-01-08 | |
| 5 | COMPOSITIONS AND METHODS USING TETRAHYDROCANNABINOL AND COMPOSITIONS INCLUDING SAME FOR TREATING INDICATIONS INVOLVING INFLAMMATION Summary Related Patents View Save Abstract: Compositions and methods for treating any one of the disclosed indications involving inflammation in a subject in need thereof, which includes administering to the subject a … |
AURANGZEB NAFEES NAGY | 2025-07-25 | 2025-11-20 | |
| 6 | SARS-CoV-2 Vaccine Constructs Summary Related Patents View Save Abstract: The present disclosure describes, inter alia, fusion polypeptides comprising a SARS-CoV-2 Spike polypeptide fragment comprising at least a portion of the N-terminal domain, … |
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 2025-07-22 | 2025-11-13 | |
| 7 | NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-CoV-2 SPIKE PROTEINS, AND mRNA VACCINE SPIKE PROTEIN Summary Related Patents View Save Abstract: Combinations of cannabinoids, vitamins, trace elements, bioactive components, bioflavonoid polyphenols, proteolytic enzymes, amino acids, and antioxidants which work independently … |
PONO LIFESTYLE | 2025-07-15 | 2026-01-08 | |
| 8 | METHOD FOR DETECTING CORONAVIRUS (SARS-CoV-2) Summary Related Patents View Save Abstract: Disclosed are oligonucleotide primers that hybridize specifically with any base sequence designed from the base sequences of the N gene, RNA-dependent RNA polymerase gene, M gene, … |
EIKEN KAGAKU | 2025-07-09 | 2025-10-30 | |
| 9 | VACCINES AND RELATED METHODS Summary Related Patents View Save Abstract: Provided herein are SARS-CoV-2 spike proteins and polypeptides (e.g., SARS-CoV-2 spike proteins and polypeptide immunogens (and immunogenic fragments and immunogenic variants … |
FLAGSHIP PIONEERING INNOVATIONS VII | 2025-07-02 | 2025-10-30 | |
| 10 | ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE Summary Related Patents View Save Abstract: The present disclosure provides recombinantly manufactured fusion proteins comprising a SARS-CoV-2 Receptor Binding Domain (SARS-CoV-2-RBD) fragment or an analog thereof linked to … |
VAKSTON | 2025-06-30 | 2026-01-01 | |
| 11 | THERAPEUTICS DIRECTED AGAINST CORONAVIRUS Summary Related Patents View Save Abstract: This invention provides compositions and methods to treat, prevent, and diagnose viral infections. The methods provided herein involve administering polypeptides of the invention … |
SINGH BIOTECHNOLOGY | 2025-06-27 | 2025-10-16 | |
| 12 | USE OF IFN-LAMBDA MRNA FOR TREATING VIRAL INFECTIONS Summary Related Patents View Save Abstract: The present invention relates to pharmaceutical compositions comprising an mRNA encoding an IFN-λ polypeptide for use in treating a viral-induced disorder, preferably a … |
ETHRIS | 2025-06-24 | 2025-10-16 | |
| 13 | SYSTEMS AND METHODS FOR USE OF ADENOSINE TRIPHOSPHATE (ATP) TO RELIEVE SYMPTOMS OF COVID-19 AND RELATED INFECTIONS Summary Related Patents View Save Abstract: Treatments for SARS-CoV-2 infection, COVID-19, symptoms of COVID-19, and similar infections. Specifically, treatments for patients identified as having Acute Respiratory Distress … |
ADENYLATE THERAPEUTICS | 2025-06-17 | 2025-10-09 | |
| 14 | VIRUS DETECTION VIA PROGRAMABLE TYPE III-A CRISPR-CAS SYSTEMS AND METHODS Summary Related Patents View Save Abstract: Methods and systems, which use a reconstituted Type III-A CRISPR-Cas system, MORIARTY (Multipronged, One-pot, RNA Induced, Augmentable, Rapid, Test sYstem) for the detection of … |
FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION | 2025-06-16 | 2026-01-08 | |
| 15 | FLAVONOID-CONTAINING COMPOSITIONS AND TREATMENT OF VIRAL DISEASES WITH SAME Summary Related Patents View Save Abstract: Compositions that contain flavonoids such as hesperidin, quercetin, hesperetin, and rutin and methods of treating viral diseases such as coronavirus (e.g., SARS COV-2) infection, … |
AMH BIOTECH | 2025-06-13 | 2025-12-18 | |
| 16 | Methods for Preventing and Treating Cardiac Dysfunction and COVID-19 with Activin A Antagonists Summary Related Patents View Save Abstract: The present invention provides methods for preventing and treating cardiac dysfunction, including cardiomyopathy and heart failure. The methods of the invention feature the … |
REGENERON PHARMACEUTICALS | 2025-05-22 | 2025-09-04 | |
| 17 | METHODS OF TREATING INFLAMMATORY DISEASES BY BLOCKING GALECTIN-3 Summary Related Patents View Save Abstract: Disclosed herein are methods, antibodies, and compositions for disrupting an interaction between Galectin-3 (Gal3) and viral proteins, such as proteins of the SARS-CoV-2 virus or … |
TRUEBINDING | 2025-04-18 | 2025-07-31 | |
| 18 | SYNTHETIC MODIFIED VACCINIA ANKARA (SMVA) BASED CORONAVIRUS VACCINES Summary Related Patents View Save Abstract: Disclosed are synthetic MVA-based vaccines for preventing or treating coronavirus infections and methods of producing the vaccines. … |
CITY OF HOPE | 2025-04-18 | 2025-10-09 | |
| 19 | THERAPEUTIC COMBINATIONS AND METHODS TO TREAT LONG COVID Summary Related Patents View Save Abstract: The disclosure relates in some aspects to methods of treating a subject having post-acute sequelae of COVID-19 (PASC), sometimes also known as “long COVID.” Also provided are … |
ROHAN DIXIT | 2025-04-10 | 2025-07-24 | |
| 20 | METHODS AND REAGENTS OF IMMUNOLOGICALLY DETECTING SARS-CoV-2 Summary Related Patents View Save Abstract: The present invention provides a method of immunologically detecting SARS-CoV-2, the method comprising detecting a SARS-CoV-2 N protein in a specimen taken from a subject by using … |
FUJIREBIO | 2025-04-07 | 2025-08-14 | |
| 21 | ALPHAVIRUS REPLICON ENCODING CHIMERIC SARS-COV-2 RECEPTOR BINDING DOMAINS Summary Related Patents View Save Abstract: Provided herein is an isolated polynucleotide, which encodes alphavirus non-structural proteins nsp1, nsp2, nsp3 and nsp4 and a polypeptide comprising a coronavirus protein fused … |
VLP THERAPEUTICS | 2025-04-02 | 2025-07-17 | |
| 22 | METHOD AND COMPOSITION FOR TREATING CORONA VIRUS, INFLUENZA, AND ACUTE RESPIRATORY DISTRESS SYNDROME Summary Related Patents View Save Abstract: A method of treating a Corona Virus, e.g., COVID 19, Influenza and ARDS, is provided. A copper chelator including a tetrathiomolybdate salt is administered with a 5-lipoxygenase … |
REVERSPAH | 2025-03-31 | 2025-07-10 | |
| 23 | METHODS AND SYSTEMS OF PREDICTING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) Summary Related Patents View Save Abstract: A method and system for predicting/diagnosing inflammatory diseases, such as, multisystem inflammatory syndrome in children (MIS-C), Kawasaki disease, Severe Acute Respiratory … |
UNIVERSITY OF CONNECTICUT et. al. | 2025-03-28 | 2025-10-02 | |
| 24 | DUAL-SYSTEM METHOD FOR ASSESSING TRANSMISSIBILITY AND DISEASE SEVERITY OF RESPIRATORY VIRUSES Summary Related Patents View Save Abstract: The present invention uses ex vivo human airway cultures to assess the human transmissibility and replication competence of influenza and coronavirus strains. By comparing … |
CENTRE FOR IMMUNOLOGY & INFECTION | 2025-03-18 | 2025-09-25 | |
| 25 | VIRAL PREPARATIONS AND METHODS FOR TREATING AND MODULATING MITOCHONDRIAL EFFECTS OF CORONAVIRUS INFECTIONS. Summary Related Patents View Save Abstract: Attenuate coronavirus species that are able to fully replicate and spread are proposed together with the methods of obtaining thereof. The proposed coronavirus species are … |
JULIAN DAICH | 2025-03-17 | 2025-10-23 | |
| 26 | Anti COVID-19 Therapies targeting nucleocapsid and spike proteins Summary Related Patents View Save Abstract: Disclosed herein are methods for inducing immunity against a virus such as a coronavirus in the mucosal tissue of a patient, include administering a vaccine composition to the … |
IMMUNITYBIO | 2025-03-14 | 2025-07-24 | |
| 27 | HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 1 (SARS-CoV-1) Summary Related Patents View Save Abstract: The present disclosure is directed to antibodies binding to and neutralizing the coronavirus designated SARS-CoV-1 and methods for use thereof. … |
VANDERBILT UNIVERSITY | 2025-03-13 | 2025-10-02 | |
| 28 | Antibodies that bind the spike protein of SARS-CoV-2 Summary Related Patents View Save Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to the spike protein of SARS-COV-2 and methods of making and using the … |
ASTRAZENECA UK | 2025-02-20 | 2025-12-02 | |
| 29 | SARS-COV-2 RNA VACCINE COMPOSITIONS AND METHODS OF USE Summary Related Patents View Save Abstract: The disclosure provides compositions, methods of treatment, and methods of making and using compositions to deliver a nucleic acid to a subject. Methods of using the compositions … |
HDT BIO | 2025-02-19 | 2025-07-17 | |
| 30 | COMPOSITIONS AND METHODS FOR MUCOSAL VACCINATION AGAINST SARS-COV-2 Summary Related Patents View Save Abstract: Disclosed are peptides comprising a monomeric Fc fragment of an immunoglobulin recognized by a FcRn; SARS-CoV-2 antigen; and a trimerization domain. Disclosed are peptide … |
UNIVERSITY OF MARYLAND COLLEGE PARK | 2025-02-13 | 2025-08-14 | |
| 31 | Methods and Compositions for Treating Infections Summary Related Patents View Save Abstract: The invention provides a compound comprising one, two, three or more non-natural HRC sequence of a viral spike peptide conjugated to a hydrophobic moiety via an optional linker. … |
DECOY THERAPEUTICS | 2025-02-06 | 2025-12-25 | |
| 32 | METHODS FOR THE PROPHYLAXIS AND TREATMENT OF COVID AND COVID-19 Summary Related Patents View Save Abstract: The present invention recognizes that there is a need for the prophylaxis or treatment of COVID and COVID-19. A first aspect of the present invention generally relates to methods … |
LLOYD HUNG LOI TRAN | 2025-01-25 | 2025-10-16 | |
| 33 | RECOMBINANT PLASMID, IMMUNOGENIC COMPOSITION, KIT AND USES THEREOF Summary Related Patents View Save Abstract: Recombinant plasmids and immunogenic DNA compositions including a recombinant plasmid which carries the gene sequence encoding the Spike protein or the gene sequence encoding the … |
FUNDAÇÃO OSWALDO CRUZ | 2025-01-17 | 2025-08-07 | |
| 34 | CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: The present invention is directed to a nucleic acid suitable for use in treatment or prophylaxis of an infection with a coronavirus, preferably with a Coronavirus SARS-CoV-2, or a … |
CUREVAC | 2025-01-16 | 2025-05-15 | |
| 35 | mRNA vaccine encoding fusion antigen against Mpox and severe acute respiratory syndrome coronavirus 2 Summary Related Patents View Save Abstract: An mRNA molecule is disclosed. The mRNA molecule contains a polynucleotide encoding an M1R antigen of Mpox and a polynucleotide encoding an RBD antigen of severe acute respiratory … |
ACADEMY OF MILITARY MEDICAL SCIENCES AMS PLA | 2025-01-16 | 2025-06-10 | |
| 36 | DEVICE AND METHOD FOR PATHOGEN DETECTION Summary Related Patents View Save Abstract: Systems and methods are disclosed herein for pathogen detection employing a lateral flow assay (LFA) device or ELISA assay, e.g. for detecting SARS-COV-2, the virus that causes … |
KING ABDULAZIZ UNIVERSITY | 2025-01-13 | 2025-05-15 | |
| 37 | TETANUS VACCINE PLATFORM FOR EMBEDDING COVID-19 VACCINE Summary Related Patents View Save Abstract: A method of immunizing against COVID-19 by administering a recombinant SARS-CoV2 protein-based vaccine, developed by either embedding the epitopes/domains, or chemically … |
PRIME BIO | 2025-01-12 | 2025-05-08 | |
| 38 | COMPOSITIONS AND METHODS FOR SUPPORTING IMMUNE HEALTH Summary Related Patents View Save Abstract: Various embodiments provide a method of increasing immunity to a virus in a subject. The method can comprise administering to the subject one or more effective doses of an … |
PLEXUS WORLDWIDE | 2025-01-06 | 2025-05-01 | |
| 39 | ALLOSTERIC INHIBITORS OF THE MAIN PROTEASE OF SARS-COV-2 Summary Related Patents View Save Abstract: SARS-CoV-2 has raised the alarm to search for effective therapy for this virus. To date several vaccines have been approved, but few available drugs reported recently still need … |
ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA et. al. | 2024-12-31 | 2025-06-12 | |
| 40 | PHARMACEUTICAL COMPOSITIONS Summary Related Patents View Save Abstract: A method of treating or reducing symptoms of coronavirus disease includes administering a therapeutically effective amount of a pharmaceutical composition to a patient, the … |
HISHAM HASSAN ABDELWAHAB et. al. | 2024-12-30 | 2025-07-03 | |
| 41 | ANTIBODIES FOR TREATMENT OF CORONAVIRUS DISEASE Summary Related Patents View Save Abstract: Provided herein are antibodies and pharmaceutical compositions for treating coronavirus disease, and methods of their use. … |
NORTHWESTERN UNIVERSITY et. al. | 2024-12-23 | 2025-07-17 | |
| 42 | VACCINES AGAINST CORONAVIRUS AND METHODS OF USE Summary Related Patents View Save Abstract: Disclosed herein are nucleic acid molecules encoding a SARS-CoV-2 spike antigen. SARS-CoV-2 spike antigens, immunogenic compositions, and vaccines and their use in inducing immune … |
INOVIO PHARMACEUTICALS et. al. | 2024-12-20 | 2025-04-17 | |
| 43 | COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION Summary Related Patents View Save Abstract: The present disclosure includes a multiplexed peptide assay to generate an epitope-resolved view of antibody reactivity across all human coronaviruses (CoVs). PepSeq accurately … |
TRANSLATIONAL GENOMICS RESEARCH INSTITUTE et. al. | 2024-12-19 | 2025-04-24 | |
| 44 | HYBRID FLU-CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: A hybrid vaccine composition that prevents infection or reinfection by both influenza and coronaviruses, comprising at least a portion of a Coronavirus spike(S) protein and at … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-12-09 | 2025-04-03 | |
| 45 | VALACYCLOVIR AND CELECOXIB IN COMBINATION WITH NIRMATRELVIR AND RITONAVIR FOR THE TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: The present disclosure relates to methods of diseases and/or conditions associated with Covid-19 infection, including long COVID, comprising administration of a COX-2 inhibitor, … |
WILLIAM LANGLEY PRIDGEN | 2024-12-06 | 2025-06-12 | |
| 46 | COMPOSITIONS AND METHODS FOR DETECTING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2), INFLUENZA A AND INFLUENZA B Summary Related Patents View Save Abstract: Methods for the rapid detection of the presence or absence of SARS-CoV-2, influenza A and influenza B in a biological or non-biological sample are described. The methods can … |
ROCHE MOLECULAR SYSTEMS | 2024-12-05 | 2025-05-29 | |
| 47 | CORONAVIRUS VACCINE COMPOSITIONS AND METHODS Summary Related Patents View Save Abstract: Provided herein are nucleic acid molecules encoding viral replication proteins and antigenic coronavirus proteins or fragments thereof. Also provided herein are compositions that … |
ARCTURUS THERAPEUTICS HOLDINGS | 2024-12-04 | 2025-05-22 | |
| 48 | Recombinant RNA Molecules Comprising Untranslated Regions or Segments Encoding Spike Protein from the Omicron Strain of Severe Acute Respiratory Coronavirus-2 Summary Related Patents View Save Abstract: Provided herein are 3′ and 5′ UTRs that provide an amount, duration, or both of protein expression from a recombinant RNA. Compositions of matter, methods, or uses of said 3′ and … |
GLAXOSMITHKLINE BIOLOGICALS | 2024-12-02 | 2025-03-27 | |
| 49 | METHODS AND KITS FOR VIRUS DETECTION Summary Related Patents View Save Abstract: The invention relates to methods and kits for detecting a virus, e.g., a respiratory virus such as a coronavirus, in a biological sample. The invention also relates to methods and … |
MESO SCALE TECHNOLOGIES | 2024-12-02 | 2025-07-24 | |
| 50 | NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS Summary Related Patents View Save Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 … |
INSTITUT PASTEUR | 2024-11-27 | 2025-03-20 | |
| 51 | LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF CORONAVIRUS DISEASE AND SYMPTOMS THEREOF Summary Related Patents View Save Abstract: Certain embodiments described herein include methods and formulations for treating or preventing symptoms and conditions associated with coronavirus disease (e.g., COVID-19). The … |
IRR | 2024-11-27 | 2025-03-20 | |
| 52 | NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS Summary Related Patents View Save Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-COV-2), comprising a nucleic acid construct encoding a SARS-COV-2 … |
INSTITUT PASTEUR | 2024-11-27 | 2025-03-20 | |
| 53 | METHOD OF TREATING LONG-COVID INDUCED NEUROLOGIC DISEASES Summary Related Patents View Save Abstract: A method of treating or preventing Alzheimer’s disease or related dementias in patients previously infected with a respiratory virus such as SARS CoV2 is presented. Brain gene … |
UNIVERSITY OF SOUTH FLORIDA | 2024-11-26 | 2025-03-20 | |
| 54 | Preparation method and application of single-chain antibody fragment targeting SARS-CoV-2 nucleocapsid protein Summary Related Patents View Save Abstract: Disclosed are a preparation method and application of a single-chain antibody fragment targeting SARS-CoV-2 nucleocapsid protein, aiming to provide a single-chain antibody … |
NANJING UNIVERSITY | 2024-11-19 | 2025-09-23 | |
| 55 | METHODS AND DEVICES FOR RAPID DETECTION OF COVID-19 AND OTHER PATHOGENS Summary Related Patents View Save Abstract: A device and method for detecting COVID-19 and other pathogens includes a sample compartment contained within an interior of the device and having multiple apertures for … |
KHALIFA UNIVERSITY OF SCIENCE AND TECHNOLOGY | 2024-11-14 | 2025-05-08 | |
| 56 | Nucleic acid vaccine against the SARS-CoV-2 coronavirus Summary Related Patents View Save Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-COV-2), comprising a nucleic acid construct encoding a SARS-COV-2 … |
INSTITUT PASTEUR | 2024-11-08 | 2025-06-10 | |
| 57 | ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure relates to an antibody or antigen-binding fragment thereof that specifically binds to a spike protein of SARS-CoV-2. The present disclosure also relates to … |
ACADEMIA SINICA | 2024-11-08 | 2025-05-01 | |
| 58 | DYSREGULATION OF TRAUMA REGULATION PATHWAY TREATMENT AND MONITORING TECHNIQUES Summary Related Patents View Save Abstract: The subject matter of the present disclosure generally relates to techniques for addressing or correcting dysregulation of the trauma regulation pathway. The dysregulation may be … |
GE PRECISION HEALTHCARE | 2024-11-06 | 2025-02-20 | |
| 59 | METHOD FOR TREATING INFECTIOUS DISEASE Summary Related Patents View Save Abstract: The present invention provides a method of treating an infectious disease. The method comprises the step of administering to a subject in need thereof an effective amount of (i) a … |
SUNTEC MEDICAL | 2024-11-06 | 2025-03-06 | |
| 60 | PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION Summary Related Patents View Save Abstract: In alternative embodiments, provided are pharmaceutical compositions comprising combinations of drugs, including products of manufacture and kits, and methods for using them, for … |
TOPELIA AUST | 2024-11-05 | 2025-02-20 | |
| 61 | CHIMERA MOLECULES FOR SARS-COV-2 AND METHODS OF USE Summary Related Patents View Save Abstract: The subject matter described herein is directed to a chimera molecule such as a polypeptide or protein chimera useful for treating or preventing a viral infection or reducing the … |
SHAOXIAO WANG et. al. | 2024-11-02 | 2025-05-08 | |
| 62 | USE OF NOVEL POLYMER FOR PREVENTING SARS-COV-2 Summary Related Patents View Save Abstract: The present invention relates to a novel vaccine composition for coronavirus infection-19 comprising a polymer-based mRNA carrier. Specifically, the present invention provides a … |
POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION; KOREA NATIONAL INSTITYTE OF HEALTH | 2024-10-30 | 2025-05-01 | |
| 63 | IMPROVED CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: The present disclosure provides a glycoengineered SARS-COV-2 spike protein which is capable of eliciting an enhanced immune response relative to a native spike protein of … |
ACADEMIA SINICA | 2024-10-25 | 2025-10-30 | |
| 64 | RECOMBINANT MULTIVALENT VACCINE Summary Related Patents View Save Abstract: A recombinant multivalent vaccine including a recombinant protein is provided. The recombinant protein includes, from a N-terminus to a C-terminus, a first antigenic peptide, an … |
SHANGHAI PUBLIC HEALTH CLINICAL CENTER | 2024-10-22 | 2025-02-06 | |
| 65 | C3D4 Human Cell Model for MERS and SARS-C0V-2 Infection Summary Related Patents View Save Abstract: A robust human cell culture model permissive to both SARS-COV-2 variants and MERS-COV is critical for assessment and validation of antivirals. Human alveolar A549 cells are … |
HACKENSACK MERIDIAN HEALTH | 2024-10-17 | 2025-04-17 | |
| 66 | IMMUNOGENIC AND VACCINE COMPOSITIONS AGAINST SARS-CoV-2 Summary Related Patents View Save Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe acute respiratory syndrome (SARS). The compositions and methods include … |
IOWA STATE UNIVERSITY RESEARCH FOUNDATION | 2024-10-16 | 2025-02-06 | |
| 67 | Nitrile-Containing Antiviral Compounds Summary Related Patents View Save Abstract: The invention relates to compounds of Formula I″ wherein R, R , R , R , p, q and q′ are as defined herein, pharmaceutical compositions comprising the compounds, methods of … |
PFIZER | 2024-10-16 | 2025-03-27 | |
| 68 | LOW-SUGAR CORONAVIRUS VACCINE AND METHODS THEREOF Summary Related Patents View Save Abstract: The present disclosure relates to a low glycosylated spike protein and a vaccine designed to express the spike protein in vivo. The present disclosure also teaches a method for … |
ROCK BIOMEDICAL | 2024-10-08 | 2025-04-10 | |
| 69 | Composition For Treating and Preventing COVID-19 and Method For Treatment of COVID-19 Summary Related Patents View Save Abstract: A composition for the treatment of or prevention of COVID-19 or long COVID may be a mixture of: water; green tea; lemon juice; red onions; and garlic. One embodiment of the … |
TIMOTHY GALVIN | 2024-10-04 | 2025-04-10 | |
| 70 | CRISPR-BASED PROGRAMMABLE RNA EDITING Summary Related Patents View Save Abstract: CRISPR RNA-guided nucleases are routinely used for sequence-specific manipulation of DNA. While CRISPR-based DNA editing has become routine, analogous methods for editing RNA have … |
MONTANA STATE UNIVERSITY | 2024-10-02 | 2025-02-27 | |
| 71 | VACCINES AND RELATED METHODS Summary Related Patents View Save Abstract: Provided herein are SARS-CoV-2 spike proteins and polypeptides (e.g., SARS-CoV-2 spike proteins and polypeptide immunogens (and immunogenic fragments and immunogenic variants … |
FLAGSHIP PIONEERING INNOVATIONS VII | 2024-10-01 | 2025-04-03 | |
| 72 | ANTI-SARS-CoV-2 SPIKE (S) ANTIBODIES AND THEIR USE IN TREATING COVID-19 Summary Related Patents View Save Abstract: The present invention provides antibodies that bind to the SARS-CoV-2 Spike (S) protein. The invention further relates to pharmaceutical compositions, immunotherapeutic … |
NOVAVAX | 2024-09-28 | 2025-04-03 | |
| 73 | PROBES FOR IMPROVING CORONAVIRUS SAMPLE SURVEILLANCE Summary Related Patents View Save Abstract: Described herein are compositions and methods for enriching library fragments prepared for coronavirus sequences prepared from various samples. These methods may incorporate … |
ILLUMINA | 2024-09-26 | 2025-01-09 | |
| 74 | PORCINE CORONAVIRUS VACCINES Summary Related Patents View Save Abstract: The present invention relates to a vaccine for protecting a pig against diseases associated with corona virus infection including porcine epidemic diarrhea virus (PEDV) and/or … |
BOEHRINGER INGELHEIM ANIMAL HEALTH | 2024-09-23 | 2025-03-13 | |
| 75 | SARS-CoV-2 BINDING PROTEINS AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: Certain embodiments of the invention provide isolated anti-SARS-CoV-2 sdAbs, as well as polypeptides and protein molecules comprising such sdAbs. Certain embodiments of the … |
REGENTS OF THE UNIVERSITY OF MINNESOTA | 2024-09-18 | 2025-04-03 | |
| 76 | BIOLOGICAL SAMPLE EXTRACTION BUFFER, AND APPLICATION AND METHOD THEREOF Summary Related Patents View Save Abstract: The present invention provides a biological sample extraction buffer, and an application and a method of use thereof. The biological sample extraction buffer includes a surfactant … |
LEADWAY | 2024-09-17 | 2025-01-09 | |
| 77 | LIFE WAVES FOR THERAPY AND USES THEREOF Summary Related Patents View Save Abstract: The present invention provides an acumoxa therapy device utilizing energy waves for preventing, alleviating or treating COVID-19 (SARS-COV-2) coronavirus infection. In one … |
XUNHUA ZHANG | 2024-09-13 | 2025-03-13 | |
| 78 | STABLE CORONAVIRUS PROTEINS AND VACCINE COMPOSITIONS THEREOF Summary Related Patents View Save Abstract: Provided herein are compositions and methods comprising mutated coronavirus “S” spike proteins or receptor binding domains thereof that have an increased expression level, yield … |
UNIVERSITY OF WASHINGTON et. al. | 2024-09-13 | 2025-01-02 | |
| 79 | TEA FRACTION FOR TREATING IDIOPATHIC PULMONARY FIBROSIS Summary Related Patents View Save Abstract: The present invention provides a new tea fraction, which is made from the non-ethanol extract, and does not contain caffeine, epigallocatechin gallate (EGCG), gallic acid and … |
GT COMFORT HEALTH | 2024-09-12 | 2025-05-01 | |
| 80 | METHOD FOR DETECTING ANTI-SARS-COV-2 SPIKE (S) IMMUNOGLOBULINS Summary Related Patents View Save Abstract: Disclosed are methods for detecting if a biological sample (e.g., serum, blood, plasma) contains antibodies against SARS-CoV-2 S glycoproteins comprising: (i) providing a surface … |
NOVAVAX | 2024-09-11 | 2025-03-13 | |
| 81 | NANOENCAPSULATED PHARMACEUTICAL COMPOSITION AND USE THEREOF Summary Related Patents View Save Abstract: This disclosure is directed to a pharmaceutical composition for treating or preventing a disease. The pharmaceutical composition can comprise a polymer-drug nanoaggregate having a … |
FULGENT GENETICS et. al. | 2024-09-10 | 2025-04-03 | |
| 82 | CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against … |
BIONTECH | 2024-09-10 | 2025-07-31 | |
| 83 | SARS-COV-2 N PROTEIN-SPECIFIC SINGLE-CHAIN ANTIBODY, AND FUSION PROTEIN AND USE THEREOF Summary Related Patents View Save Abstract: A SARS-COV-2 N protein-specific single-chain antibody, a fusion protein, and use thereof are provided. The antibody includes a heavy chain variable region V , a linker and a light … |
GUIZHOU MEDICAL UNIVERSITY | 2024-09-05 | 2025-09-04 | |
| 84 | Graphene-Based Sensor for Detecting SARS-COV-2 Virus in a Biological Sample Summary Related Patents View Save Abstract: In one aspect, a sensor for detecting SARS-COV-2 virus in a sample, e.g., a blood sample, is disclosed, which includes a graphene layer, a plurality of binding agents coupled to … |
GRAPHENE-DX | 2024-08-13 | 2025-02-13 | |
| 85 | COMPOUNDS FOR THE TREATMENT OF SARS Summary Related Patents View Save Abstract: Bis-amide inhibitors of SARS-CoV-2 (COVID), compositions comprising same, and methods of treating a severe acute respiratory syndrome. … |
PURDUE RESEARCH FOUNDATION | 2024-08-06 | 2024-12-12 | |
| 86 | INHIBITION OF COVID-19 VIRUS BY MULTIPLE-COMPONENT FORMULATIONS Summary Related Patents View Save Abstract: Formulations for treatment of human subjects exposed to, or potentially exposed to SARS-CoV-2 virus, or suffering from COVID-19, comprising a multiple-component antiviral … |
ANKH LIFE SCIENCES | 2024-08-05 | 2024-11-28 | |
| 87 | COXSACKIEVIRUS B4 STRAIN AND APPLICATION THEREOF Summary Related Patents View Save Abstract: A coxsackievirus B4 strain and application thereof are disclosed. The strain is named KM140-G01 and is preserved in China Center for Type Culture Collection (CCTCC) on Jun. 18, … |
INSTITUTE OF MEDICAL BIOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES | 2024-08-02 | 2025-01-09 | |
| 88 | RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of Use Summary Related Patents View Save Abstract: Described are RNAi agents, compositions that include RNAi agents, and methods for inhibition of coronavirus (CoV) viral genome. The CoV RNAi agents and RNAi agent conjugates … |
ARROWHEAD PHARMACEUTICALS | 2024-08-01 | 2024-11-28 | |
| 89 | ACTION OF L-CITRULLINE TO PREVENT OR TREAT ENDOTHELIAL DYSFUNCTION Summary Related Patents View Save Abstract: This invention provides methods for treating endothelial dysfunction by administering an effective amount of citrulline to a patient. The patients may be suffering from acute … |
ASKLEPION PHARMACEUTICALS et. al. | 2024-07-19 | 2025-05-29 | |
| 90 | T Cell Modulatory Polypeptides with Conjugation Sites and Methods of Use Thereof Summary Related Patents View Save Abstract: The present disclosure provides T cell modulatory polypeptide-epitope conjugates (T-Cell-MP-epitope conjugates) comprising a chemical conjugation site at which a coronavirus … |
CUE BIOPHARMA | 2024-07-12 | 2025-02-06 | |
| 91 | CORONAVIRUS (COVID-19) AIR SANITIZATION/ISOLATION SYSTEM WITH ANTI-VIRUS CURTAIN WALLS Summary Related Patents View Save Abstract: Various embodiments are directed to a coronavirus air sanitization/isolation system with anti-virus curtain. The system may include a group of anti-virus strips with attached … |
FLORIDA A&M UNIVERSITY | 2024-07-09 | 2024-10-31 | |
| 92 | TREATMENT FOR SARS-COV-2 AND OTHER CORONAVIRUSES Summary Related Patents View Save Abstract: A method of treating a corona virus infection in a human includes administering to the human an effective amount of at least one a natriuretic peptide (NP) and a neprilysin … |
DRORA SHEVY | 2024-07-08 | 2024-10-31 | |
| 93 | BRET-BASED, DUAL PROTEASE BIOSENSOR Summary Related Patents View Save Abstract: A biosensor for detecting proteolytic cleavage activity of two proteases, coronavirus main protease (M ) and papain-like protease (PL ) is provided. The biosensor utilizes … |
QATAR FOUNDATION FOR EDUCATION SCIENCE AND COMMUNITY DEVELOPMENT | 2024-07-03 | 2025-01-30 | |
| 94 | POWER AND TEMPERATURE LIMITED METHOD FOR SELECTIVE CORONAVIRUS STERILIZATION Summary Related Patents View Save Abstract: An apparatus and method for deactivating coronavirus from a liquid having entrained coronavirus. The apparatus comprises a nanosecond pulsed electric field (nsPEF) generator which … |
GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2024-06-28 | 2025-01-02 | |
| 95 | STATIC APPARATUS AND METHOD FOR DELIVERING NANOSECOND PULSED ELECTRIC FIELDS TO CORONAVIRUS FOR SELECTIVE CORONAVIRUS STERILIZATION Summary Related Patents View Save Abstract: An apparatus and method for deactivating coronavirus from a liquid having entrained coronavirus. The apparatus comprises a nanosecond pulsed electric field (nsPEF) generator which … |
GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE | 2024-06-28 | 2025-01-02 | |
| 96 | ORAL VACCINE VIA DENTAL BACTERIA AND EMITTED PEPTIDES TO PREVENT INFECTION FROM A PATHOGEN Summary Related Patents View Save Abstract: Disclosed is a pharmaceutical composition to prevent transmission of a pathogen (i.e., including SARS-CoV-2 amongst other pathogens), the pharmaceutical composition comprising: … |
DAVID KOTLYAR | 2024-06-26 | 2024-10-17 | |
| 97 | IMMUNE MEMORY ENHANCED PREPARATIONS AND USES THEREOF Summary Related Patents View Save Abstract: Formulations and preparations having immune memory enhanced properties are disclosed that provide for enhancing immune response against a tumor growth, cancer, infectious agent, … |
TORIGEN PHARMACEUTICALS | 2024-06-24 | 2025-02-20 | |
| 98 | EFFICIENT VACCINE Summary Related Patents View Save Abstract: ABSTRACT OF DISCLOSURE Provided herein is a bivalent alphavirus replicon vaccine, which is a combination of a first polynucleotide which encodes alphavirus non-structural proteins … |
VLP THERAPEUTICS JAPAN | 2024-06-21 | 2024-10-10 | |
| 99 | SUPERREPELLENT DOUBLY REENTRANT TOPOLOGY (DRT) SURFACE FOR PROMOTING ANTIBIOFOULING AND PREVENTION OF VIRUS CONTAMINATION Summary Related Patents View Save Abstract: Doubly reentrant topology (DRT) is a unique structure. The present invention first validated the outstanding performance of an anti-biofouling artificial surface comprising a … |
TAIPEI VETERANS GENERAL HOSPITAL | 2024-06-17 | 2025-12-18 | |
| 100 | ACTIVATING ENDOGENOUS ANTIMICROBIALS TO TREAT SARS-COV-2 INFECTION Summary Related Patents View Save Abstract: Provided herein are methods of treating COVID-19 in a subject in need thereof, comprising administering to the subject a 25-hydroxyvitamin D compound. Also provided herein are … |
EIRGEN PHARMA | 2024-06-14 | 2025-05-08 | |
| 101 | ELECTRON-TUNNELING OR HOPPING BASED AERIAL VIRAL DETECTOR Summary Related Patents View Save Abstract: In one aspect, the disclosure relates to an aerial viral detection device comprising a sensor cartridge comprising at least one sensor, the at least one sensor comprising a … |
BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2024-06-14 | 2024-12-19 | |
| 102 | TIS-L TARGETING ANTIVIRAL ANTISENSE OLIGONUCLEOTIDE WITH ABILITY TO INHIBIT VIRAL REPLICATION OF SARS-COV-2 Summary Related Patents View Save Abstract: The present disclosure relates to a TIS-L targeting antisense oligonucleotide that inhibits the viral replication of SARS-COV-2 and antiviral use thereof. Since the TIS-L … |
SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION; KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY; KOREA NATIONAL INSTITUTE OF HEALTH | 2024-06-14 | 2024-12-19 | |
| 103 | A BLOOD PROFILE ANALYSIS METHOD FOR IDENTIFICATION OF NEW DIABETES DIAGNOSTIC MARKERS IN SARS-COV-2 INFECTED PATIENTS Summary Related Patents View Save Abstract: This invention describes a cross-sectional study that examines the trends of long-term complications, particularly the incidence of type 2 diabetes mellitus (T2D), in the Saudi … |
FIROZ ANWAR et. al. | 2024-06-12 | 2024-11-07 | |
| 104 | CORONAVIRUS VACCINE COMPRISING A MOSAIC PROTEIN Summary Related Patents View Save Abstract: Disclosed herein are mosaic coronavirus (MoCoV) spike(S) proteins or antigenic fragments thereof. Also disclosed herein are nucleic acid constructs comprising one or more nucleic … |
VAXTHERA | 2024-06-04 | 2024-09-26 | |
| 105 | PRODUCTION OF SINGLE DOMAIN COVID-19 ANTIBODIES IN PLANT CELLS Summary Related Patents View Save Abstract: Methods for producing single N-terminal domain functional camelid-derived heavy (H)-chain antibody fragments (VHH) that specifically bind to a receptor binding domain (RBD) of … |
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 2024-05-31 | 2024-12-05 | |
| 106 | SARS COV-2 VACCINES, ASSOCIATED POLYNUCLEOTIDES, AND METHODS OF USE Summary Related Patents View Save Abstract: The present disclosure relates to a vaccines and related polynucleotides useful in eliciting an immune response to the SARS-CoV-2 virus and related methods of use. … |
AEGIS LIFE et. al. | 2024-05-30 | 2024-12-05 | |
| 107 | Conserved region T cell vaccines for coronavirus and methods of use Summary Related Patents View Save Abstract: Immunogenic compositions and methods of their use in eliciting immune responses to coronaviruses, such as SARS-CoV-2 are provided. … |
TRIAD NATIONAL SECURITY; OXFORD UNIVERSITY INNOVATION; TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA; BETH ISRAEL DEACONESS MEDICAL CENTER | 2024-05-21 | 2025-07-22 | |
| 108 | DOPAMINE RECEPTOR AGONISTS OR ANGIOTENSIN RECEPTOR BLOCKERS OR COMBINATIONS THEREOF FOR COVID-19 SEQUELAE Summary Related Patents View Save Abstract: Methods and compositions are disclosed to treat acute COVID-19 or sequelae of acute COVID-19 infection, commonly called “long COVID”. Two therapeutic agents, a selective dopamine … |
ADONIS SFERA | 2024-05-17 | 2024-11-21 | |
| 109 | ANTIGEN LATERAL FLOW Summary Related Patents View Save Abstract: The present disclosure relates to methods of detecting a protein from the SARS-CoV-2 virus, or a fragment thereof, in a sample obtained from a subject using a first antibody or … |
ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLTD. | 2024-05-15 | 2024-10-17 | |
| 110 | ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CONONAVIRUS SARS-COV-2 Citation: 1 Summary Related Patents View Save Abstract: The invention relates to antibodies useful for the prevention, treatment and/or diagnosis of coronavirus infections, and diseases and/or complications associated with coronavirus … |
RQ BIOTECHNOLOGY | 2024-05-14 | 2024-11-14 | |
| 111 | Variant nucleic acid libraries for coronavirus Summary Related Patents View Save Abstract: Provided herein are methods and compositions relating to libraries of optimized antibodies having nucleic acids encoding for an antibody comprising modified sequences. Libraries … |
TWIST BIOSCIENCE | 2024-05-14 | 2025-05-20 | |
| 112 | NCOVSIRNA DRUG FOR TARGETED DELIVERY SHRNA by RBD, SYNTHESIS METHOD, AND APPLICATION THEREOF Summary Related Patents View Save Abstract: The present disclosure relates to a synthesis method of A targeted drug nCoVshRNA, using RBD derived from the receptor binding domain of Covid-19 as a targeted delivery carrier, … |
BINGHUAN WENG | 2024-05-10 | 2024-11-07 | |
| 113 | SARS-COV-2 IMMUNIZING COMPOSITIONS AND METHODS Summary Related Patents View Save Abstract: In one aspect, an immunogen includes an immunogenic carrier comprising an RNA bacteriophage virus-like particle (VLP) and an antigenic SARS-CoV-2 stem-helix peptide linked to the … |
UNM RAINFOREST INNOVATIONS | 2024-05-10 | 2024-11-14 | |
| 114 | METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACIDS AND NUCLEASES IN A BODY FLUID AS INDICATORS OF DISEASE Summary Related Patents View Save Abstract: Provided herein are methods and compositions for analyzing extracellular (cell-free) nucleic acids and/or nucleases in a body fluid, to identify subjects having a disease or … |
ARNA GENOMICS US | 2024-05-10 | 2024-09-12 | |
| 115 | SARS-COV-2 VACCINES Summary Related Patents View Save Abstract: Disclosed herein are vaccine compositions that include SARS-CoV-2 MHC epitope-encoding cassettes and/or full-length SARS-CoV-2 proteins. Also disclosed are nucleotides, cells, and … |
GRITSTONE BIO | 2024-05-08 | 2025-04-17 | |
| 116 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CORONAVIRUS INFECTION, INCLUDING SARS-COV-2 Summary Related Patents View Save Abstract: Disclosed herein are exosomes, compositions, and methods for the treatment of subjects infected with, or at risk for infection with a coronavirus, such as SARS-COV-2, HCoV-NL63, … |
NORTHWESTERN UNIVERSITY | 2024-05-08 | 2024-12-05 | |
| 117 | DNA ANTIBODY CONSTRUCTS FOR USE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS Summary Related Patents View Save Abstract: Disclosed herein is a composition including a recombinant nucleic acid sequence that encodes an antibody to a Middle East Respiratory Syncytial Coronavirus (MERS-COV) viral … |
WISTAR INSTITUTE OF ANATOMY AND BIOLOGY et. al. | 2024-05-07 | 2024-11-14 | |
| 118 | USE OF CEREBRAL DOPAMINE NEUROTROPHIC FACTOR FOR AMELIORATING PNEUMONIA Summary Related Patents View Save Abstract: The present invention relates to a method for treating and/or preventing pneumonia, including administering a therapeutically effective amount of cerebral dopamine neurotrophic … |
NATIONAL DEFENSE MEDICAL CENTER | 2024-04-26 | 2025-10-30 | |
| 119 | Method For Concentration And Avidity Detection Of Antibodies Against Immune System Related Diseases Measured With Evanescent Field Based Biosensors Using A Continuous Gradient Of Ligand Densities Summary Related Patents View Save Abstract: The core of this patent application is about the invention of a plug & play method and device for concentration (titer) and avidity parameters using continuous gradients of ligand … |
VYSENS | 2024-04-26 | 2024-09-19 | |
| 120 | Methylene Blue COVID-19 Composition Summary Related Patents View Save Abstract: A methylene blue COVID-19 composition for treating short-term and long-term COVID-19 symptoms. The methylene blue COVID-19 composition consists of methylene blue and aspirin. The … |
DORRA FRIKHA | 2024-04-26 | 2025-10-30 | |
| 121 | SARS-COV-2 VACCINE COMPOSITIONS Summary Related Patents View Save Abstract: Disclosed herein are coronavirus (CoV) Spike(S) polypeptides, including naturally and non-naturally occurring polypeptides, and nanoparticles and immunogenic compositions … |
NOVAVAX | 2024-04-24 | 2024-11-14 | |
| 122 | OLIGOMERIZATION PARTICLE FORMATION FUSION PROTEIN WITH IMMUNOGENIC ANTIGEN Summary Related Patents View Save Abstract: A fusion protein can include: a series of polypeptide domains starting from an N-terminus or C-terminus, the series of polypeptide domains comprising in order: an oligomerization … |
VIROVAX | 2024-04-22 | 2024-10-24 | |
| 123 | Protease Inhibitors as Antivirals Summary Related Patents View Save Abstract: Provided herein, inter alia, are compounds, pharmaceutical compositions and methods related to the treatment of viral infections caused by coronavirus or enterovirus. Provided … |
ACEA THERAPEUTICS | 2024-04-22 | 2025-04-17 | |
| 124 | COMPOSITIONS FOR AND METHODS OF INHIBITING SARS-COV-2 INFECTION Summary Related Patents View Save Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent for coronavirus disease 2019 (COVID-19), has emerged as an ongoing global pandemic. Presently, … |
TEXAS SOUTHERN UNIVERSITY | 2024-04-18 | 2024-08-29 | |
| 125 | UNGULATE-DERIVED POLYCLONAL IMMUNOGLOBULIN SPECIFIC FOR CORONAVIRUS PROTEIN AND USES THEREOF Summary Related Patents View Save Abstract: Provided are human polyclonal immunoglobulin products for use in treating or preventing coronavirus disease. Further provided are methods for making such compositions in a … |
SAB BIOTHERAPEUTICS | 2024-04-16 | 2024-11-14 | |
| 126 | Antigen Binding Molecules Targeting SARS-CoV-2 Summary Related Patents View Save Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that specifically bind to S2 domains of betacoronavirus … |
GENERATE BIOMEDICINES | 2024-04-15 | 2024-10-31 | |
| 127 | ULTRASENSITIVE RAPID ANTIGEN DETECTION KIT AND DETECTION METHOD THEREOF Summary Related Patents View Save Abstract: The present invention relates to an ultrasensitive rapid antigen detection kit for detecting N protein from SARS-CoV-2 virus in a sample, and methods for detecting N protein. The … |
UNIVERSITY OF HONG KONG et. al. | 2024-04-12 | 2024-10-17 | |
| 128 | CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM Summary Related Patents View Save Abstract: An immunogenic composition for inducing immune responses against both influenza and coronaviruses includes: (a) a coronavirus S (CoV S) glycoprotein in the form of a … |
NOVAVAX | 2024-04-03 | 2024-10-03 | |
| 129 | Sesquiterpenoid derivative and use thereof in preparing broad-spectrum antiviral drug Summary Related Patents View Save Abstract: A sesquiterpenoid derivative and use thereof in preparing a broad-spectrum antiviral drug provided. The sesquiterpenoid derivative can stimulate heterogeneous nuclear … |
KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY | 2024-04-02 | 2025-03-25 | |
| 130 | SMALL MOLECULE COMPOUNDS Summary Related Patents View Save Abstract: The SARS-CoV-2 is highly contagious and has caused coronavirus disease 2019 (COVID-19) outbreaks worldwide. Some embodiments of the present invention relate to a method of … |
ANIVIVE LIFESCIENCES | 2024-03-26 | 2024-08-22 | |
| 131 | Nucleic acid vaccine against the SARS-CoV-2 coronavirus Citation: 1 Summary Related Patents View Save Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-COV-2), comprising a nucleic acid construct encoding a SARS-COV-2 … |
INSTITUT PASTEUR | 2024-03-25 | 2024-12-24 | |
| 132 | Method for Obtaining SARS-CoV-2 Aerosol Variants for Oral Vaccines Inducing Gut-based Immunity Against COVID-19 Summary Related Patents View Save Abstract: A method involving collecting viral particles from exhaled breath for developing oral vaccines against diseases like COVID-19. Infected individuals exhale breath into sterile … |
STEVEN MARK HAYDEN | 2024-03-25 | 2025-09-25 | |
| 133 | HIGH-THROUGHPUT SCREENING OF SARS-COV-2 VARIANTS Summary Related Patents View Save Abstract: Provided herein are compositions and methods to identify mutations in one or more SARS-CoV-2 structural proteins that affect infectivity. … |
J. DAVID GLADSONE INSTITUTES A TESTAMENTARY TRUST ESABLISHED UNDER THE WILL OF J. DAVID GLADSTO | 2024-03-25 | 2024-09-26 | |
| 134 | Small Molecule Targeting of BRD4 for Treatment of COVID-19 Summary Related Patents View Save Abstract: Embodiments are directed to molecules for the treatment of Coronavirus infection, including SARS-COV-2 infection. In certain aspects the small molecule is administered via … |
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2024-03-22 | 2024-10-03 | |
| 135 | SYSTEMS AND METHODS FOR AUTOMATICALLY CONSTRUCTING KNOWLEDGE GRAPHS Summary Related Patents View Save Abstract: Described herein are systems and methods providing online, interactive, trustworthy knowledge graphs for a specific topic (e.g., COVID-19) and search engines using such knowledge … |
FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION | 2024-03-21 | 2024-09-26 | |
| 136 | REVERSE GENETICS-BASED COMPOSITIONS OF ATTENUATED RECOMBINANT SARS-COV-2 Summary Related Patents View Save Abstract: Provided here are compositions for a bacterial artificial chromosome-based construct containing a replication-competent recombinant severe acute respiratory syndrome coronavirus-2 … |
TEXAS BIOMEDICAL RESEARCH INSTITUTE | 2024-03-21 | 2024-09-19 | |
| 137 | SARS-CoV-2 RNA vaccine compositions and methods of use Summary Related Patents View Save Abstract: The disclosure provides compositions, methods of treatment, and methods of making and using compositions to deliver a nucleic acid to a subject. Methods of using the compositions … |
HDT BIO | 2024-03-21 | 2025-03-25 | |
| 138 | ORAL VACCINE VIA DENTAL BACTERIA AND EMITTED PEPTIDES TO PREVENT COVID-19 INFECTION Summary Related Patents View Save Abstract: Disclosed is a pharmaceutical composition to prevent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pharmaceutical composition comprising: … |
DAVID KOTLYAR | 2024-03-18 | 2024-07-11 | |
| 139 | Compositions that Block Activation of the Sars-CoV-2 Replication and Transcription Complex (RTC) and Methods of Use Thereof Summary Related Patents View Save Abstract: The invention provides nanobodies that bind with high affinity to SARS-CoV-2 non-structural protein (Nsp), as well and compositions comprising the identified nanobodies and … |
NEW YORK UNIVERSITY IN ABU DHABI et. al. | 2024-03-15 | 2024-09-12 | |
| 140 | METHODS OF DIAGNOSING, PROGNOSING, AND TREATING MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN (MIS-C) AND SEVERE COVID-19, AND APPARATUSES THEREOF Summary Related Patents View Save Abstract: Embodiments disclosed here are directed to novel methods for diagnosing MIS-C or severe acute COVID-19, by detecting a biomarker in a blood sample from a subject suspected of or … |
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 2024-03-15 | 2024-10-17 | |
| 141 | NUCLEASE-DENDRIMER FORMULATIONS FOR COVID-19 AND BROAD-SPECTRUM ANTIVIRAL THERAPY AND PROPHYLAXIS Summary Related Patents View Save Abstract: Compositions of nucleases in formulations with dendrimers are used in pharmaceutically effective dosages as therapeutics for covid-19 and a broad spectrum of viruses in various … |
FULU LABS | 2024-03-13 | 2025-01-09 | |
| 142 | Treatment of COVID-19 and Associated Pathologies Summary Related Patents View Save Abstract: Unique compositions of matter and formulations useful for treatment of COVID-19. Said formulation function by induction of immune modulation, cellular protection, suppression of … |
CHONGCHA CULTURE & TECHNOLOGY | 2024-03-13 | 2024-09-19 | |
| 143 | VACCINES FOR CORONAVIRUS PREVENTION AND TREATMENT Summary Related Patents View Save Abstract: The disclosure provides messenger ribonucleic acids (mRNAs) encoding an antigenic protein capable of eliciting an immune response to a coronavirus. The disclosure also provides … |
AUSPERBIO THERAPEUTICS | 2024-03-12 | 2024-09-12 | |
| 144 | BROAD-SPECTRUM MULTI-ANTIGEN PAN-CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: Waning immunity induced by first-generation Spike-alone-based COVID-19 has failed to prevent immune escape by many variants of concern (VOCs) that emerged from 2020 to 2024, … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-03-11 | 2024-08-15 | |
| 145 | TREATING SAR-COV-2 RELATED HEALTH PROBLEMS Summary Related Patents View Save Abstract: A method of treating Sar-cov-2 re-infection in a subject, a method of reducing side effects in a subject suffering from side effects of Covid-19 vaccination, a method of reducing … |
ALLEN QIAN | 2024-03-08 | 2024-06-27 | |
| 146 | SYSTEMS AND PROCESSES TO SCREEN FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) OF 2019 (COVID-19) Summary Related Patents View Save Abstract: The present disclosure provides systems and processes to screen for SARS-CoV-2. This disclosure teaches specific (and different) workable ranges for starting materials in a … |
BATTELLE MEMORIAL INSTITUTE | 2024-03-06 | 2025-09-11 | |
| 147 | SARS-CoV-2 TEST KIT FOR RT-qPCR ASSAYS Summary Related Patents View Save Abstract: The present invention provides synthetic nucleic acid sequences comprising 10-30 nucleotides of the N1 and N2 gene regions and/or the 3′ non-coding region of the SARS-associated … |
QING SUN et. al. | 2024-03-06 | 2024-11-07 | |
| 148 | THERAPEUTICS DIRECTED AGAINST CORONAVIRUS Summary Related Patents View Save Abstract: This invention provides compositions and methods to treat, prevent, and diagnose viral infections. The methods provided herein involve administering polypeptides of the invention … |
SINGH BIOTECHNOLOGY | 2024-03-05 | 2024-07-18 | |
| 149 | ANTI-SARS-COV-2 ANTIBODY COMPOSITIONS AND USES THEREOF Summary Related Patents View Save Abstract: Provided herein are, inter alia, antibodies (e.g. human antibodies, humanized antibodies, chimeric antibodies, monoclonal antibodies, antibody fragments (e.g., scFvs)) and … |
MABLOC | 2024-03-05 | 2024-10-03 | |
| 150 | IMMUNOGENIC COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST VARIANTS OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) Summary Related Patents View Save Abstract: The present invention relates to immunogenic compositions and methods for immunization against variants of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), especially … |
MEDIGEN VACCINE BIOLOGICS et. al. | 2024-03-01 | 2024-06-20 | |
| 151 | THERAPEUTIC COMPOSITION FOR USE IN THE TREATMENT OF COVID-19 AND OTHER CYTOKINE STORM ASSOCIATED DISORDERS Summary Related Patents View Save Abstract: It is disclosed a therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders, wherein the therapeutic composition comprises at … |
KELSIUS LABORATORIES | 2024-02-28 | 2024-10-10 | |
| 152 | MULTIVALENT ANTI-SPIKE PROTEIN BINDING MOLECULES AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure provides multivalent anti-spike protein binding molecules. The present disclosure further relates to the methods of producing the multivalent anti-spike … |
REGENERON PHARMACEUTICALS | 2024-02-27 | 2024-08-29 | |
| 153 | ACE2-IgM-Fc FUSION PROTEINS AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure provides ACE2 fusion proteins, comprising multimerization moieties linked to ACE2 moieties, that specifically bind to RBD regions of SARS-COV and/or … |
REGENERON PHARMACEUTICALS | 2024-02-27 | 2024-09-19 | |
| 154 | MULTIVALENT ANTI-SPIKE PROTEIN BINDING MOLECULES AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure provides multivalent anti-spike protein binding molecules, comprising multimerization moieties linked to anti-spike protein antigen-binding domains, that … |
REGENERON PHARMACEUTICALS | 2024-02-27 | 2024-09-19 | |
| 155 | Multicistronic Vaccine and Methods for Producing and Using the Same Summary Related Patents View Save Abstract: The present disclosure provides multicistronic vaccines and method for producing and using the same in preventing infection or transmission, or reducing severity of disease caused … |
OCUGEN | 2024-02-23 | 2025-02-13 | |
| 156 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE Summary Related Patents View Save Abstract: Provided herein are compositions and methods for treating and preventing lung disease. In particular, provided herein are SP-A peptides and uses thereof in the treatment and … |
ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA et. al. | 2024-02-23 | 2024-08-15 | |
| 157 | PROTEIN-DERIVED PEPTIDE FOR IMPROVING IMMUNITY AGAINST 2019 NOVEL CORONAVIRUS (2019-nCoV) AND USE THEREOF Summary Related Patents View Save Abstract: In some embodiments, the disclosure provides a hazelnut-derived peptide with an inhibitory activity against a 2019 novel coronavirus main protease (2019-nCoV M-pro), including an … |
ZHEJIANG A&F UNIVERSITY | 2024-02-21 | 2024-08-22 | |
| 158 | METHOD FOR THE PROPHYLAXIS OR TREATMENT OF CORONAVIRUS INFECTION USING AN IMMUNOMODULATOR AND VACCINE COMPOSITIONS COMPRISING THE SAME Summary Related Patents View Save Abstract: The present disclosure provides a method for the treatment or prophylaxis of coronavirus infection, comprising administering a therapeutically effective amount of an … |
ADVAGENE BIOPHARMA | 2024-02-21 | 2024-06-13 | |
| 159 | METHODS OF USING PROBENECID FOR TREATMENT OF CORONAVIRUS INFECTIONS Summary Related Patents View Save Abstract: Compositions and methods of treating a subject for a coronavirus infection are provided. The methods typically include administering the subject an effective amount of probenecid, … |
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION | 2024-02-16 | 2024-08-29 | |
| 160 | Systems and processes to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of 2019 (COVID-19) Summary Related Patents View Save Abstract: Alternative antibodies to screen for SARS-CoV-2 are disclosed. One alternative antibody is Mouse Species Coronavirus (COVID-19, MERS, and SARS-CoV NP) Antibody, Catalog Number … |
BATTELLE MEMORIAL INSTITUTE | 2024-02-14 | 2025-09-23 | |
| 161 | Compositions and methods of mRNA vaccines against novel coronavirus infection Summary Related Patents View Save Abstract: Provided herein is a ribonucleic acid (RNA) encoding a spike (S) protein or an immunogenic fragment thereof of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … |
RNAIMMUNE | 2024-02-09 | 2025-04-22 | |
| 162 | MODIFIED PIV5 VACCINE VECTORS: METHODS OF MAKING AND USES Summary Related Patents View Save Abstract: A CVB viral expression vector comprising a PIV5 W3A viral genome that contains mutations at amino acid residue S157 or S156 in the P/V gene and a deletion of the small hydrophobic … |
CYANVAC | 2024-02-05 | 2024-08-29 | |
| 163 | RESPIRATORY BIOMARKER PANEL Summary Related Patents View Save Abstract: The present disclosure provides a set of primers and optional probes for identifying the presence of α-coronavirus, β-coronavirus, SARS-COV- , adenovirus, , Influenza A, … |
CEPHEID | 2024-01-29 | 2024-12-05 | |
| 164 | CIRCULATING LEVELS OF ENDOTHELIAL MICRORNA PREDICT NEW-ONSET DIABETES IN COVID-19 AND LONG COVID Summary Related Patents View Save Abstract: Provided herein are compositions and methods for identifying COVID-19 subjects at risk for developing diabetes. … |
ALBERT EINSTEIN COLLEGE OF MEDICINE | 2024-01-26 | 2024-08-29 | |
| 165 | Broadly SARS-CoV-2 neutralizing monoclonal antibodies and uses thereof Summary Related Patents View Save Abstract: The invention relates to antibodies against Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2), in particular human neutralizing monoclonal antibodies against … |
INSTITUT PASTEUR; SPIKIMM | 2024-01-19 | 2025-04-22 | |
| 166 | VACCINE Summary Related Patents View Save Abstract: The present disclosure relates to methods of inducing a pan-sarbecoronavirus variant immune response for the treatment and prevention of coronavirus infections. … |
ASTRAZENECA | 2024-01-19 | 2024-08-22 | |
| 167 | METHOD OF DETECTING SARS-COV IN A SAMPLE Summary Related Patents View Save Abstract: A method of detecting SARS-CoV-2 includes contacting a sample with a primer set and reverse transcription loop-mediated isothermal amplification (RT-LAMP) reagents, which includes … |
IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY | 2024-01-18 | 2025-07-24 | |
| 168 | PROXIMITY INTELLIGENCE™: THE CONVERGENCE OF ARTIFICIAL INTELLIGENCE, MINDSET AND LOCATION SERVICES Summary Related Patents View Save Abstract: To prevent the spread of Covid-19 and other contagious diseases, a touchless handshake is able to be implemented using mobile devices. The touchless handshake is able to be … |
AIRWAVE WORLD | 2024-01-12 | 2024-05-16 | |
| 169 | Host cell including expression vector for encoding catalysis deactivated angiotensin-converting enzyme 2 (ACE2) variants Summary Related Patents View Save Abstract: Angiotensin-converting enzyme 2(ACE2) has been confirmed as a specific receptor for several β group coronaviruses include severe respiratory syndrome (SARS) coronavirus … |
AVIRMAX | 2024-01-05 | 2025-10-14 | |
| 170 | RECOMBINANT VIRAL CLASS I FUSION PROTEINS AND USES THEREOF Summary Related Patents View Save Abstract: Recombinant viral class I fusion proteins that favor a prefusion conformational state over a postfusion conformational state, polynucleotides encoding same, vaccines comprising … |
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION | 2024-01-04 | 2024-07-11 | |
| 171 | Antibody specific to spike protein of SARS-CoV-2 and uses thereof Citation: 3 Summary Related Patents View Save Abstract: The present disclosure relates to an antibody or antigen-binding fragment thereof that specifically binds to a spike protein of SARS-CoV-2. The present disclosure also relates to … |
ACADEMIA SINICA | 2024-01-03 | 2024-12-03 | |
| 172 | Photon enhanced bone growth system and method Summary Related Patents View Save Abstract: The present disclosure relates generally to a therapeutic system and method to manage and modulate inflammation by reducing inflammation with enhanced anti-inflammatory measures. … |
HELEN FENG et. al. | 2023-12-29 | 2025-02-04 | |
| 173 | Vaccine Compositions For Preventing Coronavirus Disease Summary Related Patents View Save Abstract: The present disclosure provides Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) vaccines, recombinant vesicular stomatitis virus (VSV) vectors encoding the SARS-CoV-2 … |
INTERNATIONAL AIDS VACCINE INITIATIVE et. al. | 2023-12-26 | 2024-11-14 | |
| 174 | Combination therapy of omega-3, black cumin, manuka honey, Anise, Vitamin-D, Nutmeg in treating COVID-19 Summary Related Patents View Save Abstract: The present invention relates to treating SARS-CoV-2 infection by concurrent administration of different treatment supplementation through anti-inflammatory, antioxidant, … |
MOHAMED MEDHAT ABDELWAHAB GAMALELDIN | 2023-12-24 | 2025-04-24 | |
| 175 | ACE2 FUSION PROTEINS AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure provides ACE2 fusion proteins, comprising multimerization moieties linked to ACE2 moieties, that specifically bind to RBD regions of SARS-CoV and/or … |
REGENERON PHARMACEUTICALS | 2023-12-22 | 2024-08-01 | |
| 176 | SYSTEMS AND METHODS FOR TREATING PATIENTS WITH DISEASES ASSOCIATED WITH VIRUSES Summary Related Patents View Save Abstract: Systems and methods are provided for treating an inflammatory or allergic response associated with a replicating pathogen, such as a virus in the coronaviridae family. The methods … |
ELECTROCORE | 2023-12-21 | 2024-05-23 | |
| 177 | ANTIBODIES FOR SARS-COV-2 AND USES THEREOF Summary Related Patents View Save Abstract: The disclosure relates generally to the field of immune binding proteins and method for obtaining immune binding proteins from genomic or other sources. The disclosure also … |
AUGMENTA BIOWORKS | 2023-12-20 | 2024-06-13 | |
| 178 | ANTIBODIES BINDING TO SARS-COV-2 VIRUS AND USES THEREOF Summary Related Patents View Save Abstract: The embodiments of the present disclosure provide an antibody or antigen-binding fragment against SARS-CoV-2 spike(S) protein, comprising: three complementarity determining … |
ASSURE TECH. | 2023-12-20 | 2024-04-18 | |
| 179 | NUCLEOCAPSID-SPECIFIC ANTIBODIES AND METHODS FOR THE TREATMENT AND PREVENTION OF SARS-COV-2 INFECTION THEREWITH Summary Related Patents View Save Abstract: Provided herein are compositions and methods for the treatment and/or prevention of SARS-COV-2 infection, and symptoms and conditions associated therewith (e.g., COVID-19). In … |
NORTHWESTERN UNIVERSITY | 2023-12-05 | 2024-07-04 | |
| 180 | NUCLEIC ACID VACCINES FOR CORONAVIRUS Summary Related Patents View Save Abstract: Provided herein are therapeutic nucleic acid molecules for managing, preventing and/or treating infectious diseases caused by coronavirus. Also provided herein are therapeutic … |
SUZHOU ABOGEN BIOSCIENCES | 2023-12-01 | 2024-04-25 | |
| 181 | CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against … |
BIONTECH | 2023-12-01 | 2024-11-07 | |
| 182 | Coronavirus vaccine formulations Summary Related Patents View Save Abstract: Disclosed herein are coronavirus Spike (S) proteins and nanoparticles comprising the same, which are suitable for use in vaccines. The nanoparticles present antigens from … |
NOVAVAX | 2023-12-01 | 2025-12-09 | |
| 183 | Method and Device for Inactivating New Coronavirus Summary Related Patents View Save Abstract: Provided are a new coronavirus inactivation method and a new coronavirus inactivation device that are capable of quick inactivation, are safe, and are practical. The new … |
YOKOTA TRADING | 2023-11-30 | 2024-05-30 | |
| 184 | SARS-COV-2 ANTIBODIES AND METHODS OF SELECTING AND USING THE SAME Summary Related Patents View Save Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to the spike protein of SARS-CoV-2 and methods of making and selecting the … |
ASTRAZENECA UK | 2023-11-30 | 2024-06-06 | |
| 185 | IMPEDANCE-BASED NEUTRALIZING ANTIBODY DETECTION BIOSENSOR WITH APPLICATION TO SARS-CoV-2 INFECTION Summary Related Patents View Save Abstract: A neutralizing antibody detection system comprising a plurality of electrodes, wherein neutralizing antibody antigens are bound to a respective surface of each electrode, and … |
SOUTHERN METHODIST UNIVERSITY | 2023-11-29 | 2024-06-06 | |
| 186 | METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: A method of treatment for coronavirus disease 2019 (COVID-19) is disclosed herein. The method comprises administering a therapeutically effective dose of a combination of … |
ESRAIL MEDICAL | 2023-11-28 | 2024-03-21 | |
| 187 | ANTIVIRAL THERAPEUTIC COMPOUNDS AND COMPOSITIONS FOR USE IN TREATMENT OF CORONAVIRUS AND INFLUENZA VIRUS Summary Related Patents View Save Abstract: Antiviral therapeutic compounds and compositions that may be used in methods of preventing and/or treating infection(s) caused by coronaviruses or influenza viruses. … |
VIREO SYSTEMS | 2023-11-27 | 2024-05-23 | |
| 188 | Antiviral application of nucleoside analog or combination formulation containing nucleoside analog Summary Related Patents View Save Abstract: The present invention relates to an antiviral application of nucleoside analogs. Specifically, the present invention relates to uses of nucleoside analogs and a pharmaceutical … |
SHANGHAI INSTITUTE OF MATERIA MEDICA CHINES ACADEMY OF SCIENCES; WUHAN INSTITUTE OF VIROLOGY CHINESE ACADEMY OF SCIENCE; XINJIANG TECHNICAL INSTITUTE OF PHYSICS AND CHIMESTRY CHINESE ACADEMY OF SCIENCES; VIGONVITA LIFE SCIENCES | 2023-11-27 | 2025-07-08 | |
| 189 | METHOD FOR PREPARING AND CERTIFYING NOVEL CORONAVIRUS NUCLEOCAPSID PROTEIN Summary Related Patents View Save Abstract: Disclosed in the present invention is a method for preparing and certifying a novel coronavirus nucleocapsid protein (nCOV N protein) reference material, the method including: … |
NATIONAL INSTITUTE OF METROLOGY CHINA | 2023-11-24 | 2024-06-20 | |
| 190 | SECRETORY IGA ANTIBODIES AGAINST COVID INFECTION Summary Related Patents View Save Abstract: The present disclosure provides an immunoglobulin A neutralizing SARS-CoV-2 Omicron variant, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the … |
QIANG HAMMARSTRÖM PAN et. al. | 2023-11-22 | 2024-06-27 | |
| 191 | ALPHA-1-ANTITRYPSIN PHENOTYPE C DETECTION AND TREATMENT OF INFLAMMATION AND INFLAMMATORY CONDITIONS ASSOCIATED WITH SAID PHENOTYPE Summary Related Patents View Save Abstract: A method of treating a patient infected with SARS-COV-2 virus includes phenotyping a sample obtained from the patient; and administering alpha-1-antitrypsin to the patient only if … |
KEVIN F. LAW | 2023-11-22 | 2024-05-30 | |
| 192 | COMPOSITIONS AND METHODS FOR MUCOSAL VACCINATION AGAINST SARS-COV-2 Summary Related Patents View Save Abstract: Disclosed are peptides comprising a monomeric Fc fragment of an immunoglobulin recognized by a FcRn; SARS-CoV-2 antigen; and a trimerization domain. Disclosed are peptide … |
UNIVERSITY OF MARYLAND COLLEGE PARK | 2023-11-22 | 2024-07-11 | |
| 193 | Deuterium-Enriched Nirmatrelvir as SARS-CoV-2 Mpro Inhibitor for the Treatment of COVID-19 Summary Related Patents View Save Abstract: The present invention is concerned with novel deuterium-enriched compounds of the general chemical structural formula I., and pharmaceutically acceptable salts, compositions, and … |
DALJIT SINGH DHANOA | 2023-11-21 | 2025-05-22 | |
| 194 | MERS CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: The present invention relates to mRNAs suitable for use as mRNA-based vaccines against infections with MERS coronaviruses. Additionally, the present invention relates to a … |
CUREVAC | 2023-11-20 | 2024-03-21 | |
| 195 | Method for inducing cellular immunity to infection by SARS-CoV-2 Summary Related Patents View Save Abstract: A pDNA-based vaccine against SARS-COV-2 and methods for preventing or treating COVID-19 using it. … |
IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY | 2023-11-20 | 2025-12-02 | |
| 196 | USE OF AMINOPYRIDINE, IN PARTICULAR AMIFAMPRIDINE, FOR THE TREATMENT OF A VIRALLY-ASSOCIATED FATIGUE Summary Related Patents View Save Abstract: The present invention relates to a new use of an Aminopyridine, such as Pyridine-3,4-diamine, a derivative thereof and/or of a physiologically tolerable salt thereof for the … |
THOMAS BOEHMEKE | 2023-11-15 | 2025-05-15 | |
| 197 | 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS Summary Related Patents View Save Abstract: The present disclosure is concerned with 6-aza-nucleoside prodrugs that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, … |
SOUTHERN RESEARCH INSTITUTE et. al. | 2023-11-15 | 2024-04-11 | |
| 198 | METHOD FOR DETECTING ANTI-SARS-COV-2 ANTIBODY, CHIMERIC PROTEIN, POLYNUCLEOTIDE, EXPRESSION VECTOR, HOST CELL, METHOD FOR PRODUCING CHIMERIC PROTEIN, AND REAGENT Summary Related Patents View Save Abstract: Disclosed is a method for detecting an anti-SARS-CoV-2 antibody, the method comprising: detecting an antibody against a chimeric protein comprising an amino acid sequence of a … |
SYSMEX | 2023-11-14 | 2024-08-01 | |
| 199 | COMPOSITION AND METHOD FOR TREATING COVID-19 Summary Related Patents View Save Abstract: A nanosystem and methods of treating, including prophylactically, coronavirus infections, such as those caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), by … |
UNIVERSITY OF SOUTH FLORIDA | 2023-11-14 | 2024-03-28 | |
| 200 | Benzimidazoles and methods of using same Citation: 1 Summary Related Patents View Save Abstract: The present disclosure is concerned with benzimidazole compounds and methods of using these compounds for the treatment of hepatitis (e.g., hepatitis C), RNA virus infections … |
UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2023-11-10 | 2025-02-18 | |
| 201 | Compositions And Methods for Treating Acute Respiratory Distress Syndrome (ARDS) And Inflammatory Disorders Caused by Corona Viruses and Other Respiratory Pathogens or Agents That Mediate Pulmonary Injury, Inflammation or Acute Respiratory Distress, And Related Compositions and Methods for Treating and Preventing Human SARS Coronavirus Infection, COVID-19 Disease and Related Symptoms Summary Related Patents View Save Abstract: Methods and compositions containing a phorbol ester or derivative of a phorbol ester are provided for prevention and treatment of sudden acute respiratory syndrome (SARS) … |
RICHARD L. CHANG et. al. | 2023-11-10 | 2024-03-14 | |
| 202 | Formulation, use and method for broad-spectrum prophylaxis and treatment of viral infections caused by SARS-CoV-2 and other emergent viruses Summary Related Patents View Save Abstract: EGCG-Zn molecular complexes exhibit a significantly higher affinity than the EGCG molecule alone or Zn alone for binding to different SARS-CoV-2 molecular targets and show … |
MELISA INSTITUTE GENOMICS & PROTEOMICS RESEARCH | 2023-11-10 | 2024-12-24 | |
| 203 | RNA POLYMERASE ASSAY Summary Related Patents View Save Abstract: Provided herein is a method for determining the activity of an RNA polymerase, in particular, an RNA-dependent RNA polymerase (RDRP) of a coronavirus. Also provided herein is a … |
QIYI XIE et. al. | 2023-11-10 | 2024-08-29 | |
| 204 | Compounds for the treatment of SARS Citation: 1 Summary Related Patents View Save Abstract: Inhibitors of SARS-CoV-2 (COVID), pharmaceutical compositions comprising same; and methods of treating a severe acute respiratory syndrome. … |
PURDUE RESEARCH FOUNDATION | 2023-11-08 | 2025-11-11 | |
| 205 | NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES, CHIMERIC IMMUNOGENS, AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: This disclosure provides novel potent neutralizing antibodies directed against SARS-CoV-2 Omicron and other variants, related nucleic acids, related cells, related kits, related … |
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 2023-11-08 | 2024-05-16 | |
| 206 | Stabilized coronavirus spike (s) protein immunogens and related vaccines Summary Related Patents View Save Abstract: The present invention provides redesigned soluble coronavirus S protein derived immunogens that are stabilized via specific modifications in the wildtype soluble S sequences. Also … |
SCRIPPS RESEARCH INSTITUTE | 2023-11-07 | 2025-10-21 | |
| 207 | PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES Citation: 1 Summary Related Patents View Save Abstract: Peptides and methods of use thereof, are disclosed for use in treating disorders caused by the novel coronavirus SARS-COV-2 or resulting from COVID-19 disease, such as systemic … |
RAJENDRA SAHAI BHATNAGAR | 2023-11-03 | 2024-06-06 | |
| 208 | METHODS AND SYSTEMS FOR RAPID DETECTION OF ANALYTES Summary Related Patents View Save Abstract: The present disclosure provides for surface-enhanced Raman spectroscopy (SERS) systems and methods for detecting, analyzing, and/or quantifying biomolecules or biological agents … |
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION | 2023-11-02 | 2025-03-20 | |
| 209 | MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND VARIANTS Summary Related Patents View Save Abstract: The present invention provides monoclonal antibodies against SARS-CoV-2 and methods of use and making thereof. … |
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2023-11-02 | 2024-05-09 | |
| 210 | Composition and methods for MRNA vaccines against novel omicron coronavirus infections Citation: 1 Summary Related Patents View Save Abstract: Provided herein is a ribonucleic acid (RNA) encoding a spike (S) protein or an immunogenic fragment thereof of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … |
RNAIMMUNE | 2023-10-31 | 2025-04-22 | |
| 211 | COMPOSITION AND METHOD FOR TREATING COVID-19 Summary Related Patents View Save Abstract: A multi-functional broad-spectrum antiviral and anti-inflammatory nanosystem and methods of treating, including prophylactically, coronavirus infections, such as those caused by … |
UNIVERSITY OF SOUTH FLORIDA | 2023-10-27 | 2024-02-29 | |
| 212 | Nucleic acid base vaccine against emerging SARS-CoV-2 variants Summary Related Patents View Save Abstract: The present invention is directed to nucleic acids suitable for use in treatment or prophylaxis of an infection with a coronavirus, such as a Coronavirus SARS-CoV-2 variant, or a … |
GLAXOSMITHKLINE BIOLOGICALS | 2023-10-26 | 2025-01-07 | |
| 213 | ANTIBODY BINDING SPECIFICALLY TO SARS-COV-2 S PROTEIN OR ANTIGEN-BINDING FRAGMENT THEREOF, BISPECIFIC ANTIBODY, AND USES THEREOF Summary Related Patents View Save Abstract: The present invention relates to an anti-SARS-CoV-2 S protein-specific antibody or an antigen-binding fragment thereof, and therapeutic and diagnostic uses thereof. The … |
KOOKMIN UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION | 2023-10-25 | 2024-02-08 | |
| 214 | ANTIBODY COCKTAIL AGAINST SARS-COV-2 SPIKE PROTEIN Summary Related Patents View Save Abstract: Provided herein are antibodies that are useful for treating SARS-CoV-2 infections in a subject. Also provided herein are compositions comprising one or more antibodies, methods of … |
IMMUNOME | 2023-10-24 | 2024-02-29 | |
| 215 | Compounds for the treatment of SARS Citation: 1 Summary Related Patents View Save Abstract: Inhibitors of SARS-COV-2 (COVID), pharmaceutical compositions comprising same; and methods of treating a severe acute respiratory syndrome. … |
PURDUE RESEARCH FOUNDATION | 2023-10-23 | 2025-11-11 | |
| 216 | ASSAY FOR DETECTION OF SARS-COV-2 Summary Related Patents View Save Abstract: A method of detecting SARS-CoV includes amplifying isothermally a target sequence in a sample with at least one set of oligonucleotide primers and assaying the sample with a SARS … |
IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY | 2023-10-18 | 2025-04-24 | |
| 217 | COMPOSITIONS AND METHODS FOR TREATING SARS-COV-2 INFECTION Summary Related Patents View Save Abstract: The present disclosure provides small hairpin nucleic acid molecules capable of stimulating interferon production. The nucleic acid molecules of the present disclosure has a … |
YALE UNIVERSITY | 2023-10-17 | 2024-04-11 | |
| 218 | SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens Summary Related Patents View Save Abstract: Disclosed herein are methods for inducing immunity against a virus such as a coronavirus in the mucosal tissue of a patient, include administering a vaccine composition to the … |
IMMUNITYBIO | 2023-10-17 | 2025-05-06 | |
| 219 | SYSTEM TO CONNECT FACE MASKS TO HEPA FILTRATION IN AIRCRAFT TO PREVENT SPREAD OF RESPIRATORY VIRUSES Summary Related Patents View Save Abstract: Aspects of the invention relate to personal protection systems against influenza or COVID-19 virus and include face masks and methods, systems or devices of managing, regulating … |
NOAH LANG | 2023-10-14 | 2024-02-08 | |
| 220 | METHODS AND COMPOSITIONS FOR TREATING LONG COVID-19 Summary Related Patents View Save Abstract: The invention provides methods of treating long COVID in a patient in need thereof, comprising administering to said patient a composition comprising a therapeutically effective … |
INTRINSIC MEDICINE | 2023-10-13 | 2024-09-12 | |
| 221 | FORMULATION FOR THE PREVENTION AND/OR TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: A novel formulation for the prevention and treatment of COVID-19 is disclosed, featuring the antiviral properties of xylitol and bee propolis. These natural compounds were tested … |
SERVIDENCE | 2023-10-06 | 2024-04-11 | |
| 222 | MERS-CoV Vaccine Summary Related Patents View Save Abstract: Disclosed herein is a vaccine comprising a Middle East Respiratory Syndrome coronavirus (MERS-CoV) antigen. The antigen can be a consensus antigen. The consensus antigen can be a … |
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA et. al. | 2023-09-28 | 2024-04-18 | |
| 223 | COMPOSITIONS FOR CORONAVIRUS DETECTION AND METHODS OF MAKING AND USING THEROF Summary Related Patents View Save Abstract: Sequences for detection of SARS-CoV-2 are provided and include example, SEQ ID NOs:4-8. The sequences are useful for amplifying the SARS-CoV-2 nsp8 gene in a sample, using Reverse … |
VERSITECH et. al. | 2023-09-25 | 2024-04-18 | |
| 224 | Fusion peptide inhibitors of human coronavirus 229E Summary Related Patents View Save Abstract: Fusion peptide inhibitors of human coronavirus 229E are provided. The fusion peptide inhibitors of HCOV-229E include peptide #121 The fusion peptide inhibitors of HCoV-229E may be … |
KING FAISAL UNIVERSITY | 2023-09-25 | 2024-09-10 | |
| 225 | Benzaldehyde Extracted From Pit or Seeds of Rosales as a Foodstuff Preservative, Animal Feed Additive, as a Treatment for Preventing Infectious Diseases and as a Drug and Supportive Care for Treating the COVID-19 Virus Summary Related Patents View Save Abstract: Benzaldehyde (C H CHO), for example in a form extracted from a pit or seed of a plant of the Rosales order, in a solution of water wherein the benzaldehyde comprises at least … |
2B-SHVAT | 2023-09-24 | 2024-01-11 | |
| 226 | ELECTRO-PNEUMATIC INTELLIGENT SYRINGE Summary Related Patents View Save Abstract: An electro-pneumatic intelligent syringe includes an injection assembly including a fixing component and a moving component, and a pneumatic assembly including an airway component … |
HUZHOU UNIVERSITY | 2023-09-22 | 2024-09-12 | |
| 227 | AIR FILTER WITH PATHOGEN MONITORING AND INACTIVATION Summary Related Patents View Save Abstract: An improved technology for inactivation of viruses, for example the SARS-CoV-2 virus that is causing the Covid-19 pandemic, is described. The technology can include a device that … |
INDUSTRIAL POLYMERS AND CHEMICALS | 2023-09-18 | 2024-01-04 | |
| 228 | HIGHLY ACTIVE COMPOUNDS AGAINST COVID-19 Citation: 1 Summary Related Patents View Save Abstract: The present invention is the use of purine nucleotide phosphoramidates or pharmaceutically acceptable salts thereof administered in an effective amount for the treatment or … |
ATEA PHARMACEUTICALS | 2023-09-15 | 2024-08-08 | |
| 229 | COMBINATION THERAPY FOR TREATING COVID-19 Summary Related Patents View Save Abstract: The present disclosure provides methods of treating coronavirus-associated diseases in an individual comprising administering to the individual an effective amount of peramivir, … |
DRUGARRAY | 2023-09-14 | 2024-02-08 | |
| 230 | Nucleic acid vaccine against the SARS-CoV-2 coronavirus Citation: 2 Summary Related Patents View Save Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 … |
INSTITUT PASTEUR | 2023-09-12 | 2024-04-23 | |
| 231 | Nucleic acid vaccine against the SARS-CoV-2 coronavirus Citation: 2 Summary Related Patents View Save Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 … |
INSTITUT PASTEUR | 2023-09-12 | 2024-04-30 | |
| 232 | COMPOUNDS AND THEIR USE AS VACCINE ADJUVANTS Summary Related Patents View Save Abstract: Provided herein are a series of compounds and their use as an adjuvant. Provided herein are the compounds, a composition comprising the compounds, and the use thereof. These … |
FULGENT GENETICS et. al. | 2023-09-12 | 2024-01-04 | |
| 233 | THERAPEUTIC AGENTS FOR TREATMENT OF CORONAVIRUS INFECTION Summary Related Patents View Save Abstract: A therapeutic method for treatment of coronavirus infections. The therapeutic method includes using a composition containing a gold compound effective for Rheumatoid Arthritis … |
XUEYUN GAO | 2023-09-11 | 2025-03-13 | |
| 234 | Method and composition for preventing and treating Covid-19 and long Covid Summary Related Patents View Save Abstract: Coronavirus Disease 2019 (COVID-19) remains a threat with the emergence of new variants, especially Delta and Omicron, without specific effective therapeutic drugs. The present … |
GLOBAL PREVENTIVE MEDICINE BIOTECH | 2023-09-11 | 2024-11-26 | |
| 235 | SENSE INDICATOR COMPOSITION Summary Related Patents View Save Abstract: Compositions, kits, and methods for indicating a symptom of a disease. The composition may include one or more components having a taste or smell property as an indicator of a … |
CONTEMPORARY HEALTH SYSTEMS | 2023-09-08 | 2023-12-28 | |
| 236 | MODIFIED POLYNUCLEOTIDES ENCODING THE SARS-COV-2 SPIKE PROTEIN FOR SAFER DESIGNS OF CORONAVIRUS VACCINES Summary Related Patents View Save Abstract: Recombinant polynucleotides including a nucleic acid sequence encoding an engineered SARS-CoV-2 spike protein (S12) or an immunogenic fragment thereof, in which the engineered … |
UNIVERSITY OF PITTSBURGH – OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2023-09-06 | 2024-03-28 | |
| 237 | ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM CR3022 Summary Related Patents View Save Abstract: This disclosure provides antibodies and that can be administered to an individual that is infected with a virus. Antibodies herein can be capable of treating or curing the virus, … |
CENTIVAX | 2023-08-24 | 2024-08-15 | |
| 238 | NASAL SPRAY USING PENTOSAN POLYSULFATE AND MUCOPOLYSACCHARIDE POLYSULFATE FOR COVID-19 PREVENTION AND TREATMENT Summary Related Patents View Save Abstract: Prophylaxis and treatment of patients susceptible to infection by coronaviruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is achieved using compositions … |
RENSSELAER POLYTECHNIC INSTITUTE | 2023-08-24 | 2024-02-29 | |
| 239 | Vaccine booster compositions for respiratory viral diseases Citation: 1 Summary Related Patents View Save Abstract: The present application provides chimeric proteins comprising comprising a receptor binding domain (“RBD”) of a SARS-CoV-2 spike protein (“S protein”) fused to a booster enhancer … |
CENTRE FOR VIROLOGY VACCINOLOGY AND THERAPEUTICS | 2023-08-21 | 2024-10-01 | |
| 240 | Rapid Diagnostic Test for LAMP Summary Related Patents View Save Abstract: Compositions and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids … |
NEW ENGLAND BIOLABS | 2023-08-18 | 2023-12-21 | |
| 241 | VARIANT CLASSIFICATION THROUGH HIGH-CONFIDENCE MUTATION DETECTION FROM FLUORESCENCE SIGNALS MEASURED WITH A MULTIPLE MUTATION ASSAY Summary Related Patents View Save Abstract: A system and method for SARS-CoV-2 variant classification through mutation detection from qPCR fluorescence signals. The system receives fluorescence signals, wherein a first … |
BIO-RAD LABORATORIES | 2023-08-16 | 2024-03-07 | |
| 242 | METHODS FOR DETERMINING RISK OF MORTALITY FROM COVID-19 Summary Related Patents View Save Abstract: Provided herein are biomarkers associated with mortality in COVID-19 patients. In particular, provided herein are fecal biomarkers that correlate with elevated risk of mortality … |
UNIVERSITY OF CHICAGO | 2023-08-11 | 2024-10-17 | |
| 243 | SARS-COV-2 ANTIBODIES FOR TREATMENT AND PREVENTION OF COVID-19 Citation: 1 Summary Related Patents View Save Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to the spike protein of SARS-CoV-2 and methods of using such antibodies and … |
ASTRAZENECA UK | 2023-08-09 | 2024-03-21 | |
| 244 | VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE Summary Related Patents View Save Abstract: Provided herein is a method for preventing a person from an infection by a Coronaviridae virus with a poliomyelitis vaccine. Also provided herein is a method of inducing a … |
E-MO BIOLOGY | 2023-08-08 | 2024-01-04 | |
| 245 | CORONAVIRUS MUTATION DETERMINATION DEVICE COMPRISING METAMATERIAL ARRAY AND ELECTROMAGNETIC WAVE IRRADIATION UNIT Summary Related Patents View Save Abstract: The present specification relates to a device and method capable of determining a coronavirus mutation using a highly sensitive label-free terahertz electromagnetic wave … |
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 2023-08-04 | 2024-02-08 | |
| 246 | Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19 Summary Related Patents View Save Abstract: Methods of assigning a COVID pathological type for a subject suffering from COVID-19 are provided. Aspects of the methods include assigning a COVID pathological type for the … |
INCELLDX | 2023-08-01 | 2024-01-18 | |
| 247 | Lipid delivery system and virus-like structure (VLS) vaccine constructed therefrom Summary Related Patents View Save Abstract: A lipid delivery system, a virus-like structure (VLS) vaccine constructed therefrom, and a lipid particle capable of encapsulating an mRNA molecule encoding a SARS-CoV-2-specific … |
WEIRUI BIOTECHNOLOGY; SHANDONG WEIGAO LITONG BIOLOGICAL PRODUCTS | 2023-08-01 | 2024-02-27 | |
| 248 | HIGH PHASE-PURITY GROWTH OF 1T’-TRANSITION METAL DICHALCOGENIDE MONOLAYERS Summary Related Patents View Save Abstract: A method of forming a 1T′-phase transition metal dichalcogenide monolayer. A transition metal precursor and a first solvent are mixed to form a first mixture. A non-oxygen … |
CITY UNIVERSITY OF HONG KONG | 2023-07-25 | 2024-02-08 | |
| 249 | Highly active compounds against COVID-19 Citation: 1 Summary Related Patents View Save Abstract: The present invention is the use of a small group of purine nucleotide phosphoramidate disclosed herein or a pharmaceutically acceptable salt thereof in an effective amount for … |
ATEA PHARMACEUTICALS | 2023-07-24 | 2025-02-18 | |
| 250 | THERAPEUTIC NEUTRALIZING ANTIBODIES FOR SARS-COV-2 Summary Related Patents View Save Abstract: Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein. Also provided are compositions, methods, and kits for using said … |
CALIFORNIA INSTITUTE OF TECHNOLOGY et. al. | 2023-07-21 | 2024-03-14 | |
| 251 | Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use Summary Related Patents View Save Abstract: The present disclosure provides recombinantly manufactured fusion proteins comprising a SARS-CoV-2 Receptor Binding Domain (SARS-CoV-2-RBD) fragment or an analog thereof linked to … |
VAKSTON | 2023-07-20 | 2025-07-01 | |
| 252 | MRNA FOR SARS-COV-2 S PROTEIN AND USE THEREOF Summary Related Patents View Save Abstract: The present invention relates to an RNA encoding the S protein of SARS-COV-2, a vaccine comprising the RNA, and uses thereof. The present invention also relates to a universal … |
SHENZHEN SHENXIN BIOTECHNOLOGY | 2023-07-18 | 2026-01-15 | |
| 253 | COMBINED USE OF NANOBODY, CYCLODEXTRIN AND QUERCETIN FOR PROTECTION FROM ENVELOPED VIRUSES Citation: 1 Summary Related Patents View Save Abstract: Disclosed are engineered nanobodies against different target antigens such as the spike protein of the SARS-CoV-2 virus and or to the ACE2 receptor at the host cell surface, binds … |
VIRON | 2023-07-17 | 2023-11-09 | |
| 254 | ENVELOPED VIRUS LIKE PARTICLES COMRISING SARS-COV-2 S PROTEIN Summary Related Patents View Save Abstract: Provided is an enveloped virus-like particle (eVLP) comprising a substantially full-length recombinant SARS-CoV-2 spike (S) protein. The eVLP may further comprise an additional … |
NATIONAL RESEARCH COUNCIL OF CANADA | 2023-07-17 | 2026-01-15 | |
| 255 | REAGENT FOR DETECTING SARS-RELATED CORONAVIRUS Summary Related Patents View Save Abstract: The present invention relates to a compound represented by the following general formula (1), or a salt or solvate thereof: in the formula (1), R , R , and R are as defined in the … |
NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY | 2023-07-14 | 2026-01-15 | |
| 256 | SARS-COV-2 LACKING THE ENVELOPE PROTEIN AS AN ATTENUATED VACCINE VIRUS AGAINST COVID-19 Summary Related Patents View Save Abstract: An isolated nucleic acid comprising a recombinant coronavirus genome having a genetic modification that inhibits or prevents expression of coronavirus envelope (E) protein and/or … |
WISCONSIN ALUMNI RESEARCH FOUNDATION | 2023-07-13 | 2025-12-25 | |
| 257 | Nucleic acid vaccine against the SARS-CoV-2 coronavirus Citation: 2 Summary Related Patents View Save Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 … |
INSTITUT PASTEUR | 2023-07-12 | 2024-02-27 | |
| 258 | SARS-COV-2 VACCINE BOOSTER COMPOSITION Summary Related Patents View Save Abstract: The present disclosure provides a composition for inducing or maintaining an immune response against SARS-COV-2 virus. … |
SK BIOSCIENCE | 2023-07-12 | 2026-01-15 | |
| 259 | USE OF PYRONARIDINE, TILORONE, AND QUINACRINE AGAINST MARBURG VIRUS AND OTHER VIRUS INFECTIONS Summary Related Patents View Save Abstract: Methods of treating or preventing diseases caused by viral infections via the administration of pyronaridine, quinacrine, and/or tilorone are described. The viral infections can … |
COLLABORATIONS PHARMACEUTICALS | 2023-07-10 | 2024-01-11 | |
| 260 | Covid-19 binding aerosols Citation: 1 Summary Related Patents View Save Abstract: Covid-19 binding aerosols are provided. The Covid-19 binding aerosols include Fe O microparticles, at least one organoselenium compound, at least one essential oil, and incense. … |
KING FAISAL UNIVERSITY | 2023-07-07 | 2024-04-30 | |
| 261 | CORONAVIRUS VACCINES AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: The present disclosure relates to coronavirus vaccines and methods for use thereof. … |
GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION et. al. | 2023-07-06 | 2026-01-01 | |
| 262 | Covid-19 binding aerosols Summary Related Patents View Save Abstract: Covid-19 binding aerosols are provided. The Covid-19 binding aerosols include Fe O microparticles, at least one organoselenium compound, at least one essential oil, and incense. … |
KING FAISAL UNIVERSITY | 2023-07-06 | 2023-11-14 | |
| 263 | Purified and Enhanced Hydrogen Peroxide Disinfecting Solution for the Rapid Inactivation of COVID-19 and Other Pathogens Summary Related Patents View Save Abstract: The development, formulations, and uses of a purified and enhanced hydrogen peroxide-based surface disinfectant. The disinfectant is optimized to provide for the rapid … |
ALIRA HEALTH BOSTON | 2023-07-05 | 2023-11-02 | |
| 264 | Method and system for early detection of COVID-19 Summary Related Patents View Save Abstract: The present invention relates to a method and system for early detection of COVID-19. Existing methods require data from multiple sensors for training a prediction model whose … |
TATA CONSULTANCY SERVICES | 2023-07-03 | 2025-07-08 | |
| 265 | STEM CELL COMPOSITIONS FOR CULTURING CORONAVIRUSES AND METHODS OF MAKING AND USING THEREOF Summary Related Patents View Save Abstract: Disclosed are methods for culturing coronavirus particles in early syncytiotrophoblasts (eSTBs). The derived eSTBs are mononucleated or bi-nucleated cells with high ACE2 … |
CENTRE FOR TRANSLATIONAL STEM CELL BIOLOGY | 2023-06-30 | 2023-12-07 | |
| 266 | METHODS FOR DETERMINING SARS-COV-2 ANTIGEN AND ANTI-SARS-COV-2 ANTIBODY IN A SAMPLE Summary Related Patents View Save Abstract: Disclosed herein are methods, kits, and systems for detecting at least one type of SARS-CoV-2 antigen and at least one type of anti-SARS-CoV-2 antibody in a subject, which … |
ABBOTT LABORATORIES | 2023-06-30 | 2024-02-29 | |
| 267 | Coronavirus vaccine compositions and methods Citation: 1 Summary Related Patents View Save Abstract: Provided herein are nucleic acid molecules encoding viral replication proteins and antigenic coronavirus proteins or fragments thereof. Also provided herein are compositions that … |
ARCTURUS THERAPEUTICS HOLDINGS | 2023-06-30 | 2025-02-11 | |
| 268 | Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2 Summary Related Patents View Save Abstract: The present invention includes antibodies and antigen-binding fragments thereof that specifically bind a SARS-CoV-2 antigen and are in certain embodiments capable of neutralizing … |
OKLAHOMA MEDICAL RESEARCH FOUNDATION | 2023-06-29 | 2024-07-18 | |
| 269 | Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2 Summary Related Patents View Save Abstract: The present invention includes antibodies and antigen-binding fragments thereof that specifically bind a SARS-CoV-2 antigen and are in certain embodiments capable of neutralizing … |
OKLAHOMA MEDICAL RESEARCH FOUNDATION | 2023-06-29 | 2024-01-18 | |
| 270 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Summary Related Patents View Save Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and … |
REGENERON PHARMACEUTICALS | 2023-06-29 | 2025-03-18 | |
| 271 | Treating Acute Respiratory Distress Syndrome With Alternating Electric Fields Summary Related Patents View Save Abstract: A method of treating acute respiratory distress syndrome (ARDS) in a subject by applying an alternating electric field (AEF) to a region of the subject’s torso. The ARDS may be … |
NOVOCURE | 2023-06-28 | 2024-01-04 | |
| 272 | BED HAVING FEATURES FOR AUTOMATIC SENSING OF ILLNESS STATES SUCH AS POST-ACUTE SEQUALAE OF COVID-19 (PASC OR LONG COVID) Citation: 2 Summary Related Patents View Save Abstract: A bed has a mattress. One or more sensors are configured to sense one or more physical phenomena of a sleeper on the bed and generate data signals based on the sensed physical … |
SLEEP NUMBER | 2023-06-28 | 2023-12-28 | |
| 273 | Coronavirus vaccine Citation: 3 Summary Related Patents View Save Abstract: This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against … |
BIONTECH | 2023-06-26 | 2024-01-23 | |
| 274 | CORONAVIRUSES, VACCINES COMPRISING THE SAME, AND METHODS FOR PREVENTING DISEASE Summary Related Patents View Save Abstract: Coronaviruses, vaccines comprising the same, and methods for preventing disease. One embodiment of such includes a live, attenuated coronavirus comprising a variant replicase gene … |
LOYOLA UNIVERSITY OF CHICAGO | 2023-06-26 | 2024-12-26 | |
| 275 | SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS Summary Related Patents View Save Abstract: Provided herein are compounds, pharmaceutical compositions, and methods for treating a SARS-CoV-2 infection. … |
INSILICO MEDICINE IP | 2023-06-22 | 2024-01-25 | |
| 276 | 3D PHARMACOPHORE MODEL FOR THE RAPID COMPUTATIONAL SCREENING OF SARS-COV-2 MODULATORS AND COMPOSITIONS AND METHODS THEREOF Summary Related Patents View Save Abstract: The invention encompasses compositions and compounds for inhibiting CoV2 Spike GP and human ACE2 proteins and a 3D pharmacophore model described herein provides the means for … |
FLUOROME | 2023-06-21 | 2023-11-09 | |
| 277 | METHOD FOR TREATING INFECTIONS Summary Related Patents View Save Abstract: The composition for treating infections may be used for treating a wide variety of different infection and conditions, including viral infections, such as coronavirus disease 2019 … |
ECOPLANET ENVIRONMENTAL | 2023-06-21 | 2023-10-19 | |
| 278 | SEQUENCING MICROBIAL CELL-FREE NUCLEIC ACIDS TO DETECT INFLAMMATION, SECONDARY INFECTION, AND DISEASE SEVERITY Summary Related Patents View Save Abstract: Described herein is a method of detecting secondary infection in a patient, particularly a patient with a primary infection that is a pneumonia, a COVID-19 infection, or a … |
KARIUS et. al. | 2023-06-20 | 2024-07-11 | |
| 279 | Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza Summary Related Patents View Save Abstract: Provided herein are formulations containing copper ions and methods of treating underlying infections and conditions caused by coronavirus, particularly COVID-19, and influenzas, … |
CDA RESEARCH GROUP | 2023-06-20 | 2025-06-17 | |
| 280 | SEQUENCING MICROBIAL CELL-FREE NUCLEIC ACIDS TO DETECT INFLAMMATION, SECONDARY INFECTION, AND DISEASE SEVERITY Summary Related Patents View Save Abstract: Described herein is a method of detecting secondary infection in a patient, particularly a patient with a primary infection that is a pneumonia, a COVID-19 infection, or a … |
KARIUS et. al. | 2023-06-19 | 2024-04-25 | |
| 281 | VIRAL STRAIN SEROLOGY ASSAYS Summary Related Patents View Save Abstract: The invention relates to methods and kits for determining a SARS-CoV-2 strain in a sample. The invention also provides methods and kits for detecting a single nucleotide … |
MESO SCALE TECHNOLOGIES et. al. | 2023-06-16 | 2025-11-27 | |
| 282 | METHOD FOR RAPIDLY AND ACCURATELY DETECTING SARS-CoV-2 NUCLEIC ACID Summary Related Patents View Save Abstract: Methods and a kit for detection of genetic material from SARS-CoV-2 that combines reverse transcription loop-mediated isothermal amplification (RT-LAMP) technology with specific … |
COLORADO GENOMICS | 2023-06-16 | 2024-07-11 | |
| 283 | METHOD FOR RAPIDLY AND ACCURATELY DETECTING SARS-CoV-2 NUCLEIC ACID Summary Related Patents View Save Abstract: Methods and a kit for detection of genetic material from SARS-CoV-2 that combines reverse transcription loop-mediated isothermal amplification (RT-LAMP) technology with specific … |
COLORADO GENOMICS | 2023-06-15 | 2024-04-25 | |
| 284 | Protease inhibitors as antivirals Summary Related Patents View Save Abstract: Provided herein, inter alia, are compounds, pharmaceutical compositions and methods related to the treatment of viral infections caused by coronavirus or enterovirus. Provided … |
VIVASOR | 2023-06-15 | 2024-05-21 | |
| 285 | DSG2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: The disclosure generally relates to compositions and methods of treating COVID-19 by administering compositions disclosed herein. The methods also include the treatment of … |
ARVADA THERAPEUTICS | 2023-06-13 | 2024-02-08 | |
| 286 | DEVICE AND METHOD FOR PATHOGEN DETECTION Summary Related Patents View Save Abstract: Systems and methods are disclosed herein for pathogen detection employing a lateral flow assay (LFA) device, e.g. for detecting SARS-CoV-2, the virus that causes COVID-19, in a … |
KING ABDULAZIZ UNIVERSITY | 2023-06-13 | 2024-12-19 | |
| 287 | PROTEASE INHIBITORS FOR TREATMENT OF CORONAVIRUS INFECTIONS Summary Related Patents View Save Abstract: Provided herein are compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions: wherein R , R , R , R , R , R , and A are defined in … |
SCRIPPS RESEARCH INSTITUTE | 2023-06-12 | 2024-05-09 | |
| 288 | SARS-CoV-2 VACCINES AND USES THEREOF Summary Related Patents View Save Abstract: SARS-CoV-2 vaccines are described herein. The SARS-CoV-2 vaccine antigens can be presented on a circular tandem repeat protein (cTRP) scaffold as trimers or tetramers. The … |
FRED HUTCHINSON CANCER CENTER | 2023-06-08 | 2023-12-14 | |
| 289 | SARS-COV-2 VARIANTS OF CONCERN-SPECIFIC MULTI-ANTIGENS UNIVERSAL VACCINE Summary Related Patents View Save Abstract: Pan-coronavirus vaccines for inducing efficient, powerful and long-lasting protection against all Coronaviruses infections and diseases, comprising multiple highly conserved large … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-06-07 | 2025-11-27 | |
| 290 | RNA VIRUS INHIBITOR COMPOUNDS WITH IMPROVED METABOLIC STABILITY AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure provides compounds with increased metabolic stability for inhibiting a virus infection, such as a Baltimore Group IV RNA virus infection, such as … |
GOVERNORS OF THE UNIVERSITY OF ALBERTA | 2023-06-02 | 2023-12-14 | |
| 291 | LIVE-ATTENUATED SARS-COV-2 VACCINE Summary Related Patents View Save Abstract: Engineered SARS-CoV-2 variants having a combination of attenuating modifications, and their use as live-attenuated SARS-CoV-2 vaccines, are described. The recombinant genome of … |
U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2023-06-02 | 2025-10-23 | |
| 292 | Methods and Systems for Quantitative Detection of SARS-CoV-2 Antibodies Using Dried Samples Summary Related Patents View Save Abstract: In certain aspects, disclosed are methods and systems for detecting SARS-CoV-2 analytes in dried samples, as for example, dried blood spots. For example, disclosed are methods for … |
LABORATORY CORP. OF AMERICA HOLDINGS | 2023-06-02 | 2023-12-07 | |
| 293 | Coronavirus vaccine Summary Related Patents View Save Abstract: The present invention is directed to a nucleic acid suitable for use in treatment or prophylaxis of an infection with a coronavirus, preferably with a Coronavirus SARS-CoV-2, or a … |
CUREVAC | 2023-06-01 | 2024-01-30 | |
| 294 | Coronavirus vaccine Summary Related Patents View Save Abstract: The present invention is directed to a nucleic acid suitable for use in treatment or prophylaxis of an infection with a coronavirus, preferably with a Coronavirus SARS-CoV-2, or a … |
CUREVAC | 2023-06-01 | 2025-08-19 | |
| 295 | Infectious disease screening device Summary Related Patents View Save Abstract: A disease screening device ( ) comprising a substrate ( ) and a sonication chamber ( ) formed on the substrate ( ). The sonication chamber ( ) is provided with an ultrasonic … |
SHAHEEN INNOVATIONS HOLDING | 2023-05-30 | 2024-04-16 | |
| 296 | USE OF PERILLA IN THE MANUFACTURE OF MEDICAMENT FOR INHIBITION OF COVID-19 VIRUS Summary Related Patents View Save Abstract: A use of perilla in the manufacture of a medicament for inhibition of Coronavirus disease 2019 (COVID-19) virus is provided. Perilla is treatment by ultrafine pulverization and … |
YING-LING HUANG et. al. | 2023-05-26 | 2024-11-28 | |
| 297 | High-Accuracy Electrochemical Sensors for Instant Detection of Pathogens Summary Related Patents View Save Abstract: A novel MIP electrochemical sensor for instant detecting pathogens from aerosol or liquid with high sensitivity and high specificity, the pathogens include SARS-COV-2, SARS-COV-2 … |
XIAOLING SHI | 2023-05-24 | 2024-11-28 | |
| 298 | PREPARATION METHOD FOR AND APPLICATION OF CLASS OF STELLATE BIFUNCTIONAL COMPOUNDS TARGETING SPIKE PROTEIN AGAINST RESPIRATORY TRACT INFECTION VIRUS AND SALT THEREOF Summary Related Patents View Save Abstract: Provided are stellate compounds that target spike proteins and have a significant anti-SARS-CoV-2 ability and a certain broad spectrum. Such molecules and salts thereof have at … |
SHENZHEN CELL INSPIRE PHARMACEUTICAL DEVELOPMENT | 2023-05-24 | 2023-10-12 | |
| 299 | SARS-COV-2 NSP14 METHYLTRANSFERASE INHIBITORS Summary Related Patents View Save Abstract: Disclosed herein are compounds of formula or pharmaceutically acceptable salts thereof, and methods of using the same for treating a viral infection or inhibiting replication of a … |
REGENTS OF THE UNIVERSITY OF MINNESOTA | 2023-05-23 | 2026-01-01 | |
| 300 | METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH SARS-COV-2 Summary Related Patents View Save Abstract: Provided herein are methods of treating or preventing SARS-CoV-2 infection comprising modulating interactions between the SARS-CoV-2 spike protein and plasma membrane-expressed … |
GENENTECH | 2023-05-22 | 2024-01-25 | |
| 301 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTION Summary Related Patents View Save Abstract: The disclosure provides methods for treating or preventing coronavirus infection comprising administration of a therapeutically effective amount of lactoferrin or a … |
AVIRUS | 2023-05-22 | 2023-10-19 | |
| 302 | SARBECOVIRUS SPIKE S2 SUBUNIT BINDERS Summary Related Patents View Save Abstract: Sarbecovirus binding agents, in particular antibodies and antigen-binding fragments thereof, which are capable of potently neutralizing a Sarbecovirus, in particular capable of … |
VIB VZW et. al. | 2023-05-17 | 2025-10-09 | |
| 303 | SARS-CoV-2 DETECTION KIT AND SARS-CoV-2 DETECTION METHOD Summary Related Patents View Save Abstract: An object of the present invention is to provide a SARS-CoV-2 detection kit and a SARS-CoV-2 detection method which make it possible to simply detect SARS-CoV-2 with higher … |
FUJIFILM; PUBLIC UNIVERSITY CORP. YOKOHAMA CITY UNIVERSITY | 2023-05-17 | 2023-10-26 | |
| 304 | VACCINE FOR PREVENTING OR TREATING CORONAVIRUS INFECTION Summary Related Patents View Save Abstract: The present specification relates to vaccines comprising an mRNA polynucleotide encoding a coronavirus antigen; and an amphipathic cell penetrating RALA peptide. … |
PHION THERAPEUTICS | 2023-05-17 | 2025-10-09 | |
| 305 | Fusion peptide inhibitors of human coronavirus 229E Summary Related Patents View Save Abstract: Fusion peptide inhibitors of human coronavirus E are provided. The fusion peptide inhibitors of HCoV- E include peptide # (SEQ ID NO: : … |
KING FAISAL UNIVERSITY | 2023-05-16 | 2024-01-09 | |
| 306 | CRISPR-Cas13 System, Kit and Method for Detecting SARS-CoV-2 Summary Related Patents View Save Abstract: Provided herein is a CRISPR-Cas13 system, a kit and a method for detecting SARS-COV-2. The CRISPR-Cas13a system includes a Cas13a protein and crRNA, or a complex formed by Cas13a … |
RAFAEL BIOTECHNOLOGY | 2023-05-16 | 2024-08-08 | |
| 307 | GLYCEROPHOSPHOINOSITOL IN PREVENTING AND TREATING COVID-19 INFECTIONS AND METHOD FOR OBTAINING IT Summary Related Patents View Save Abstract: Glycerophosphoinositol (GPI) is used in preventing and treating COVID-19 infections. An environmentally sustainable method is for obtaining glycerophosphoinositol. In particular, … |
PLANTAREI BIOTECH | 2023-05-16 | 2025-11-13 | |
| 308 | USE OF CANNABINOIDS IN THE TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: A method of treating COVID-19 in a subject, whereby the subject in need thereof is administered, via the oral mucosa, a bioefficient rapidly infusing composition that includes (a) … |
ORCOSA | 2023-05-16 | 2023-11-23 | |
| 309 | ATTENUATED POXVIRUS VECTOR BASED VACCINE FOR PROTECTION AGAINST COVID-19 Summary Related Patents View Save Abstract: The present invention relates to a composition for raising an immune response in an animal which prevents or decreases the risk of a coronavirus infection and decreases severity … |
SEMENTIS | 2023-05-15 | 2023-11-30 | |
| 310 | Fusion protein and use thereof Summary Related Patents View Save Abstract: Provided are a fusion protein and use thereof. Provided is a fusion protein, comprising a trimerization block and an immunogenic block which are connected by a linker, wherein the … |
SHANXI JINBO BIO-PHARMACEUTICAL; FUDAN UNIVERSITY | 2023-05-15 | 2025-07-08 | |
| 311 | Silyl lipids suitable for enhanced delivery of anti-viral therapeutics Summary Related Patents View Save Abstract: This disclosure provides silyl lipid molecules in which one or more carbon-to-carbon double bonds in the lipophilic portion is substituted with a silicon atom. Guidance is … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-05-10 | 2024-08-20 | |
| 312 | Antigen Binding Molecules Targeting SARS-CoV-2 Citation: 4 Summary Related Patents View Save Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that specifically bind to S2 domains of betacoronavirus … |
GENERATE BIOMEDICINES | 2023-05-08 | 2023-11-09 | |
| 313 | COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF SEVERE COVID 19 AND OTHER INFLAMMATORY AUTOIMMUNE DISORDERS Summary Related Patents View Save Abstract: Compositions and methods for the diagnosis and treatment of severe Covid 19 and other inflammatory autoimmune disorders are disclosed. … |
CHILDREN’S HOSPITAL OF PHILADELPHIA | 2023-05-08 | 2025-09-25 | |
| 314 | CROSS-REACTIVE CORONAVIRUS SPIKE PROTEIN AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: Embodiments provided here include engineered viral proteins, such as but not limited to coronavirus spike proteins, e.g., SARS-CoV-2 spike proteins. These engineered viral … |
EXCELLGENE et. al. | 2023-05-05 | 2025-12-04 | |
| 315 | MULTI-EPITOPE CONSTRUCT Summary Related Patents View Save Abstract: The invention is situated in the field of vaccination therapy. More specifically, the invention relates to a multi-epitope construct comprising nucleic acid sequences encoding … |
ETHERNA IMMUNOTHERAPIES et. al. | 2023-05-05 | 2025-11-20 | |
| 316 | Antigen binding molecules targeting SARS-CoV-2 Citation: 1 Summary Related Patents View Save Abstract: The disclosure provides, in various embodiments, polypeptides (e.g., antibodies and antigen binding fragments thereof) that specifically bind to S2 domains of betacoronavirus … |
GENERATE BIOMEDICINES | 2023-05-05 | 2024-05-28 | |
| 317 | Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use Summary Related Patents View Save Abstract: Disclosed herein are adjuvanted protein vaccines comprising: a SARS-CoV-2 variant C.1.2 modified S1 Spike protein sequence and a non-phospholipid liposome, wherein the protein is … |
D4 LABS | 2023-05-05 | 2024-02-27 | |
| 318 | Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein Summary Related Patents View Save Abstract: Compositions and methods are presented for prevention and/or treatment of a coronavirus disease wherein the composition comprises comprises a recombinant entity. The recombinant … |
NANTCELL | 2023-05-04 | 2025-04-29 | |
| 319 | VACCINES AGAINST CORONAVIRUS AND METHODS OF USE Summary Related Patents View Save Abstract: Disclosed herein are nucleic acid molecules encoding a SARS-CoV-2 spike antigen, SARS-CoV-2 spike antigens, immunogenic compositions, and vaccines and their use in inducing immune … |
INOVIO PHARMACEUTICALS et. al. | 2023-05-02 | 2023-10-26 | |
| 320 | MODIFIED CORONAVIRUS S PROTEIN Summary Related Patents View Save Abstract: The present disclosure relates to modified coronavirus S protein and virus-like particles (VLPs) comprising modified coronavirus S protein. The present invention also relates to … |
ARAMIS BIOTECHNOLOGIES | 2023-05-01 | 2025-09-25 | |
| 321 | Compositions and Methods for Treating COVID-19 and/or Acute Respiratory Failure and/or Acute Respiratory Distress Syndrome Using Tetrahydrocannabinol and Compositions Including Same Summary Related Patents View Save Abstract: A composition for treating COVID-19 and/or acute respiratory failure (ARF) and/or acute respiratory distress syndrome (ARDS) (optionally caused in a subject afflicted with … |
AURANGZEB NAFEES NAGY | 2023-04-29 | 2023-08-24 | |
| 322 | METHOD FOR ENHANCING IMMUNITY Summary Related Patents View Save Abstract: The invention relates to a method of enhancing immunity, mRNA-based vaccines for SARS-COV-2 have demonstrated the enormous potential of mRNA therapeutics for safe and effective … |
XANADU BIO et. al. | 2023-04-28 | 2025-09-25 | |
| 323 | Hyperimmunized egg product for treatment or prevention of coronavirus infection Summary Related Patents View Save Abstract: In one aspect, the present disclosure is directed to a method for preventing or treating a coronavirus infection in a subject in need thereof, comprising administering to the … |
LAY SCIENCES | 2023-04-28 | 2025-06-10 | |
| 324 | SARS-COV-2 ANTIBODIES AND METHODS OF USING THE SAME Summary Related Patents View Save Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that specifically bind to the spike protein of SARS-CoV-2 and methods of making and using the … |
ASTRAZENECA UK | 2023-04-28 | 2025-09-18 | |
| 325 | PLPRO PROTEIN INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF Summary Related Patents View Save Abstract: Disclosed in the present invention are a PLpro protease inhibitor, and a preparation method and application thereof. The PLpro protease inhibitor can be combined with one or more … |
TSINGHUA UNIVERSITY | 2023-04-28 | 2025-09-18 | |
| 326 | METHODS AND KITS FOR DETECTING VIRUS Summary Related Patents View Save Abstract: Disclosed herein are methods of detecting viruses and methods of making a diagnosis of viral infection, by using RNA and DNA probes. According to some embodiments of the present … |
CITY UNIVERSITY OF HONG KONG | 2023-04-27 | 2023-11-02 | |
| 327 | METHODS FOR IMPROVING COVID VACCINE IMMUNOGENICITY Citation: 2 Summary Related Patents View Save Abstract: The present disclosure provides an improved vaccine compositions and methods for eliciting an immune response against SARS-COV-2 and providing broader protection against … |
NORTHWESTERN UNIVERSITY | 2023-04-27 | 2024-06-27 | |
| 328 | Method for preparing a porcine-derived interferon-delta 5 and application of porcine-derived interferon-delta 5 Summary Related Patents View Save Abstract: Disclosed are a method for preparing a porcine-derived interferon-delta 5 (pIFN-δ5) and an application of the pIFN-δ5, where the method for preparing pIFN-δ5 includes the … |
JIANGSU ACADEMY OF AGRICULTURAL SCIENCES | 2023-04-27 | 2024-04-23 | |
| 329 | Neutralizing Anti-SARS-CoV-2 Antibodies and Methods of Use Thereof Summary Related Patents View Save Abstract: This disclosure provides novel broadly neutralizing anti-SARS-CoV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-CoV-2 antibodies constitute a novel … |
ROCKEFELLER UNIVERSITY | 2023-04-24 | 2024-05-09 | |
| 330 | BACTERIOPHAGE-BASED, NEEDLE AND ADJUVANT-FREE, MUCOSAL COVID-19 VACCINE Summary Related Patents View Save Abstract: A bacteriophage T4-based, multivalent/multicomponent, needle and adjuvant-free, mucosal vaccine by engineering spike trimers on capsid exterior and nucleocapsid protein in the … |
CATHOLIC UNIVERSITY OF AMERICA | 2023-04-24 | 2023-11-09 | |
| 331 | Heteromultivalent DNA-Functionalized Materials to Detect Genetic Mutations and Use in Diagnostic Applications Summary Related Patents View Save Abstract: This disclosure relates to heteromultivalent nucleic acid-functionalized surfaces, such as particles, and uses in optimizing hybridization specificity for targets containing one, … |
EMORY UNIVERSITY | 2023-04-21 | 2025-09-04 | |
| 332 | COMPOSITIONS AND METHOD OF USE OF MUTANT ACE2 DECOY VARIANTS Summary Related Patents View Save Abstract: A mutant soluble human Ace2 (hAce2) protein useful in preventing infection with betacoronaviruses, including SARS-CoV2 is provided, as are compositions useful in treating disease … |
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2023-04-20 | 2023-10-26 | |
| 333 | Use of verapamil for the treatment of SARS-Cov-2 induced COVID-19 Summary Related Patents View Save Abstract: The invention relates to methods for treating or preventing infections with coronavirus, in aspects including Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and … |
MANOJ P. JADHAV | 2023-04-20 | 2024-03-26 | |
| 334 | KYNURENINE: USEFUL BIOMARKER IN ACUTE COVID-19 AND LONG COVID Summary Related Patents View Save Abstract: An in vitro method for the detection of inflammation caused by an acute COVID-19 infection, long COVID and/or PIMS. The level of kynurenine in a body fluid is determined and the … |
SALION | 2023-04-19 | 2023-10-26 | |
| 335 | METHOD OF TREATING COVID-19 INFECTION USING SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE Summary Related Patents View Save Abstract: A method of treating a COVID-19 infection including administering to a subject in need thereof an effective amount of a composition, where the composition includes silica … |
IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY | 2023-04-19 | 2024-10-24 | |
| 336 | Therapeutics directed against coronavirus Summary Related Patents View Save Abstract: This invention provides compositions and methods to treat, prevent, and diagnose viral infections. The methods provided herein involve administering polypeptides of the invention … |
SINGH BIOTECHNOLOGY | 2023-04-17 | 2024-04-09 | |
| 337 | VIRAL AND HOST BIOMARKERS FOR DETECTION, THERAPEUTIC EFFECTIVENESS, AND MONITORING OF CANCER LINKED TO SARS-CoV-2 AND HUMAN PAPILLOMA VIRUS Summary Related Patents View Save Abstract: Methods of detecting, including early detection, of cancer mediated by SARS-CoV-2 and HPV, may include detection of such viral infections alone or together with one or more … |
RAFAEL GUERRERO-PRESTON | 2023-04-17 | 2023-08-31 | |
| 338 | Immunogenic Compositions Against SARS-COV-2 Variants And Their Methods Of Use Summary Related Patents View Save Abstract: Disclosed herein are nucleic acid molecules encoding a Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) spike antigen, SARS-CoV-2 spike antigens, immunogenic … |
INOVIO PHARMACEUTICALS | 2023-04-14 | 2023-10-26 | |
| 339 | COVID PREVENTION AND TREATMENT USING AN INTEGRIN INHIBITOR Summary Related Patents View Save Abstract: A method of treating or preventing COVID-19 in a subject in need thereof is described. The method includes administering to the subject a therapeutically effective amount of an … |
BROWN UNIVERSITY et. al. | 2023-04-14 | 2023-10-19 | |
| 340 | METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA, FUNGUS, OR VIRUS BY ADMINISTRATION OF TAFENOQUINE Citation: 1 Summary Related Patents View Save Abstract: Methods and composition for treating or preventing a lung infection, or related symptoms, caused by a bacterium, fungus, and/or virus using an effective amount of tafenoquine are … |
60 DEGREES PHARMACEUTICALS | 2023-04-14 | 2024-07-11 | |
| 341 | CARBOBICYCLIC NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTION Summary Related Patents View Save Abstract: Carbobicyclic nucleoside compounds useful for the treatment of coronavirus disease 2019 (COVID-19), RSV and other viral infections are provided. The carbobicyclic nucleoside … |
CHINESE UNIVERSITY OF HONG KONG | 2023-04-14 | 2023-11-09 | |
| 342 | PHARMACOLOGIC APPROACH FOR SUPPRESSION OF CORONAVIRUSES Summary Related Patents View Save Abstract: Compositions for prevention or treatment for the SARS family of coronaviruses, e.g., SARS-CoV-2 and SARS-OC43 (common cold virus), include non-nucleoside reverse transcriptase … |
TEMPLE UNIVERSITY – OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2023-04-14 | 2024-01-11 | |
| 343 | METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA, FUNGUS, OR VIRUS BY ADMINISTRATION OF TAFENOQUINE Citation: 1 Summary Related Patents View Save Abstract: Methods and composition for treating or preventing a lung infection, or related symptoms, caused by a bacterium, fungus, and/or virus using an effective amount of tafenoquine are … |
60 DEGREES PHARMACEUTICALS | 2023-04-13 | 2024-04-25 | |
| 344 | COMPOSITION CONTAINING HOTSPOT-DERIVED PEPTIDE-NUCLEIC ACID HYBRID MOLECULE FOR TREATING INFECTION CAUSED BY MUTATED CORONAVIRUS Summary Related Patents View Save Abstract: The present disclosure relates to a composition for preventing or treating coronavirus infection, including a hotspot-derived peptide-nucleic acid hybrid molecule. It was … |
POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION | 2023-04-13 | 2025-12-11 | |
| 345 | COMPOSITIONS AND METHODS FOR TREATING POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION (LONG COVID) Summary Related Patents View Save Abstract: Disclosed are methods and compositions for treating a subject with Long COVID (e.g., Post-Acute Sequelae of SARS CoV-2 (PASC)). … |
VITRO BIOPHARMA | 2023-04-12 | 2025-08-28 | |
| 346 | METHODS OF PREVENTING OR TREATING INFECTION BY RESPIRATORY VIRUSES INCLUDING SARS-CoV-2 Citation: 4 Summary Related Patents View Save Abstract: Methods and compositions to treat or prevent infections by respiratory virus, including SARS-CoV-2 (COVID-19). Included are chimeric antibodies comprising an immunoglobin region … |
PARADIGM IMMUNOTERAPEUTICS | 2023-04-12 | 2023-11-23 | |
| 347 | COMPOSITION FOR ANTIVIRUS COMPRISING NATURAL KILLER CELL Summary Related Patents View Save Abstract: The present invention relates to an antiviral composition comprising Natural Killer (NK) cells as an active ingredient and, more particularly, to a composition for preventing or … |
NOVOCELL BIO | 2023-04-12 | 2023-11-16 | |
| 348 | RAPID AND LOW-COST SAMPLING FOR DETECTION OF AIRBORNE SARS-COV-2 IN DEHUMIDIFIER CONDENSATE Summary Related Patents View Save Abstract: The present invention relates to the use of a condensate collector such as portable or stationary dehumidifier placed in a defined testing space or area and used as a readily … |
UNIVERSITY OF MARYLAND BALTIMORE COUNTY et. al. | 2023-04-11 | 2023-10-12 | |
| 349 | STABILIZED SPIKE PROTEIN AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE Summary Related Patents View Save Abstract: Disclosed herein is a new method referred to as Conformational Shifting by Distance and Volume Analysis (CS-DVA) which can be employed to change the dynamics of multi-state … |
YUANHAN WU et. al. | 2023-04-11 | 2025-08-14 | |
| 350 | SARS-CoV-2 VACCINE COMPOSITIONS Summary Related Patents View Save Abstract: The present disclosure provides compositions of adjuvanted SARS-CoV-2 vaccines and their use to prevent and manage Covid-19 infection, including host hyperinflammatory responses … |
MERCIA PHARMA | 2023-04-11 | 2025-07-24 | |
| 351 | PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + NIRMATRELVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDING COVID-19 Summary Related Patents View Save Abstract: The present application relates to the new the pharmaceutical combination therapy and prevention of SARS-CoV-2 and/or disease associated with this infection, including viral and … |
ASAVI | 2023-04-10 | 2023-11-02 | |
| 352 | Low-Cost Rapid Diagnostic Biosensors Summary Related Patents View Save Abstract: Provided are devices for assessing the presence of SARS-CoV-2 in a biological sample, the devices comprising a substrate comprising a top surface and a back surface; and, an … |
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA et. al. | 2023-04-06 | 2023-08-03 | |
| 353 | METHODS FOR TREATING SARS COV-2 INFECTIONS Citation: 7 Summary Related Patents View Save Abstract: Provided are methods for treating 2019-nCoV virus (SARS-CoV-2) infections by administering nucleosides and prodrugs thereof, of Formula I: wherein the 1′ position of the … |
GILEAD SCIENCES | 2023-04-05 | 2023-11-02 | |
| 354 | Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof Summary Related Patents View Save Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the … |
GIGAGEN | 2023-04-04 | 2025-09-02 | |
| 355 | STABILIZED ACE2 VARIANT, ACE2-FC FUSION PROTEIN USING SAME, AND METHOD FOR PREVENTING OR TREATING COVID-19 Summary Related Patents View Save Abstract: A stabilized Ace2 variant has a disulfide bond introduced by substituting cysteine for amino acid residue pairs at specific positions of the Ace2 protein, thereby having excellent … |
IUCF-HYU | 2023-04-04 | 2023-09-21 | |
| 356 | Novel Peptides and Vaccines Capable of Eliciting Protective Immunity Against SARS-CoV-2 Summary Related Patents View Save Abstract: The invention generally relates to the development of a vaccine capable of providing broad protection against SARS-CoV-2 virus as well as the production of antibodies to treat the … |
BIOMED PROTECTION | 2023-04-03 | 2025-07-10 | |
| 357 | SARS-COV2 ANTIBODIES AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure is directed to antibodies and antigen binding fragments thereof having binding specificity for the S protein of coronaviruses (CoV-S), such as the S protein … |
INVIVYD | 2023-04-01 | 2025-07-10 | |
| 358 | Anti-coronavirus antibodies and methods of use Summary Related Patents View Save Abstract: Antibodies that bind SARS-CoV spike protein, SARS-CoV-2 spike protein, and methods of using same for treating or preventing conditions associated with SARS or COVID-19 and for … |
ABCELLERA BIOLOGICS; UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SVCS. | 2023-03-31 | 2024-12-24 | |
| 359 | RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN IMMUNIZING AGAINST SARS-COV-2 OMICRON VARIANT Summary Related Patents View Save Abstract: Described herein are recombinant Newcastle disease viruses (“NDVs”) comprising a packaged genome, wherein the packaged genome comprises a transgene comprising a nucleotide … |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2023-03-31 | 2025-07-17 | |
| 360 | FLUOROARABINO NUCLEIC ACID (FANA) APTAMERS THAT BIND SARS-2 RECEPTOR BINDING DOMAIN AND BLOCK BINDING TO THE ACE2 CELLULAR RECEPTOR Summary Related Patents View Save Abstract: The present disclosure generally relates to aptamers and, more specifically, to fluoroarabino nucleic acid (FANA) aptamers, that bind to the SARS-CoV-2 receptor binding domain … |
UNIVERSITY OF MARYLAND COLLEGE PARK | 2023-03-30 | 2023-10-05 | |
| 361 | PAN-CHEMOKINE ANTAGONISTS FOR USE IN TREATING CANCER AND IMMUNE DISORDERS Summary Related Patents View Save Abstract: A chemical compound 2-({6-phenylthieno[2,3-d]pyrimidin-4-yl}oxy)benzamide for use as a CCR7 (C-C chemokine receptor type 7) antagonist. It is also a pan-chemokine antagonist and … |
MICAR INNOVATION | 2023-03-30 | 2025-06-26 | |
| 362 | ONE-TO-STOP ATTENUATED SARS-COV-2 VIRUS Summary Related Patents View Save Abstract: The invention relates to a polynucleotide encoding an attenuated SARS-CoV-2 or a fragment thereof, wherein the polynucleotide comprises at least 20 one-to-stop codons. The … |
UNIVERSITÄT BERN et. al. | 2023-03-28 | 2025-09-25 | |
| 363 | ANTIVIRAL COMPOSITION COMPRISING CHITOSAN AND XANTHOHUMOLONE Summary Related Patents View Save Abstract: The present invention relates to a composition comprising at least chitosan and xanthohumolone, to a process for preparing same and to the uses thereof. More particularly, the … |
HEALTH PLUS | 2023-03-27 | 2025-06-26 | |
| 364 | At-Home Covid Nucleic Acid Detection Kit for Rapid Molecular Diagnostics Citation: 1 Summary Related Patents View Save Abstract: The present invention describes kits and methods for rapid detection of nucleic acid sequences in real-time and in any setting. Unique features of this kit include isothermal … |
RULA ABBUD-ANTAKI | 2023-03-27 | 2025-01-02 | |
| 365 | SPECIALIZED PRO-RESOLVING LIPID MEDIATORS FOR TREATING LONG COVID-19 Summary Related Patents View Save Abstract: The present invention concerns a treatment of Long COVID-19 by using specialized pro-resolving lipid mediators (SPM) or their active precursors. optionally in combination with a … |
SOLUTEX GC | 2023-03-24 | 2025-08-14 | |
| 366 | COMBINATION OF EPITOPES AND USE THEREOF, VACCINE CONSTRUCT, METHOD OF INDUCING AN IMMUNE RESPONSE, METHOD FOR THE IDENTIFICATION OF EPITOPES Summary Related Patents View Save Abstract: COMBINATION OF EPITOPES AND USE THEREOF, VACCINE CONSTRUCT, METHOD OF INDUCING AN IMMUNE RESPONSE, METHOD FOR THE IDENTIFICATION OF EPITOPES The present invention refers to a … |
FUNDAÇÃO ZERBINI | 2023-03-24 | 2025-10-02 | |
| 367 | DEVELOPMENT OF NOVEL APTAMER-BASED BIOSENSOR FOR DETECTION OF SARS-COV-2 PROTEIN IN NASOPHARYNGEAL SWABS OF COVID-19 PATIENTS Summary Related Patents View Save Abstract: An aptamer-based biosensor for detecting SARS-COV-2 in symptomatic and asymptomatic patients capable of onsite testing of large-scale population of up to 96 people at once … |
UNIVERSITY OF SHARJAH | 2023-03-24 | 2024-09-26 | |
| 368 | Compositions and Methods for Adjuvanted Vaccines Summary Related Patents View Save Abstract: Provided herein are, in various embodiments, methods and compositions comprising polynucleotides (e.g., mRNA) for eliciting an immune response. In certain embodiments, the … |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-03-24 | 2023-10-12 | |
| 369 | NEW MERS-COV VACCINE Summary Related Patents View Save Abstract: The present invention relates to a mutant receptor-binding domain (MERS-mRBD) of MERS-CoV (middle east respiratory syndrome coronavirus) or a fragment thereof and/or a mutant … |
MAX-DELBRUECK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT et. al. | 2023-03-23 | 2026-01-15 | |
| 370 | DUAL PROMOTER-DRIVEN AND DUAL REPORTER-EXPRESSING SARS-COV-2 REPLICONS AND METHODS OF USE Summary Related Patents View Save Abstract: The present disclosure provides constructs and kits comprising SARS-CoV-2 (SARS2) replicons and methods for screening and/or evaluating anti-SARS2 drugs using the replicons. … |
ROSALIND FRANKLIN UNIVERSITY OF MEDICINE & SCIENCE | 2023-03-23 | 2023-09-28 | |
| 371 | METHODS FOR TREATING COVID-19 Summary Related Patents View Save Abstract: The invention relates to methods for treating COVID-19 by targeting the inflammasome/caspase1/pyroptosis axis as a key inflammatory pathway. In particular, the invention relates … |
MEDSTAR HEALTH | 2023-03-22 | 2023-11-16 | |
| 372 | RESPIRATORY TRACT INFECTION THERAPEUTICS AGAINST COVID-19 Summary Related Patents View Save Abstract: Provided herein, inter alia, are compositions comprising nucleic acid compounds and methods of using the compositions for the prevention and treatment of respiratory diseases, … |
CITY OF HOPE et. al. | 2023-03-21 | 2025-06-26 | |
| 373 | Coronavirus vaccine Summary Related Patents View Save Abstract: This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against … |
BIONTECH | 2023-03-20 | 2025-01-28 | |
| 374 | Coronavirus disease (COVID-19) vaccine Summary Related Patents View Save Abstract: The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof. … |
THOMAS JEFFERSON UNIVERSITY | 2023-03-20 | 2024-05-07 | |
| 375 | 3-tetrazolylmethyl-1,3,5-triazin-2,4-dione compound inhibiting coronavirus 3CL protease activity and preparation method and use thereof Summary Related Patents View Save Abstract: The present invention relates to the technical field of medicinal chemistry, and particularly to a method for preparing a 3-tetrazolylmethyl-1,3,5-triazin-2,4-dione compound … |
SHAANXI PANLONG PHARMACEUTICAL; XIXIAN NEW DISTRICT FENGHOU ORIGINAL PHARMACEUTICAL TECHNOLOGY | 2023-03-18 | 2025-02-11 | |
| 376 | Biological Detection Sensor Chip and COVID-19 Test Kit Summary Related Patents View Save Abstract: The invention discloses a biosensor chip and a COVID-19 test kit. The COVID-19 test kit includes a biosensor chip, rolling circle amplification (RCA) primers, RCA padlock probes, … |
XUDONG CAO | 2023-03-16 | 2023-09-21 | |
| 377 | REPAIRED THERAPEUTIC AND PROPHYLACTIC ANTIBODIES AGAINST SARS-CoV-2 VARIANTS Summary Related Patents View Save Abstract: Provided herein are novel monoclonal antibodies and antibody fragments with improved binding to and/or neutralization against multiple SARS-CoV-2 variants, e.g., Omicron lineages. … |
LAWRENCE LIVERMORE NATIONAL SECURITY et. al. | 2023-03-16 | 2023-11-16 | |
| 378 | Methods for treating infections Summary Related Patents View Save Abstract: The invention features methods that are useful for treatment of a patient at increased risk for infection and for selecting a patient for treatment for an infection. In various … |
BROAD INSTITUTE; YALE UNIVERSITY; GENERAL HOSPITAL; UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2023-03-14 | 2025-07-29 | |
| 379 | Germicidal UV light device Summary Related Patents View Save Abstract: A device for capturing momentarily an exhaled breath of a COVID 19 patient containing active SARS-CoV-2 virions within an accessible compartment of said device and converting said … |
HERMAN DAVID PALMIERI | 2023-03-13 | 2024-03-19 | |
| 380 | VERTICAL FLOW IMMUNOCHROMATOGRAPHIC ASSAY DEVICE AND METHOD OF USING THE SAME Summary Related Patents View Save Abstract: A method and kit for detecting SARS-CoV-2 virus antigen present in an oropharyngeal lavage includes swishing and gargling a mouth rinse to distribute the same around the inside of … |
ZEUS DIAGNOSTICS | 2023-03-13 | 2023-09-14 | |
| 381 | Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation Summary Related Patents View Save Abstract: In some aspects, provided herein are compositions of and methods for utilizing a sterically stabilized liposome carrier encapsulating a selected drug for the delivery of such drug … |
VGSK TECHNOLOGIES | 2023-03-13 | 2025-10-07 | |
| 382 | SARS-COV-2 THERAPIES Summary Related Patents View Save Abstract: Disclosed are bispecific molecules combining ACE2 with an anti-CD3 antibody and engineered T cells expressing chimeric antigen receptors that bind to SARS-CoV-2 spike protein, as … |
JACKSON LABORATORY | 2023-03-13 | 2023-11-02 | |
| 383 | METHOD FOR TREATING SARS-COV-2 INFECTIOUS DISEASE Summary Related Patents View Save Abstract: Disclosed are a composition for diagnosis of SARS-CoV-2 infectious disease, a diagnostic kit, a method for providing information for diagnosis, a method for screening a … |
RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY | 2023-03-10 | 2023-12-21 | |
| 384 | PROTEASE BIOSENSORS AND METHODS OF VIRUS DETECTION Summary Related Patents View Save Abstract: The present disclosure provides a biosensor for the detection of protease activity. The detection of protease activity can be used for the detection of viral infection, in … |
MONTANA MOLECULAR | 2023-03-10 | 2023-10-26 | |
| 385 | COPPER FILTER WITH FAST VIRUS KILLING ABILITY Summary Related Patents View Save Abstract: A porous copper-based filter material that is electrodeposited with nanotwin copper to provide anti-pathogenic properties, particularly against Covid-19 or the SARS virus. The … |
CITY UNIVERSITY OF HONG KONG et. al. | 2023-03-10 | 2023-09-14 | |
| 386 | Assessment of pulmonary function in coronavirus patients Summary Related Patents View Save Abstract: Assessment of pulmonary function in coronavirus patients includes use of a computer aided diagnostic system to assess pulmonary function and risk of mortality in patents with … |
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION | 2023-03-10 | 2025-12-30 | |
| 387 | Covid-19 binding aerosols Citation: 1 Summary Related Patents View Save Abstract: Covid-19 binding aerosols are provided. The Covid-19 binding aerosols include Fe O microparticles, at least one organoselenium compound, at least one essential oil, and incense. … |
KING FAISAL UNIVERSITY | 2023-03-10 | 2023-11-14 | |
| 388 | METHODS FOR DETECTING GENOMIC VARIANTS OF SARS-COV-2 IN MULTIPLEX ASSAYS Summary Related Patents View Save Abstract: Methods are provided for detecting the presence of a specific genomic variant in a multiplex assay and distinguishing it from other genomic variants by interrogating one or more … |
GENXPRO | 2023-03-10 | 2025-09-25 | |
| 389 | RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN PREVENTING COVID-19 Summary Related Patents View Save Abstract: Described herein are recombinant Newcastle disease viruses (“NDVs”) comprising a packaged genome, wherein the packaged genome comprises a transgene comprising a nucleotide … |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2023-03-09 | 2025-06-12 | |
| 390 | Method for Rapid Capture, Detection and Analysis of Viruses on Surfaces Summary Related Patents View Save Abstract: Provided herein are, in various embodiments, methods and kits for assaying one or more virions. In certain embodiments, the methods and kits of the disclosure provide for the … |
NORTHEASTERN UNIVERSITY | 2023-03-09 | 2025-06-05 | |
| 391 | CDP-CHOLINE A HOST-DIRECTED THERAPEUTIC FOR DISEASE CAUSED BY SARS COV-2 INFECTION Summary Related Patents View Save Abstract: Compositions and methods are disclosed for treating coronavirus infections, such as SARS CoV-2 coronavirus infections. For example, a composition is disclosed that contains one, … |
OHIO STATE INNOVATION FOUNDATION | 2023-03-07 | 2025-05-29 | |
| 392 | Coronavirus vaccine Summary Related Patents View Save Abstract: The present invention is directed to a nucleic acid suitable for use in treatment or prophylaxis of an infection with a coronavirus, preferably with a Coronavirus SARS-CoV-2, or a … |
CUREVAC | 2023-03-06 | 2024-04-23 | |
| 393 | Coronavirus vaccine Citation: 1 Summary Related Patents View Save Abstract: The present invention is directed to a nucleic acid suitable for use in treatment or prophylaxis of an infection with a coronavirus, preferably with a Coronavirus SARS-CoV-2, or a … |
CUREVAC | 2023-03-06 | 2024-04-23 | |
| 394 | SARS-CoV-2 Vaccines and Antibodies Summary Related Patents View Save Abstract: The invention describes a method of generating antibodies to a mixture of SARS-CoV-2 peptidogenic proteins or polynucleotides encoding SARS-CoV-2 peptidogenic proteins wherein the … |
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 2023-03-02 | 2023-07-06 | |
| 395 | CORONAVIRUS: EARLY DETECTION AND TREATMENT Summary Related Patents View Save Abstract: The application relates to certain new epitope peptides associated with coronavirus envolop protein and the use thereof. In particular, the application describes the antibodies … |
RUEY J YU et. al. | 2023-02-27 | 2024-04-25 | |
| 396 | DUPILUMAB FOR TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: Methods for treating coronavirus disease 2019 (COVID-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, are described. The methods … |
UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-02-24 | 2025-05-29 | |
| 397 | DEVICE TO CLOSE TOILET LID BEFORE FLUSHING Summary Related Patents View Save Abstract: Device to close a toilet lid before flushing contains a base part ( ) in which a drive device in form of an electrical motor ( ) is situated. On top of the base part ( ) a motion … |
ADAM PHILIP WILEWSKI et. al. | 2023-02-24 | 2025-05-29 | |
| 398 | VIRAL RECEPTOR-DERIVED PEPTIDES AGAINST VIRAL DISEASES Summary Related Patents View Save Abstract: The present disclosure provides novel computational methods for identifying potential therapeutic peptides as antivirals, and methods of using viral receptor-derived peptides as … |
HOWARD UNIVERSITY | 2023-02-23 | 2023-10-05 | |
| 399 | Anti-spike glycoprotein antibodies and the therapeutic use thereof Summary Related Patents View Save Abstract: The present application relates to neutralizing antibodies or antigen-binding fragments thereof against betacoronaviruses such as severe acute respiratory syndrome coronavirus 2 … |
TALEM THERAPEUTICS | 2023-02-23 | 2024-07-16 | |
| 400 | DJUVANTED PROTEIN VACCINES COMPRISING MODIFIED FULL-LENGTH SPIKE PROTEIN OF SARS-COV-2 COMPOSITION AND METHODS OF USE Summary Related Patents View Save Abstract: Disclosed herein are adjuvanted protein vaccines comprising: a non-phospholipid liposome and one or more proteins, wherein the protein is encapsulated within the non-phospholipid … |
D4 LABS | 2023-02-22 | 2024-08-22 | |
| 401 | TRYPTANTHRIN DERIVATIVES WITH THIOSEMICARBAZONE SUBSTITUTION AND USE THEREOF Summary Related Patents View Save Abstract: The invention relates to tryptanthrin derivatives with thiosemicarbazone substitution of the general formulae I and II, where R1-R8 are independently H, OH, alkyl with 1 to 6 … |
UNIVERZITA KARLOVA | 2023-02-20 | 2025-05-29 | |
| 402 | ANTIBODIES CAPABLE OF BINDING TO THE SPIKE PROTEIN OF CONONAVIRUS SARS-COV-2 Citation: 1 Summary Related Patents View Save Abstract: The disclosure relates to antibodies useful for the prevention, treatment and/or diagnosis of coronavirus infections, and diseases and/or complications associated with coronavirus … |
RQBIO COVID | 2023-02-17 | 2025-05-15 | |
| 403 | METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST ORF1AB and N-Protein Summary Related Patents View Save Abstract: Methods are provided for prevention and treatment of 2019 coronavirus (2019-nCoV; COVID-19) infections in mammals by prophylactic or therapeutic administration of pharmaceutical … |
SIRNAOMICS | 2023-02-17 | 2024-04-04 | |
| 404 | ANTI-SARS-COV2 SPIKE (S) ANTIBODIES AND USES THEREOF Summary Related Patents View Save Abstract: The present invention includes monoclonal antibody or antigen-binding fragment thereof, methods of using, detection, recombinant vectors, host cells, kits, variants, and … |
LA JOLLA INSTITUTE FOR IMMUNOLOGY | 2023-02-17 | 2025-12-18 | |
| 405 | NOVEL CORONAVIRUS RBD SPECIFIC MONOCLONAL ANTIBODY AND LINEAR EPITOPE AND APPLICATION THEREOF Summary Related Patents View Save Abstract: The present disclosure belongs to the field of immune technology, and particularly discloses a SARS-CoV-2 RBD-specific monoclonal antibody including a heavy chain having an amino … |
YULIN FENG et. al. | 2023-02-17 | 2023-11-23 | |
| 406 | SMALL MOLECULES THAT TREAT OR PREVENT VIRAL INFECTIONS Summary Related Patents View Save Abstract: Embodiments of the present disclosure pertain to anti-viral compounds suitable for use in blocking virus entry into cells. Further embodiments of the present disclosure pertain to … |
UNIVERSITY OF HOUSTON SYSTEM | 2023-02-17 | 2023-08-24 | |
| 407 | METHODS FOR PROPHYLACTIC AND THERAPEUTIC TREATMENT OF 2019-nCoV USING siRNAs AGAINST TGFB1 AND COX2 Summary Related Patents View Save Abstract: Methods are provided for prevention and treatment of 2019 coronavirus (2019-nCoV; COVID-19) infections in mammals by prophylactic or therapeutic administration of pharmaceutical … |
SIRNAOMICS | 2023-02-17 | 2023-08-17 | |
| 408 | Antibodies capable of binding to the spike protein of coronavirus SARS-CoV-2 Citation: 2 Summary Related Patents View Save Abstract: The invention relates to antibodies useful for the prevention, treatment and/or diagnosis of coronavirus infections, and diseases and/or complications associated with coronavirus … |
RQ BIOTECHNOLOGY | 2023-02-17 | 2024-07-09 | |
| 409 | RECOMBINANT PROTEIN FOR DISPLAYING S PROTEIN OF SARS-COV-2, RECOMBINANT VIRION, AND USE THEREOF Summary Related Patents View Save Abstract: A recombinant protein for displaying an S protein of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), a recombinant virion, and a use thereof, as well as a … |
ZHEJIANG DIFFERENCE BIOLOGICAL TECHNOLOGY | 2023-02-16 | 2025-02-06 | |
| 410 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS DISEASES Summary Related Patents View Save Abstract: Compositions and methods for inhibiting coronavirus infection and for treating subjects already infected with a coronavirus such as the SARS-COV-2 virus that causes COVID-19. The … |
LAURA LILE et. al. | 2023-02-15 | 2025-07-17 | |
| 411 | COMPOSITION FOR POC PCR Summary Related Patents View Save Abstract: Liquid composition for the preparation of a biological sample for methods for assaying for the presence of SARS-COV-2 or genetic variations (mutant) of SARS-COV-2 wildtype in said … |
PROCOMCURE BIOTECH | 2023-02-15 | 2025-05-15 | |
| 412 | KETOAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF Summary Related Patents View Save Abstract: A class of ketoamide derivatives and pharmaceutical uses thereof are provided. Specifically provided are the compound represented by formula I, or a pharmaceutically acceptable … |
WESTVAC BIOPHARMA | 2023-02-15 | 2025-02-27 | |
| 413 | Treatment for diseases caused by RNA virus SARS-CoV-2 Summary Related Patents View Save Abstract: Up-regulation of caspase has been found in COVID-19 patients, and also occurs in patients suffering from diabetes, hypertension, metabolic syndrome, and other conditions. Such … |
AMERIMMUNE | 2023-02-15 | 2025-08-05 | |
| 414 | Combination drug products for treating patients suffering from one or more medical conditions caused by coronavirus infection, including by SARS-CoV-2, its alpha, beta, delta, or omicron variants and sub variants Summary Related Patents View Save Abstract: Treatments for human subjects exposed to, potentially exposed to, infected by, or potentially infected by a coronavirus, such as SARS-CoV-2, its variants and sub variants are … |
PHARSOLN | 2023-02-15 | 2024-05-21 | |
| 415 | Antigen binding molecules targeting SARS-CoV-2 Citation: 2 Summary Related Patents View Save Abstract: The invention provides, in various embodiments, polypeptides (e.g., camelid antibodies and antigen binding fragments thereof) that specifically bind to Spike glycoprotein of … |
FLAGSHIP PIONEERING INNOVATIONS VI | 2023-02-15 | 2024-05-21 | |
| 416 | HUMAN MONOCLONAL ANTIBODIES TARGETING THE S2 SUBUNIT OF THE SARS-COV-2 SPIKE PROTEIN Summary Related Patents View Save Abstract: Provided herein are antibodies and antibody fragments that bind to the S2 subunit of the SARS-CoV-2 spike protein. Methods of treating or preventing SARS-CoV-2 infections are … |
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM et. al. | 2023-02-15 | 2025-05-08 | |
| 417 | METHODS OF DETERMINING COVID-19 MORTALITY RISK Summary Related Patents View Save Abstract: Among the various aspects of the present disclosure is the provision of detecting COVID-19 severity. One aspect provides a method of predicting survival in subjects having … |
WASHINGTON UNIVERSITY | 2023-02-14 | 2023-08-17 | |
| 418 | ANTIVIRAL SULFATED CHITOSAN DERIVATIVES Summary Related Patents View Save Abstract: The invention relates to sulfated chitosan derivatives of formula (I), wherein the meanings for the various substituents are as disclosed in the description, for their use in the … |
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS et. al. | 2023-02-13 | 2025-05-15 | |
| 419 | SARS-COV-2 NEUTRALIZING SYNTHETIC PROTEINS Summary Related Patents View Save Abstract: The present disclosure relates to compositions and methods for the treatment and/or prevention of SARS-COV-2 infections. In one embodiment the method comprises the delivery of a … |
TEXAS A&M UNIVERSITY SYSTEM | 2023-02-10 | 2025-06-05 | |
| 420 | COMPOSITIONS AND METHODS FOR FcRn-TARGETED INTRANASAL CORONAVIRUS VACCINATION Summary Related Patents View Save Abstract: The present disclosure relates generally to novel recombinant coronavirus-based fusion proteins (“RBDs-IgG Fc protein” and “RBDs protein”) and vaccine compositions using the same, … |
UNIVERSITY OF MARYLAND COLLEGE PARK | 2023-02-09 | 2025-05-08 | |
| 421 | FORMULATIONS AND METHODS OF TREATING COVID-19 AND PREVENTING INFECTION WITH SARS-CoV-2 Summary Related Patents View Save Abstract: Provided is a method of treatment of COVID-19 and/or preventing infection with SARS-CoV-2 comprising: administering to an individual in need thereof a therapeutically effective … |
PATRICK PRENDERGAST et. al. | 2023-02-09 | 2023-06-15 | |
| 422 | HUMAN MONOCLONAL ANTIBODIES THAT BROADLY TARGET CORONAVIRUSES Summary Related Patents View Save Abstract: Disclosed are monoclonal antibodies and antigen binding fragments that specifically bind a coronavirus spike protein, such as SARS-CoV-2. Also disclosed is the use of these … |
U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2023-02-09 | 2025-05-08 | |
| 423 | SARS-CoV-2 inhibitors for treating coronavirus infections Summary Related Patents View Save Abstract: Provided herein are compounds, pharmaceutical compositions, and methods for treating a SARS-CoV-2 infection. … |
INSILICO MEDICINE IP | 2023-02-08 | 2023-08-22 | |
| 424 | ALZ-801 FOR USE IN TREATING A COVID-19 ASSOCIATED NEUROLOGICAL SYMPTOM Summary Related Patents View Save Abstract: Provided herein are methods for reducing p-tau, Abeta40, Abeta42, and/or the p-tau/Abeta+2 ratio in subjects using ALZ-801. Also provided are methods of treating conditions … |
ALZHEON | 2023-02-07 | 2025-04-24 | |
| 425 | TREATMENT OF COVID-19 ASSOCIATED COGNITIVE DYSFUNCTION BY NUTRACEUTICAL PREPARATIONS Summary Related Patents View Save Abstract: Disclosed are means and methods of treating cognitive dysfunction associated with COVID-19 and/or other associated with inflammatory conditions. In one embodiment treatment of … |
THERAPEUTIC SOLUTIONS INTERNATIONAL | 2023-02-07 | 2023-09-28 | |
| 426 | BLOOD BIOMARKERS IN LONG-COVID-19 Summary Related Patents View Save Abstract: A method of diagnosing long-COVID in a subject, the method comprising: (a) measuring the level of one or more biomarkers in a test sample obtained from the subject, and (b) … |
LONDON HEALTH SCIENCES CENTRE RESEARCH | 2023-02-03 | 2025-07-31 | |
| 427 | Pan-Coronavirus Immunogenic Compositions Summary Related Patents View Save Abstract: The present invention generally relates to immunogenic compositions comprising pan-coronavirus antigenic polypeptides and antibodies, and methods of use thereof for the treatment … |
WISTAR INSTITUTE OF ANATOMY AND BIOLOGY | 2023-02-03 | 2025-05-01 | |
| 428 | Peptides and Combinations of Peptides for Use in Immunotherapy Against an Infection by Sars-COV-2 (COVID-19) Summary Related Patents View Save Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the … |
EBERHARD KARLS UNIVERSITÄT TÜBINGEN MEDIZINISCHE FAKULTÄT | 2023-02-03 | 2023-10-12 | |
| 429 | ON-SITE VIRAL INACTIVATION AND RNA PRESERVATION OF GARGLE AND SALIVA SAMPLES COMBINED WITH DIRECT ANALYSIS OF SARS-COV-2 RNA ON MAGNETIC BEADS Summary Related Patents View Save Abstract: On-site viral inactivation and RNA preservation of gargle and saliva samples combined with direct analysis of SARS-COV2 RNA on magnetic beads. … |
GOVERNORS OF THE UNIVERSITY OF ALBERTA | 2023-02-03 | 2023-10-05 | |
| 430 | Air filter with pathogen monitoring and inactivation Summary Related Patents View Save Abstract: An improved technology for inactivation of viruses, for example the SARS-CoV-2 virus that is causing the Covid-19 pandemic, is described. The technology can include a device that … |
INDUSTRIAL POLYMERS AND CHEMICALS | 2023-02-02 | 2023-06-27 | |
| 431 | USE OF VE607 FOR THE TREATMENT OF SARS-COV-2 INFECTIONS AND RELATED DISEASES Summary Related Patents View Save Abstract: The present application relates to the use of 3,3′-(1,3-phenylenebis(oxy))bis(1-(piperidin-1-yl)propan-2-ol (VE607) or a pharmaceutically acceptable salt thereof for the … |
ANDRÉS FINZI et. al. | 2023-01-31 | 2025-05-08 | |
| 432 | 7DW8-5 TREATMENT FOR COVID-19 AND OTHER VIRUS-INDUCED RESPIRATORY INFECTIONS Summary Related Patents View Save Abstract: The subject matter described herein relates to methods of zNKT cell activation by the 7DW8-5 glycolipid. … |
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2023-01-31 | 2025-12-04 | |
| 433 | Therapeutic treatment for the coronavirus disease COVID-19 Citation: 2 Summary Related Patents View Save Abstract: A therapeutic treatment for the treatment of COVID-19 disease, the treatment to be initiated soon after and preferably within approximately twenty four hours after the patient … |
PETER JOSEPH MOLLICK | 2023-01-31 | 2024-01-09 | |
| 434 | METHOD AND BIOMARKER FOR PREDICTING SEVERITY OF COVID-19 DISEASE AND METHOD FOR THERAPEUTIC INTERVENTION IN COVID-19 DISEASE Summary Related Patents View Save Abstract: Method for predicting severity of COVID-19 disease resulting from infection with SARS-COV-2 (severe acute respiratory syndrome coronavirus 2). The method uses a high dimensional … |
UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION | 2023-01-31 | 2025-06-19 | |
| 435 | Pharmaceutical Compositions and Methods for Treating Covid Summary Related Patents View Save Abstract: Pharmaceutical compositions and methods for preventing, treating, relieving, or ameliorating symptoms of coronavirus infection, including COVID-19 and variants thereof, including … |
STEVEN BARANOWITZ | 2023-01-30 | 2025-05-22 | |
| 436 | MULTIPLEXED COVID-19 PADLOCK ASSAY Citation: 5 Summary Related Patents View Save Abstract: Methods and systems for detecting the presence of a target nucleic acid sequence in one or more samples of a plurality of samples are described. The methods may comprise the use … |
ELEMENT BIOSCIENCES | 2023-01-30 | 2023-09-21 | |
| 437 | SARS-COV-2 RECEPTOR BINDING DOMAIN IN NATIVE OUTER MEMBRANE VESICLES Summary Related Patents View Save Abstract: The disclosure provides native outer membrane vesicle (NOMV) vaccines containing a coronavirus receptor binding domain (RBD) modified to be a lipoprotein. Also provided are … |
OMVAX | 2023-01-27 | 2023-07-20 | |
| 438 | CORONAVIRUS ANTIGEN VARIANTS Summary Related Patents View Save Abstract: The present disclosure provides isolated immunogenic polypeptides comprising variant coronavirus spike proteins that are variants of a native coronavirus spike protein or fragment … |
PFIZER | 2023-01-27 | 2025-06-05 | |
| 439 | NOVEL IMMUNOGENIC CORONAVIRUS PEPTIDES AND COMPOSITIONS THEREOF Summary Related Patents View Save Abstract: This application relates to isolated proteins comprising an amino acid sequence which comprises at least 2 mutations relative to a SARS-CoV-2 Spike protein template sequence, … |
NFERENCEINC. | 2023-01-27 | 2023-10-05 | |
| 440 | HUMAN NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 HAVING BREADTH TO VARIANT STRAINS, AND ANTIGEN-BINDING FRAGMENT THEREOF Summary Related Patents View Save Abstract: In order to provide a novel human-derived monoclonal antibody that binds to a spike (S) protein of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to neutralize … |
EVEC; NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE; NATIONAL INSTITUTES OF BIOMEDICAL INNOVATION HEALTH AND NUTRITION | 2023-01-27 | 2025-03-27 | |
| 441 | BROADLY NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES TARGETING THE N-TERMINAL DOMAIN OF THE SPIKE PROTEIN AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: This disclosure provides anti-SARS-COV-2 antibodies or antigen-binding fragments thereof targeting the N-terminal domain (NTD) of the spike(S) protein. The disclosed … |
ROCKEFELLER UNIVERSITY | 2023-01-26 | 2025-10-30 | |
| 442 | ANTIVIRAL PRODRUGS, INTERMEDIATE-AND LONG-ACTING FORMULATIONS AND METHODS Summary Related Patents View Save Abstract: Compounds and pharmaceutical formulations including a compound and an oil, which may be formulated for intermediate- or long-acting intramuscular injection. Methods for treating … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-01-26 | 2025-06-05 | |
| 443 | COVID-19 THERANOSTIC Summary Related Patents View Save Abstract: A diagnostic based on Angiotensin 1-7 level, possibly in synergy with other blood parameters, to predict the outcome of infected patients by respiratory viral diseases and the … |
UNIVERSITE LIBRE DE BRUXELLES | 2023-01-26 | 2025-01-23 | |
| 444 | COMPOSITIONS AND METHODS FOR COVID-19 TREATMENT Summary Related Patents View Save Abstract: Provided herein are compositions for use in treatment fibrosis and in treatment of COVID-19, preferably moderate COVID-19, comprising Compound (1), or a pharmaceutically … |
101 THERAPEUTICS | 2023-01-24 | 2025-05-15 | |
| 445 | Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy Summary Related Patents View Save Abstract: This disclosure provides silyl lipid molecules in which one or more carbon-to-carbon double bonds in the lipophilic portion is substituted with a silicon atom. Guidance is … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-01-24 | 2024-08-20 | |
| 446 | Methods of Treating a Subject for Long-Haul COVID-19, and Compositions for Use in the Same Summary Related Patents View Save Abstract: Methods of treating a subject for long-haul COVID are provided. Aspects of the methods include administering to the subject a tropane CCR5/CCL5 interaction inhibitor in … |
INCELLDX | 2023-01-23 | 2025-03-27 | |
| 447 | PROTEIN SENSING PLATFORM WITH A COMBINATION OF CONDUCTING POLYMERS, AROMATIC AND CONJUGATED ALDEHYDES ON A CELLULOSE PAPER BASE Summary Related Patents View Save Abstract: Biosensors are provided for the detection of pathogens such as viruses. The sensors can includes a substrate, and a film disposed on the substrate. The film can include an … |
OPTEEV TECHNOLOGIES | 2023-01-23 | 2023-07-27 | |
| 448 | USE OF HEPARIN-BINDING PROTEIN (HBP) IN EARLYWARNING OF PROGNOSTIC RISK OF PATIENTSUFFERING CORONAVIRUS DISEASE (COVID-19) Summary Related Patents View Save Abstract: Provided are a method for predicting a risk of deterioration of a pathogenic condition of a patient suffering a coronavirus disease (COVID-19), especially a severe patient … |
JOINSTAR BIOMEDICAL TECHNOLOGY | 2023-01-23 | 2023-07-27 | |
| 449 | Antisense Oligonucleotides Targeting SARS-CoV-2 Summary Related Patents View Save Abstract: COVID-19 is treated with antisense oligonucleotides (ASOs) targeting SARS-CoV-2 viral RNAs or human ACE2 RNA. … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA; AALBORG UNIVERSITY | 2023-01-19 | 2024-03-28 | |
| 450 | LUNG ULTRASOUND PROCESSING SYSTEMS AND METHODS Citation: 2 Summary Related Patents View Save Abstract: Methods and systems for processing data to distinguish between a plurality of conditions in lung ultrasound images and, in particular, lung ultrasound images containing B lines. … |
ALVEOLAI DATAFUEL | 2023-01-19 | 2023-05-18 | |
| 451 | DETECTION OF SARS-COV-2 PROTEINS AND MITOCHONDRIAL PROTEINS IN PLASMA NEURON-DERIVED EXTRACELLULAR VESICLES AND ASTROCYTE-DERIVED EXTRACELLULAR VESICLES Summary Related Patents View Save Abstract: The present disclosure relates to the detection of SARS-CoV-2 proteins and mitochondrial proteins in plasma neuron-derived extracellular vesicles and astrocyte-derived … |
EDWARD J. GOETZL | 2023-01-19 | 2023-07-20 | |
| 452 | Coronavirus vaccine comprising a mosaic protein Summary Related Patents View Save Abstract: Disclosed herein are mosaic coronavirus (MoCoV) spike (S) proteins or antigenic fragments thereof. Also disclosed herein are nucleic acid constructs comprising one or more nucleic … |
VAXTHERA | 2023-01-19 | 2024-06-11 | |
| 453 | PHARMACEUTICAL FOR TREATMENT OF NOVEL CORONAVIRUS INFECTION Summary Related Patents View Save Abstract: The present invention provides a pharmaceutical composition containing a coronavirus 3CL protease inhibitor for treating novel coronavirus infections (COVID-19). A pharmaceutical … |
SHIONOGI | 2023-01-18 | 2025-03-27 | |
| 454 | COMPOSITION FOR PREVENTING, TREATING, OR ALLEVIATING VIRAL INFECTION DISEASES OR RESPIRATORY DISEASES COMPRISING VESICLE DERIVED FROM LACTOBACILLUS PARACASEI Summary Related Patents View Save Abstract: Provided is a method for preventing, alleviating, or treating a viral infectious disease or a respiratory disease, comprising administering a composition containing vesicles … |
MD HEALTHCARE | 2023-01-18 | 2023-07-13 | |
| 455 | BOOSTING SARS-COV-2 IMMUNITY WITH A LENTIVIRAL-BASED NASAL VACCINE Summary Related Patents View Save Abstract: The invention relates to the field of immunity against coronaviruses. In this respect, the invention provides a lentiviral-based immunogenic agent that is suitable for use in … |
INSTITUT PASTEUR et. al. | 2023-01-17 | 2025-03-20 | |
| 456 | METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM, ARDS, AND ACUTE LUNG INJURY USING BETA-GLUCOCEREBROSIDASE Summary Related Patents View Save Abstract: The present invention relates to methods and compositions for treating a subject with a condition selected from: i) an on-going cytokine storm, ii) acute respiratory distress … |
CLEVELAND CLINIC FOUNDATION | 2023-01-17 | 2023-07-20 | |
| 457 | METHODS AND SYSTEMS FOR DETECTING AND DISCRIMINATING BETWEEN VIRAL VARIANTS Summary Related Patents View Save Abstract: This disclosure provides an improved assay capable of identifying and distinguishing viral variants, such as SARS-CoV-2 variants and subvariants, including Alpha, Beta, Gamma, … |
RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 2023-01-13 | 2023-09-21 | |
| 458 | CASCADE OLIGONUCLEOTIDE DISPLACEMENT PROBES Summary Related Patents View Save Abstract: Aspects of the disclosure relate to compositions and methods for amplifying and/or detecting one or more target nucleic acid sequences (e.g., a nucleic acid sequence of one or … |
DETECT; BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2023-01-12 | 2023-09-21 | |
| 459 | SPIKE FURIN CLEAVAGE IS A SARS-COV-2 TARGETING STRATEGY TO BREAK THE CHAIN OF INFECTION CYCLE Summary Related Patents View Save Abstract: Provided are methods for treating viral infections in subject in need thereof. In some embodiments, the method include administering to the subject a composition that has an … |
UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2023-01-12 | 2025-06-05 | |
| 460 | AUTOLOGOUS CELL BASED SARS-COV-2 VACCINES Summary Related Patents View Save Abstract: Disclosed herein are multi-antigenic autologous, cell-based SARS-CoV-2 vaccines comprising autologous antigen presenting cells (APCs) displaying at least two different SARS-CoV-2 … |
ORGENESIS | 2023-01-12 | 2025-05-15 | |
| 461 | COMBINATION DISPLACEMENT PROBES Summary Related Patents View Save Abstract: Aspects of the disclosure relate to compositions and methods for amplifying and/or detecting one or more target nucleic acid sequences (e.g., a nucleic acid sequence of one or … |
DETECT | 2023-01-12 | 2023-07-13 | |
| 462 | Air filter with pathogen monitoring and inactivation Summary Related Patents View Save Abstract: An improved technology for inactivation of viruses, for example the SARS-CoV-2 virus that is causing the Covid-19 pandemic, is described. The technology can include a device that … |
INDUSTRIAL POLYMERS AND CHEMICALS | 2023-01-11 | 2023-10-24 | |
| 463 | BETA-CORONAVIRUS FUSION RECOMBINANT PROTEIN, AND PREPARATION METHOD AND APPLICATION THEREOF Summary Related Patents View Save Abstract: Disclosed is a betacoronavirus fusion recombinant protein, comprising an RBD region and a COVID19-SF5 fragment of a spike protein of SARS-COV-2 (COVID-19), and an amino acid … |
BIOPHARMAGEN CORP. FANGZHOU SUZHOU | 2023-01-10 | 2025-05-08 | |
| 464 | PRODUCTION OF PROTECTIVE LOZENGE/CHEWABLE TABLET AGAINST SARS-COV-2 VIRUS Summary Related Patents View Save Abstract: Clean version of Abstract A mixture consisting of extracts of green tea, bilberry, pomegranate peel, and black poplar is produced. Upon revealing the surprising efficacy of the … |
TUBITAK | 2023-01-10 | 2025-03-20 | |
| 465 | Magnetic Resonance System and Method for Weakening and Expelling Living Coronavirus from a Patient Body Summary Related Patents View Save Abstract: The present invention relates to a novel COVID-19 treatment system and associated method. The system features an electromagnetic field pulse generator for generating a low … |
SVYATOSLAV ORLOV-KURYLOV | 2023-01-10 | 2023-08-31 | |
| 466 | Method of controlling symptoms relating to COVID-19 Summary Related Patents View Save Abstract: A method of controlling symptoms relating to COVID-19 is provided. A filter is placed in a vein of a patient. The filter is placed between a heart and a palisading longitudinal … |
TAKAHIRO SATO | 2023-01-10 | 2025-07-29 | |
| 467 | CIRCULAR RNA VACCINES AGAINST SARS-COV-2 VARIANTS AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: Provided are circular RNAs (circRNAs) encoding an antigenic polypeptide of a SARS-CoV-2 variant. Provided are circRNA vaccines against a SARS-CoV-2 variant, such as a Delta or … |
PEKING UNIVERSITY | 2023-01-09 | 2025-03-13 | |
| 468 | INFECTIOUS RECOMBINANT VESICULAR STOMATITIS VIRUS (RVSV) BEARING THE SPIKE GLYCOPROTEIN S OF SARS-COV-2 AND USES THEREOF Summary Related Patents View Save Abstract: Provided herein are recombinant vesicular stomatitis virus (rVSV) or rVSV vector comprising nucleic acid encoding the spike glycoprotein S of SARS-COV-2, compositions comprising … |
ALBERT EINSTEIN COLLEGE OF MEDICINE | 2023-01-06 | 2024-07-11 | |
| 469 | Antigen binding molecules targeting SARS-CoV-2 Citation: 3 Summary Related Patents View Save Abstract: The invention provides, in various embodiments, polypeptides that specifically bind to Spike glycoprotein of severe acute respiratory syndrome coronavirus (e.g., … |
FLAGSHIP PIONEERING INNOVATIONS VI | 2023-01-06 | 2024-05-14 | |
| 470 | Antigen binding molecules targeting SARS-CoV-2 Summary Related Patents View Save Abstract: The invention provides, in various embodiments, polypeptides that specifically bind to Spike glycoprotein of severe acute respiratory syndrome coronavirus (e.g., … |
FLAGSHIP PIONEERING INNOVATIONS VI | 2023-01-06 | 2025-11-18 | |
| 471 | A SARS-COV-2 Human Parainfluenza Virus Type 3-Vectored Vaccine Summary Related Patents View Save Abstract: The disclosure is directed to a new human parainfluenza virus (HPIV)/SARS-CoV-2 vaccine or vaccine construct/polynucleotide. Specifically, the HPIV is a Human parainfluenza virus … |
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2023-01-05 | 2025-02-27 | |
| 472 | Bispecific SARS-CoV-2 antibodies and methods of use Summary Related Patents View Save Abstract: Provided herein are methods and compositions relating to improved bispecific antibodies capable of binding and neutralizing SARS-CoV-2 variants. … |
TWIST BIOSCIENCE | 2023-01-03 | 2025-06-10 | |
| 473 | VACCINE COMBINATION AGAINST SARS-COV-2 AND METHOD FOR PREVENTING INFECTION OF SARS-COV-2 Summary Related Patents View Save Abstract: A vaccine combination against SARS-CoV-2 includes a primer vaccine composition and a booster vaccine composition. The primer vaccine composition includes an effective amount of an … |
CHANCE BIOTECHNOLOGY | 2023-01-03 | 2023-07-06 | |
| 474 | POLYPEPTIDES, VACCINE COMPOSITIONS, AND USE THEREOF FOR INDUCING IMMUNE RESPONSE TO SARS-COV-2 IN PRIMATES Citation: 3 Summary Related Patents View Save Abstract: Disclosed herein, in some embodiments, are methods and compositions for inducing an immune response against SARS-CoV-2 in a primate in need thereof with a recombinant polypeptide, … |
KANG ZHANG | 2023-01-03 | 2023-09-14 | |
| 475 | CORONAVIRUS VACCINE COMPOSITIONS AND USES THEREOF Summary Related Patents View Save Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike glycoprotein. Also … |
BOOST BIOPHARMA | 2022-12-30 | 2025-03-20 | |
| 476 | RECOMBINANT POLYPEPTIDES CONTAINING AT LEAST ONE IMMUNOGENIC FRAGMENT AND ANTIBODY FC REGION AND USES THEREOF Summary Related Patents View Save Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) spike glycoprotein, and … |
BOOST BIOPHARMA | 2022-12-30 | 2025-04-03 | |
| 477 | METHODS OF TREATING CORONAVIRUS DISEASE AND COMPOUNDS FOR SAME Summary Related Patents View Save Abstract: Topotecan for use in the treatment of COVID-19 and/or its associated symptoms. Also disclosed is a method of treating an individual infected with a coronavirus, wherein said … |
BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE et. al. | 2022-12-29 | 2025-02-27 | |
| 478 | COLORIMETRIC SYSTEM FOR DETECTION OF COVID-19 USING EXHALED BREATH METABOLITES Summary Related Patents View Save Abstract: A system for detecting COVID-19 infection, including a colorimetric sensor, an image-capturing device, and a processing unit. The colorimetric sensor includes an array of chemical … |
FARIN BEHBOOD TASHKHIS; BAGIYATALLAH UNIVERSITY OF MEDICAL SCIENCES – CHEMICAL INJURIES RESEARCH CENTER | 2022-12-29 | 2023-05-04 | |
| 479 | CHIMERIC PROTEIN PRODUCTION PROCESS, CHIMERIC PROTEIN, GENE, IMMUNOGENIC COMPOSITION AND USES Summary Related Patents View Save Abstract: The production process for a chimeric protein with SEQ ID No. 1, using the nucleotide sequence with SEQ ID No. 2; the chimeric protein defined by SEQ ID No. 1, the gene in SEQ ID … |
UNIVERSIDADE FEDERAL DE MINAS GERAIS et. al. | 2022-12-28 | 2025-04-03 | |
| 480 | Method and system for determining a treatment outcome prediction for a patient based on electroencephalograph Citation: 1 Summary Related Patents View Save Abstract: A method and system for determining a treatment outcome prediction for a patient using electroencephalograph (EEG) are disclosed, which include analyzing a brain region mutual … |
NEUMARKER | 2022-12-28 | 2024-05-14 | |
| 481 | Method and system for exposing hidden or masked antigenic sites of viral specimens present in biosamples using a home-based COVID-19 rapid lateral flow immunoassay test Summary Related Patents View Save Abstract: A disease detection system including a platform or cartridge to perform testing using a rapid lateral flow chromatographic immunoassay (LFIA) test intended for the qualitative … |
PRINCETON BIOCHEMICALS | 2022-12-27 | 2025-09-16 | |
| 482 | ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF Citation: 7 Summary Related Patents View Save Abstract: The present disclosure relates to an antibody or antigen-binding fragment thereof that is specific for a spike protein of SARS-CoV-2. The present disclosure also relates to a … |
ACADEMIA SINICA | 2022-12-27 | 2023-09-07 | |
| 483 | ANTI-SARS-CoV-2 SPIKE (S) ANTIBODIES AND THEIR USE IN TREATING COVID-19 Summary Related Patents View Save Abstract: Infectious diseases remain a problem throughout the world. The outbreak of sudden acute respiratory syndrome coronavirus 2 (SARS-Co V-2) has infected more than 640 million people … |
NOVAVAX | 2022-12-23 | 2025-02-27 | |
| 484 | SARS-COV-2 SERUM ANTIBODY PROFILING Summary Related Patents View Save Abstract: Disclosed herein are reagents for use in antibody profiling platforms, such as biopanning and Digital Serology, specifically for eptiope motifs directed to SARS-CoV-2. Also … |
SERIMMUNE | 2022-12-22 | 2023-09-14 | |
| 485 | Coronavirus Spike Glycoprotein With Improved Expression and Stability Summary Related Patents View Save Abstract: Provided herein are mutant coronavirus spike proteins, methods of making and using, vaccines, vectors and nucleic acids, comprising at least one of the following modifications: a … |
LA JOLLA INSTITUTE FOR IMMUNOLOGY | 2022-12-22 | 2025-12-18 | |
| 486 | Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus Summary Related Patents View Save Abstract: The present disclosure is concerned with substituted phenyl ethynyl pyridine carboxamide compounds, pharmaceutical compositions comprising the compounds, and methods of treating … |
SOUTHERN RESEARCH INSTITUTE; VANDERBILT UNIVERSITY; UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2022-12-21 | 2024-02-20 | |
| 487 | P2ET REDUCES COVID SEVERITY BY INHIBITION OF VIRAL REPLICATION, REDUCTION OF PULMONAR FIBROSIS MARKERS AND MODULATION OF INMUNE RESPONSE Summary Related Patents View Save Abstract: The present invention provides compositions and methods for treating or prevent SARS-CoV-2 infections by delivering a therapeutically effective amount of a standardized P2Et … |
PONTIFICIA UNIVERSIDAD JAVERIANA et. al. | 2022-12-21 | 2023-06-22 | |
| 488 | PSEUDOTYPED LENTIVIRAL VECTORS Summary Related Patents View Save Abstract: The present invention relates to pseudotyped lentiviral vectors, particularly to pseudotyped with a modified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike … |
IMPERIAL COLLEGE INNOVATIONS | 2022-12-21 | 2025-10-02 | |
| 489 | METHODS OF TREATMENT Summary Related Patents View Save Abstract: This disclosure features compounds and compositions that are useful in methods of treating coronavirus infections (e.g., useful in methods of treating COVID-19) in a subject in … |
FIRST WAVE BIO | 2022-12-21 | 2023-06-29 | |
| 490 | USE OF ELAFIN IN THE TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: The present invention relates to the use of elafin or a homologue, fragment or derivative thereof in the treatment of COVID-19, in particular any disorder or disease associated … |
TIAKIS BIOTECH | 2022-12-20 | 2023-09-14 | |
| 491 | COMPOSITION COMPRISING A COMPLEX COMPRISING A CURCUMINOID COMPOUND, AND STEVIOL GLYCOSIDES OR A LICORICE EXTRACT OR A FRACTION THEREOF, AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure relates to a composition comprising a complex that includes a curcuminoid-based compound and a steviol glycoside, or a curcuminoid-based compound and a … |
KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY; BIOTEN | 2022-12-19 | 2023-06-22 | |
| 492 | EFFICIENT EXPRESSION SYSTEM OF SARS-COV-2 RECEPTOR BINDING DOMAIN (RBD), METHODS FOR PURIFICATION AND USE THEREOF Summary Related Patents View Save Abstract: The present invention relates to the production of the receptor binding domain (RBD) of the Spike glycoprotein 1 of the SARS-CoV-2 in mammalian cell expression systems, and the … |
BETAGEN SCIENTIFIC | 2022-12-19 | 2023-08-17 | |
| 493 | REGENERATIVE CELL THERAPY FOR VIRAL INDUCED SEXUAL DYSFUNCTION Summary Related Patents View Save Abstract: The invention provides means, methods, and compositions of matter useful for treatment of viral induced sexual dysfunction. In one embodiment the invention teaches the use of … |
CREATIVE MEDICAL TECHNOLOGIES | 2022-12-16 | 2023-07-27 | |
| 494 | EFFICIENT VACCINE Summary Related Patents View Save Abstract: Provided herein is an isolated polynucleotide, which encodes structural proteins nsp1, nsp2, nsp3 and nsp4 and a polypeptide comprising an antigenic protein fused to a signal … |
VLP THERAPEUTICS JAPAN | 2022-12-16 | 2023-06-29 | |
| 495 | VACCINE COMPOSITIONS AND THEIR USE Summary Related Patents View Save Abstract: The invention relates to immunogenic compositions and their use as a vaccine for the prevention of coronavirus disease in a human subject. More specifically, the invention relates … |
OSIVAX | 2022-12-16 | 2025-04-17 | |
| 496 | DIAGNOSTIC LIPID BIOMARKERS FOR COVID-19 AND METHODS FOR USE THEREOF Summary Related Patents View Save Abstract: The disclosure relates to methods for diagnosing, detecting or screening for COVID-19 in a subject. The method comprises measuring the concentration of at least two sphingolipids … |
NATIONAL RESEARCH COUNCIL OF CANADA et. al. | 2022-12-16 | 2025-02-13 | |
| 497 | CIRCULATING CARDIOVASCULAR BIOMARKERS AND VASCULAR STABILIZING THERAPY Summary Related Patents View Save Abstract: Recent literature on SARS-CoV-2 pathogenesis has suggested that the induction of substantial acute respiratory distress phenotypes is driven by a mismatched inflammatory response … |
UNIVERSITY HEALTH NETWORK | 2022-12-16 | 2023-06-22 | |
| 498 | CELL-PERMEANT INHIBITORS OF VIRAL CYSTEINE PROTEASES Summary Related Patents View Save Abstract: Provided are protease inhibitor compounds that find use in treating or preventing coronavirus disease. In some embodiments, the coronavirus disease is COVID-19. Also provided are … |
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2022-12-16 | 2025-03-06 | |
| 499 | LATERAL FLOW ASSAY DEVICE FOR DETECTION OF ANALYTES AND METHOD OF DETECTION THEREOF Summary Related Patents View Save Abstract: A lateral flow assay device for detection of an analyte in a sample and a method of detection thereof is provided. A quantitative assay for detection of an analyte in a sample is … |
NEUOME PEPTIDES | 2022-12-15 | 2023-04-20 | |
| 500 | VANDETANIB REDUCES INFLAMMATORY CYTOKINES AND AMELIORATES COVID-19 Summary Related Patents View Save Abstract: Compositions for and methods of treating lung conditions, such as those associated with elevated cytokines, are described. The methods include administration of vandetanib or a … |
COLLABORATIONS PHARMACEUTICALS | 2022-12-15 | 2025-10-30 | |
| 501 | IMPLANTABLE SCAFFOLDS FOR IMMUNOTHERAPEUTIC AND OTHER USES Summary Related Patents View Save Abstract: An implantable or injectable scaffold comprising an antigen, a T memory cell inducer, and other optional components is provided for use in enhancing the immune response to the … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-12-15 | 2025-02-13 | |
| 502 | LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF CORONAVIRUS DISEASE AND SYMPTOMS THEREOF Citation: 1 Summary Related Patents View Save Abstract: Certain embodiments described herein include methods and formulations for treating or preventing symptoms and conditions associated with coronavirus disease (e.g., COVID-19). The … |
IRR | 2022-12-15 | 2023-06-22 | |
| 503 | CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: Provided are non-naturally occurring 5′-untranslated region and 3′-untranslated region nucleotides, and use thereof. … |
HANMI PHARM | 2022-12-14 | 2025-03-27 | |
| 504 | TOOL FOR PREDICTING PROGNOSIS AND IMPROVING SURVIVAL IN COVID-19 PATIENTS Summary Related Patents View Save Abstract: A diagnostic and decision support technology is provided for determining the likely prognosis and potential treatment for patients experiencing a condition, such as COVID-19, for … |
CERNER INNOVATION | 2022-12-13 | 2024-06-13 | |
| 505 | IgG EPITOPE PEPTIDES THAT BIND RHEUMATOID FACTOR AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: Described herein are IgG epitope peptides that bind rheumatoid factors in rheumatoid arthritis (RA) and COVID-19. The IgG epitope peptides may be conjugated to a ligand, a … |
WISCONSIN ALUMNI RESEARCH FOUNDATION | 2022-12-12 | 2023-07-06 | |
| 506 | Physiological Metrics as Candidate Predictors of Antibody Response Following Vaccination Against Covid-19 Summary Related Patents View Save Abstract: Methods, systems, and devices are provided for predicting the robustness of an antibody response of a subject to the SARS-COV-2 spike protein receptor binding domain based on … |
ASHLEY E. MASON et. al. | 2022-12-09 | 2025-02-06 | |
| 507 | ATTENUATED SARS-COV-2 Summary Related Patents View Save Abstract: This composition of this invention is comprised of live attenuated SARS-CoV-2 constructs as vaccines or research tools. Described herein is a highly attenuated SARS-CoV-2 with … |
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2022-12-09 | 2025-05-22 | |
| 508 | ANTIGENIC POLYPEPTIDE AND USE THEREOF Summary Related Patents View Save Abstract: Provided are an isolated polypeptide or an antigenic fragment thereof, an antibody binding to the isolated polypeptide or the antigenic fragment thereof, a composition including … |
ANDA BIOLOGY MEDICINE DEVELOPMENT | 2022-12-08 | 2025-10-23 | |
| 509 | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses Summary Related Patents View Save Abstract: Methods for prophylaxis, treatment, and reduction of infection, re-infection, and transmission rates of Coronaviruses and more particularly Coronavirus Disease 2019 (COVID-19) … |
CUREMARK | 2022-12-08 | 2025-12-02 | |
| 510 | Personal and reusable infection status passport device that is configured to test for Covid-19 and infectious disease Summary Related Patents View Save Abstract: A personal and reusable infection status passport device is disclosed that is configured to test for Covid-19 and infectious disease using photo and color analysis. The personal … |
WALTER GEORGE BISCHOFF | 2022-12-08 | 2025-05-20 | |
| 511 | MULTIPLE RAPID DETECTION KITS AND METHODS FOR VARIOUS VIRUSES Summary Related Patents View Save Abstract: Novel Coronavirus/MERS-CoV/Influenza Virus A/B Multiple Rapid Detection Kit is disclosed. The kit has the advantages of high sensitivity, good specificity, high speed (3-15 … |
APOLLO BIOMEDICAL | 2022-12-08 | 2023-07-06 | |
| 512 | GLYCOGEN SYNTHASE KINASE-3 (GSK3) INHIBITOR COMPOUNDS FOR USE AS ANTIVIRAL AGENTS Summary Related Patents View Save Abstract: Provided herein are compounds that inhibit glycogen synthase kinase-3 (GSK3) giving them antiviral activity. In particular, the invention relates to a subset of compounds … |
UNIVERSITY OF BRITISH COLUMBIA | 2022-12-07 | 2025-02-06 | |
| 513 | Camelid Antibodies for Use in Therapy and Diagnosis Summary Related Patents View Save Abstract: The present invention relates to compositions and methods for use of the same for the diagnosis, prevention, treatment and prophylaxis of infections caused by coronavirus. In … |
NEW/ERA/MABS | 2022-12-07 | 2025-08-28 | |
| 514 | COMPOSITIONS COMPRISING DIMOCARPUS EXTRACT FOR USE IN THE TREATMENT OR PREVENTION OF AN INFECTION CAUSED BY AN ENVELOPED VIRUS Summary Related Patents View Save Abstract: The present invention relates to a composition comprising or corresponding to an extract obtained from for use in the treatment and/or prevention of a disease caused by an … |
PM GROUP | 2022-12-07 | 2025-02-13 | |
| 515 | OMICRON SARS-COV-2 ASSAY Summary Related Patents View Save Abstract: Certain embodiments of the invention include recombinant reverse genetic systems for Omicron variant of SARS-CoV-2 virus. … |
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2022-12-06 | 2023-09-28 | |
| 516 | RATIONALLY DESIGNED IMMUNOGENS Summary Related Patents View Save Abstract: The invention relates to a monomeric immunogen comprising one receptor binding domain of a Coronavirus spike protein, wherein the receptor binding domain includes at least 4 … |
GENERAL HOSPITAL et. al. | 2022-12-05 | 2025-01-30 | |
| 517 | Coronavirus vaccine formulations Citation: 1 Summary Related Patents View Save Abstract: Disclosed herein are coronavirus Spike (S) proteins and nanoparticles comprising the same, which are suitable for use in vaccines. The nanoparticles present antigens from … |
NOVAVAX | 2022-12-05 | 2025-11-18 | |
| 518 | PEPTIDE Summary Related Patents View Save Abstract: The present invention relates to peptides derived from COVID-19 virus envelope protein and spike protein. The invention further relates to polynucleotides and vectors encoding … |
QUEEN MARY UNIVERSITY OF LONDON; BARTS HEALTH NHS TRUST | 2022-12-02 | 2025-05-08 | |
| 519 | STABILIZED BETA-CORONAVIRUS ANTIGENS Summary Related Patents View Save Abstract: Provided herein are engineered protein comprising stabilized coronavirus S protein ectodomains, such as stabilized SARS-CoV-2 S protein ectodomains. In some aspects, the … |
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2022-12-02 | 2023-09-07 | |
| 520 | Prediction of Severity of COVID-19 and Methods of Treatment Summary Related Patents View Save Abstract: The invention relates generally to coronavirus disease 2019 (COVID-19) and more particularly to the prediction of severity of COVID-19 manifestation in a patient or in an … |
VANDA PHARMACEUTICALS | 2022-12-02 | 2024-11-07 | |
| 521 | ANTIBODIES FOR CORONAVIRUS AND USES THEREOF Summary Related Patents View Save Abstract: Disclosed herein include antibodies or fragments thereof having specificity to a sarbecovirus spike protein receptor binding domain. Also provided are compositions, methods, and … |
CALIFORNIA INSTITUTE OF TECHNOLOGY et. al. | 2022-12-01 | 2023-08-10 | |
| 522 | NEUTRALIZING ANTIBODIES AGAINST SARS-RELATED CORONAVIRUS Summary Related Patents View Save Abstract: The present invention relates to antibodies or antigen-binding fragments thereof against SARS-related coronavirus, pharmaceutical compositions comprising such antibodies or … |
UNIVERSITÄT ZU KÖLN | 2022-12-01 | 2025-05-15 | |
| 523 | CORONAVIRUS VACCINE FORMULATIONS Summary Related Patents View Save Abstract: Disclosed herein are coronavirus Spike (S) proteins and nanoparticles comprising the same, which are suitable for use in vaccines. The nanoparticles present antigens from … |
NOVAVAX | 2022-11-30 | 2025-01-23 | |
| 524 | BIOASSAYS TO MEASURE THE SYNERGISTIC ANTIBODY-DEPENDENT ENHANCEMENT (ADE) EFFECT OF SARS-CoV-2 NEUTRALIZING ANTIBODIES Summary Related Patents View Save Abstract: Provided herein are bioassays to measure the synergistic antibody-dependent enhancement (ADE) effect of SARS-CoV-2 neutralizing antibodies. In particular, the disclosure relates … |
WUXI BIOLOGICS IRELAND | 2022-11-30 | 2025-01-30 | |
| 525 | Tetanus vaccine platform for embedding COVID-19 vaccine Summary Related Patents View Save Abstract: A recombinant SARS-CoV2 protein-based vaccine, and method of immunizing, is developed by either embedding the epitopes/domains, or chemically attaching, to an already established … |
PRIME BIO | 2022-11-30 | 2025-01-14 | |
| 526 | RECOMBINANT FUSION PROTEIN DERIVED FROM HR REGION OF S2 PROTEIN OF SARS-COV-2 AND APPLICATION OF RECOMBINANT FUSION PROTEIN Summary Related Patents View Save Abstract: Disclosed are a recombinant fusion protein derived from an HR region of an S2 protein of SARS-CoV-2 and an application of the recombinant fusion protein. The SARS-CoV-2 … |
ETERNIVAX BIOMEDICAL | 2022-11-30 | 2025-07-17 | |
| 527 | Coronavirus vaccine Citation: 6 Summary Related Patents View Save Abstract: This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against … |
BIONTECH | 2022-11-29 | 2025-01-07 | |
| 528 | ANTIVIRAL USE OF BISEPOXYLIGNAN COMPOUND, AND BISEPOXYLIGNAN COMPOSITION AND PREPARATION OF BISEPOXYLIGNAN COMPOUND Summary Related Patents View Save Abstract: The present invention provides an application of a bisepoxylignan compound or a bisepoxylignan composition in prevention and treatment of infections with influenza viruses, … |
XIN GE | 2022-11-29 | 2025-02-13 | |
| 529 | SARS COV-2 VACCINE, ASSOCIATED POLYNUCLEOTIDES, AND METHODS OF USE Summary Related Patents View Save Abstract: The present disclosure relates to vaccines and related polynucleotides useful in eliciting an immune response to the SARS-CoV-2 virus and related methods of use. The vaccine … |
ENTOS PHARMACEUTICALS | 2022-11-29 | 2025-03-20 | |
| 530 | Modified S1 subunit of the coronavirus spike protein Summary Related Patents View Save Abstract: The present invention relates i.a. to a recombinant avian coronavirus spike protein or fragment thereof comprising a mutation at amino acid position 267 to Cysteine. Further, the … |
BOEHRINGER INGELHEIM VETMEDIA | 2022-11-28 | 2024-06-04 | |
| 531 | Modified S1 subunit of the coronavirus spike protein Summary Related Patents View Save Abstract: The present invention relates i.a. to a recombinant avian coronavirus spike protein or fragment thereof comprising a mutation at amino acid position 267 to Cysteine. Further, the … |
BOEHRINGER INGELHEIM VETMEDIA | 2022-11-28 | 2024-04-23 | |
| 532 | CORONAVIRUS DERIVED RNA REPLICONS AND THEIR USE AS VACCINES Summary Related Patents View Save Abstract: A propagation-defective, replication-competent RNA replicon derived from the SARS-CoV-2 coronavirus that comprises a polynucleotide sequence SEQ_ID 2 or a variant of SEQ_ID 2 … |
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS | 2022-11-25 | 2025-01-16 | |
| 533 | COVID-19 TREATMENT MEDICINE CHARACTERIZED BY COMBINING 3CL PROTEASE INHIBITOR AND COVID-19 TREATMENT DRUG Summary Related Patents View Save Abstract: The present invention provides a medicament useful in treatment and/or prevention, etc. of COVID-19. Provided is a medicament characterized by combining (A) a compound represented … |
SHIONOGI | 2022-11-25 | 2025-01-23 | |
| 534 | METHODS OF TREATING SARS-COV-2 INFECTION Summary Related Patents View Save Abstract: The present invention relates to the treatment or prevention of SARS-COV-2 infection or COVID-19. In particular, the present invention relates to the use of … |
BIOTRON | 2022-11-24 | 2025-01-09 | |
| 535 | Therapeutics and point of care lateral-flow test for virus and antibodies using tagged assembled proteins Summary Related Patents View Save Abstract: Provided is a multivalent protein that targets interaction of SARS-CoV-2 spike receptor binding domain (RBD) with the human angiotensin-converting enzyme 2 (ACE2) receptor … |
NEW YORK UNIVERSITY | 2022-11-23 | 2024-02-06 | |
| 536 | CORONAVIRUS IMMUNOGEN COMPOSITIONS AND THEIR USES Summary Related Patents View Save Abstract: The disclosure provides compositions and methods comprising circular polyribonucleotides comprising a sequence encoding a coronavirus immunogen, and compositions and methods … |
FLAGSHIP PIONEERING INNOVATIONS VI | 2022-11-23 | 2025-11-20 | |
| 537 | ANTIGENIC DETERMINANTS PROTECTIVE IMMUNITY, SERODIAGNOSTIC AND MULTIVALENT SUBUNITS PRECISION VACCINE AGAINST SARS-CoV-2 Summary Related Patents View Save Abstract: Immunogenic peptides, polypeptides, protein subunits, nucleic acids encoding the same, compositions and vaccines containing the immunogenic peptides or nucleic acids, and methods … |
ARABIAN GULF UNIVERSITY | 2022-11-23 | 2023-06-01 | |
| 538 | VHH ANTIBODIES AGAINST SARS-COV-2 VARIANTS Summary Related Patents View Save Abstract: The present invention pertains in the fields of antibody technology, protein engineering, medicine, pharmacology, infection biology, virology, and medical diagnostics. More … |
MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. | 2022-11-22 | 2025-01-16 | |
| 539 | DETECTION OF COVID-19 ASSOCIATED CARDIAC INJURY AND VACCINE-ASSOCIATED MYOCARDITIS Summary Related Patents View Save Abstract: This application relates to methods of treating and/or preventing a coronavirus infection in a subject in need thereof, and treating cardiac injury in said subjects. … |
NFERENCE | 2022-11-22 | 2023-06-29 | |
| 540 | VIRAL NUCLEIC ACID MOLECULES, AND COMPOSITIONS AND METHODS OF USE THEREOF Citation: 1 Summary Related Patents View Save Abstract: The disclosure relates to defective interfering genes and viruses thereof. It has been discovered that defective interfering genes designed from influenza and coronavirus species … |
VERSITECH et. al. | 2022-11-22 | 2023-05-25 | |
| 541 | Systems and methods for the preparation of vaccines utilizing predictably inactivated pathogens Summary Related Patents View Save Abstract: A method is described for producing a vaccine from a neutered pathogenic source. The neutered pathogenic source may be a SARS-COV-2 virus that is neutered with a defined dose of … |
PERUMALA HOLDINGS | 2022-11-22 | 2024-04-09 | |
| 542 | ORAL THERAPEUTIC VACCINE COMPOSITIONS, METHODS AND TREATMENT OF COVID Summary Related Patents View Save Abstract: Described herein are oral vaccine compositions for preventing and treating COVID and COVID related complications (e.g., cytokine storm related complications). These oral vaccine … |
IMMUNITOR | 2022-11-21 | 2024-12-19 | |
| 543 | COMPOSITIONS AND DEVICES FOR VACCINE RELEASE AND USES THEREOF Citation: 1 Summary Related Patents View Save Abstract: Microneedle and microneedle devices including implantable tips (e.g., silk-based tips) for sustained dermal delivery of a coronavirus and/or influenza vaccine, kits, as well as … |
VAXESS TECHNOLOGIES | 2022-11-21 | 2023-08-31 | |
| 544 | QUANTIFICATION OF AIRBORNE SARS-COV-2 USING A PAPER MICROFLUIDIC CHIP Summary Related Patents View Save Abstract: The present disclosure provides kits and methods for detecting and/or quantifying coronavirus from aerosols and droplets. … |
ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2022-11-18 | 2025-01-02 | |
| 545 | SARS-COV-2 VACCINES Summary Related Patents View Save Abstract: Disclosed herein are vaccine compositions that include SARS-CoV-2 MHC epitope-encoding cassettes and/or full-length SARS-CoV-2 proteins. Also disclosed are nucleotides, cells, and … |
GRITSTONE BIO | 2022-11-18 | 2023-10-19 | |
| 546 | EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3) Summary Related Patents View Save Abstract: Coronavirus spike protein, for example, SARS-CoV-2 spike (S) protein, expressed by an avian paramyxovirus type 3 (APMV3) as a vaccine vector for prevention and treatment against … |
U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2022-11-17 | 2025-01-30 | |
| 547 | INDUCTION OF CONCURRENT PULMONARY IMMUNE MODULATION AND REGENERATION BY PROTEIN MEDIATED CONJUGATION OF IMMUNE REGULATORY CELLS WITH ENDOGENOUS PROGENITOR CELLS Summary Related Patents View Save Abstract: Disclosed are means, methods and compositions of matter useful for treatment of inflammatory pulmonary diseases such as COVID-19 through administration of agents that facilitate … |
THERAPEUTIC SOLUTIONS INTERNATIONAL | 2022-11-17 | 2023-06-22 | |
| 548 | METHODS OF PREVENTING, TREATING, OR REDUCING THE SEVERITY OF CORONAVIRUS DISEASE 2019 (COVID-19) Summary Related Patents View Save Abstract: Disclosed are methods of preventing or treating COVID-19 caused by a coronavirus infection or variants thereof by administration to a subject in need thereof a synthetic MVA-based … |
CITY OF HOPE | 2022-11-17 | 2025-01-23 | |
| 549 | SYNTHETIC MODIFIED VACCINIA ANKARA (SMVA) BASED CORONAVIRUS VACCINES Summary Related Patents View Save Abstract: Disclosed are recombinant synthetic MVA-based vaccines for preventing or treating infections caused by a coronavirus or variants thereof. … |
CITY OF HOPE | 2022-11-17 | 2025-07-24 | |
| 550 | Systems and Methods for Targeting COVID-19 Therapies Citation: 1 Summary Related Patents View Save Abstract: The present disclosure provides systems and methods for machine learning classification and assessment of COVID-19 disease based on gene expression data, including prediction of … |
AMPEL BIOSOLUTIONS | 2022-11-17 | 2025-01-09 | |
| 551 | METHODS OF PREVENTING, TREATING, OR REDUCING THE SEVERITY OF COVID-19 IN IMMUNOCOMPROMISED BLOOD CANCER PATIENTS Summary Related Patents View Save Abstract: Disclosed are methods of preventing or treating a coronavirus infection in a blood cancer patient having received a cellular therapy by administration of a synthetic MVA-based … |
CITY OF HOPE | 2022-11-17 | 2025-01-09 | |
| 552 | POLYPEPTIDES FOR DETECTION AND TREATMENT OF CORONAVIRUS INFECTION Summary Related Patents View Save Abstract: Here, the inventors report that natural WT SARS-CoV-2 infection induces memory B cells expressing potently neutralizing antibodies against VOCs. Moreover, natural WT infection … |
UNIVERSITY OF CHICAGO | 2022-11-16 | 2025-01-23 | |
| 553 | UNIVERSAL SARBECOVIRUS VACCINES Summary Related Patents View Save Abstract: Sarbecoviruses (lineage B of genus Betacoronavirus) have caused two major outbreaks during the past two decades: SARS-CoV in 2003, and SARS-CoV-2 from 2019. SARS-CoV-2 vaccines … |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE; ASSISTANCE PUBLIQUE – HOPITAUX DE PARIS; BAYLOR RESEARCH INSTITUTE; UNIVERSITE PARIS EST CRETEIL VAL DE MARNE | 2022-11-16 | 2025-01-23 | |
| 554 | Coronavirus vaccine Summary Related Patents View Save Abstract: This disclosure relates to the field of RNA to prevent or treat coronavirus infection. In particular, the present disclosure relates to methods and agents for vaccination against … |
BIONTECH | 2022-11-16 | 2024-11-05 | |
| 555 | ADJUVANTED VACCINE COMPOSITION AND METHODS Summary Related Patents View Save Abstract: Disclosed herein are immunogenic compositions (e.g., vaccines) and methods of using and preparing the same. In some embodiments, the immunogenic compositions are suitable for use … |
D4 LABS | 2022-11-15 | 2023-08-31 | |
| 556 | SINGLE DOMAIN VHH ANTIBODIES AGAINST SARS-COV-2 VIRUS Summary Related Patents View Save Abstract: The invention provides a set of novel Single domain VHH antibodies against SARS-CoV-2 (SEQ ID N∘ 1-6) and their use to detect and neutralize the wild type virus. … |
UNIVERSIDAD AUSTRAL DE CHILE | 2022-11-15 | 2024-02-29 | |
| 557 | IMAGE AUGMENTATION IN DEEP LEARNING NETWORKS FOR DETECTING COVID-19 Summary Related Patents View Save Abstract: Embodiments may relate to techniques for image augmentation used for the detection and screening of respiratory diseases, such as COVID-19 pneumonia. For example, For example, in … |
NEWTON HOWARD | 2022-11-14 | 2023-06-08 | |
| 558 | NOVEL MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF Summary Related Patents View Save Abstract: The present invention provides novel monoclonal antibodies or the antigen-binding fragments thereof, which bind to a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) … |
CHANG GUNG MEMORIAL HOSPITAL LINKOU et. al. | 2022-11-11 | 2023-09-07 | |
| 559 | SARS-COV-2 SPIKE FUSED TO A HEPATITIS B SURFACE ANTIGEN Summary Related Patents View Save Abstract: Provided herein are nucleic acid molecules encoding a SARS-CoV-2 S ectodomain—HBsAg fusion protein. When expressed in mammalian cells (for example, by administration to a … |
UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARYDEPARTMENT OF HEALTH AND HUMAN SERVICE | 2022-11-11 | 2025-01-02 | |
| 560 | COMPOSTIONS Citation: 1 Summary Related Patents View Save Abstract: The present invention relates to antibodies capable of binding to the spike protein of coronavirus SARS-COV-2, and methods and uses thereof in the prevention, treatment and/or … |
RQ BIOTECHNOLOGY | 2022-11-11 | 2025-01-09 | |
| 561 | CELL IMPERMEABLE KINASE INHIBITORS TO TREAT SARS-COV-2 AND/OR HSV VIRAL INFECTIONS Summary Related Patents View Save Abstract: Methods of preventing or treating a coronavirus infection or a herpes simplex virus infection in a subject or preventing or treating a disease caused by a coronavirus infection or … |
ALBERT EINSTEIN COLLEGE OF MEDICINE | 2022-11-11 | 2025-01-23 | |
| 562 | SYNTHESIS METHOD OF TARGETED DRUG nCoVshRNA 2ACE2 Citation: 4 Summary Related Patents View Save Abstract: A synthesis method of a targeted drug nCoVshRNA.2ACE2 of a COVID-19 virus, which includes the following steps: designing a consensus RNAi sequence siRNA of the COVID-19 virus and … |
WOMEN’S HOSPITAL SCHOOL OF MEDICINE ZHEJIANG UNIVERSITY et. al. | 2022-11-10 | 2023-08-31 | |
| 563 | PREPARATION METHOD OF ARTIFICIAL ANTIBODY Citation: 4 Summary Related Patents View Save Abstract: The present disclosure provides a preparation method of an artificial antibody. The preparation method includes the following steps: screening a target siRNA from a conserved gene … |
BINGHUAN WENG et. al. | 2022-11-10 | 2023-06-29 | |
| 564 | HERBAL COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING SARS-COV-2 VIRUS INFECTION Summary Related Patents View Save Abstract: This invention discloses a herbal composition for treating or preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including the wild type and its different … |
CHINA MEDICAL UNIVERSITY | 2022-11-09 | 2023-05-18 | |
| 565 | ADJUVANTED SUBCUTANEOUSLY-ADMINISTERED POLYPEPTIDE SARS-COV-2 VACCINES COMPOSITION AND METHODS Summary Related Patents View Save Abstract: Disclosed herein are subcutaneously administered, immunogenic compositions (e.g., vaccines) and methods of using and preparing the same. In some embodiments, the immunogenic … |
D4 LABS | 2022-11-09 | 2024-04-25 | |
| 566 | PREDICTING COVID-19 ANTIBODIES AMONG SURVIVORS WITH DEEP RNA SEQUENCING Summary Related Patents View Save Abstract: The invention provides a method for treating COVID-19 patients. Therapeutic antibodies of certain types of antibodies to COVID-19 are identified early by targeted diagnostic … |
RHODE ISLAND HOSPITAL | 2022-11-09 | 2025-01-30 | |
| 567 | ALTERATIONS IN THE MOLECULAR COMPOSITION OF URINE FROM COVID19 PATIENTS, DETECTED USING RAMAN SPECTROSCOPIC AND COMPUTATIONAL ANALYSIS Citation: 2 Summary Related Patents View Save Abstract: The present invention comprises methods of detecting and classifying COVID-19 disease using Raman spectra obtained from subject urine samples. Raman spectra from subject urine … |
VIRGINIA TECH INTELLECTUAL PROPERTIES | 2022-11-07 | 2023-05-11 | |
| 568 | Disinfectants with iodine and copper complexes Summary Related Patents View Save Abstract: Liquid antimicrobial disinfectant compositions for treatment of coronaviruses and specifically the Covid-19 virus (SARS-CoV-2) on skin and surfaces such as PPE (personal … |
CLYRA MEDICAL TECHNOLOGIES | 2022-11-07 | 2024-12-03 | |
| 569 | METHODS FOR TREATING OR PREVENTING VIRAL INFECTION Summary Related Patents View Save Abstract: The present invention relates to methods for treating or preventing viral infection, or disease or complications associated with viral infection, in particular infection by a … |
UNIKUM THERAPEUTICS APS et. al. | 2022-11-07 | 2025-01-16 | |
| 570 | ENHANCED EXPRESSION VIA AUTOTRANSPORTERS Summary Related Patents View Save Abstract: Provided are expression cassettes that include coding sequences encoding at least one polar amino acid or at least one expression enhancement peptide that includes one or more … |
UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2022-11-04 | 2025-10-30 | |
| 571 | COMPOSITION WITH VIRUCIDAL ACTIVITY, USE AND APPLICATION THEREOF Summary Related Patents View Save Abstract: Increasingly, infectious diseases due to viruses, bacteria, fungi and other contact-transmissible microorganisms, droplets and/or aerosols, are acquiring greater importance due to … |
BIO LOGIC CROP SCIENCE | 2022-11-04 | 2025-01-16 | |
| 572 | TREATMENT OF VIRAL INFECTION, DISEASE OR DISORDER USING A SELECTIVE S1R AGONIST Summary Related Patents View Save Abstract: The subject invention provides a method for treating, reducing the incidence, suppressing or inhibiting a viral infection, disease, disorder or symptoms thereof in a subject in … |
PRILENIA NEUROTHERAPEUTICS | 2022-11-04 | 2023-03-30 | |
| 573 | KIT AND METHOD FOR DETECTING CORONAVIRUS Summary Related Patents View Save Abstract: Provided are a kit for detecting Coronavirus using magnetic nanoparticles and a method detecting Coronavirus using the same. The kit for detecting Coronavirus includes a reactor … |
KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION; INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS | 2022-11-04 | 2023-08-31 | |
| 574 | METHODS OF DETECTING AND TREATING LUNG DAMAGE IN RESPIRATORY-RELATED VIRAL INFECTIONS Summary Related Patents View Save Abstract: Provided herein are methods for detecting, monitoring, diagnosing and treating respiratory-related viral infections, including SARS-CoV-2 infected individuals and subjects that … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-11-04 | 2023-06-15 | |
| 575 | COMPOSITION FOR TREATMENT AND PREVENTION OF COVID-19 Citation: 3 Summary Related Patents View Save Abstract: The present disclosure provides pharmaceutical compositions comprising antibodies and antigen-binding fragments thereof that specifically bind to the spike protein of SARS-CoV-2 … |
ASTRAZENECA UK | 2022-11-04 | 2023-08-03 | |
| 576 | SARS-COV-2 S PROTEIN POLYPEPTIDE ANTIGEN AND APPLICATION THEREOF Summary Related Patents View Save Abstract: Provided are a polypeptide antigen derived from the S protein of SARS-CoV-2, a polypeptide vaccine containing the same, and applications thereof. The amino acid sequence of the … |
CHINESE PLA GENERAL HOSPITAL | 2022-11-03 | 2025-03-27 | |
| 577 | Immunogenic Constructs And Vaccines For Use In The Prophylactic And Therapeutic Treatment Of Diseases Caused By SARS-CoV-2 Summary Related Patents View Save Abstract: This invention relates to immunogenic constructs, such as polynucleotides, polypeptides and multimeric proteins and to antigenic units and to pharmaceutical compositions/vaccines … |
NYKODE THERAPEUTICS ASA; ADAPTIVE BIOTECHNOLOGIES | 2022-11-03 | 2025-02-13 | |
| 578 | NUCLEIC ACID VACCINES FOR CORONAVIRUS Summary Related Patents View Save Abstract: Provided herein are therapeutic nucleic acid molecules for managing, preventing and/or treating infectious diseases caused by coronavirus. Also provided herein are therapeutic … |
SUZHOU ABOGEN BIOSCIENCES | 2022-11-02 | 2024-02-08 | |
| 579 | MEDICAL USE OF N4-HYDROXY CITICOLINE COMPOUNDS Summary Related Patents View Save Abstract: The present disclosure relates to the medical use of citicoline analogs with a N -hydroxycytidine moiety and a solvate or pharmaceutically acceptable salt thereof. The compounds … |
IMMUNIC | 2022-11-01 | 2025-01-30 | |
| 580 | NUCLEIC ACID VACCINES FOR CORONAVIRUS Citation: 4 Summary Related Patents View Save Abstract: Provided herein are therapeutic nucleic acid molecules for managing, preventing and/or treating infectious diseases caused by coronavirus. Also provided herein are therapeutic … |
SUZHOU ABOGEN BIOSCIENCES | 2022-11-01 | 2023-09-07 | |
| 581 | VSV (VITAMIN C-SPIRULINA-VITAMIN D) COMPOSITION, KIT AND METHOD Summary Related Patents View Save Abstract: A formulation comprises a combination of , vitamin C and vitamin D. In some versions (i) the comprises between 0.25X and 4X, wherein X is 452 milligrams, (ii) the vitamin C … |
JOSEPH MILSTEIN | 2022-11-01 | 2023-03-02 | |
| 582 | THERAPEUTIC AND VACCINE CANDIDATES AGAINST SARS-CoV-2 Summary Related Patents View Save Abstract: Provided herein is an immunogenic composition comprising a synthetic antigen to COVID spike proteins, particularly the chimeric intermediate structure C-A Complex. Also disclosed … |
GENEONE LIFE SCIENCE | 2022-10-31 | 2025-08-07 | |
| 583 | E PROTEIN CHANNEL BLOCKERS AND ORF3 INHIBITORS AS ANTI-COVID-19 AGENTS Summary Related Patents View Save Abstract: Pharmaceutical compositions comprising a SARS-CoV-2 E protein channel blocker and ORF3 inhibitors for treating or preventing SARS-CoV-2 virulence in a subject, are provided. … |
YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM | 2022-10-31 | 2023-06-22 | |
| 584 | METHODS FOR THE TREATMENT OF VIRAL RESPIRATORY INFECTIONS Summary Related Patents View Save Abstract: Compositions and methods for treatment of a respiratory infection by a virus are disclosed herein. In some embodiments, the composition comprises pulmonary administration of a … |
GRADALIS | 2022-10-31 | 2023-05-11 | |
| 585 | STABLE CELL CLONES HARBORING REPLICATING SARS-COV-2 RNA Summary Related Patents View Save Abstract: Coronavirus genomes comprising non-native SARS-CoV-2 RNAs having genetically inactivated spike (S), envelope (E), and membrane (M) genes, and optionally a genetically inactivated … |
UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN | 2022-10-31 | 2025-08-07 | |
| 586 | ECO-FRIENDLY QUARANTINE COMPOSITION HAVING FUNCTION OF KILLING PHOSPHOLIPID ENVELOPED VIRUS Summary Related Patents View Save Abstract: An eco-friendly quarantine composition has a function of killing phospholipid enveloped viruses, The eco-friendly quarantine composition includes: 10 to 40 wt. % of … |
UE CHEMICAL et. al. | 2022-10-28 | 2025-03-20 | |
| 587 | AGENT FOR INHIBITING PROLIFERATION OF SARS-CoV-2 Summary Related Patents View Save Abstract: An object of the present invention is to provide a novel agent for inhibiting proliferation of SARS-COV-2 and a novel agent for preventing onset of COVID-19. According to the … |
JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES; KIRIN HOLDINGS | 2022-10-27 | 2024-12-19 | |
| 588 | ELECTROCHEMICAL BIOMOLECULE-FUNCTIONALIZED SENSOR DEVICE AND METHODS OF MAKING AND USING THE SAME Summary Related Patents View Save Abstract: Disclosed herein are embodiments of an electrochemical biomolecule-functionalized sensor device for rapidly determining whether a subject has, or is at risk of developing, a … |
BOARD OF REGENTS OF THE NEVEADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIV. OF NEVADA et. al. | 2022-10-27 | 2024-12-19 | |
| 589 | TRANSNASAL AND TRANSORAL NASOPHARYNGEAL DIAGNOSTICS AND THERAPEUTICS Summary Related Patents View Save Abstract: Disclosed herein are devices and methods for improved transnasal and transoral nasopharyngeal diagnostics and therapeutics, particularly to detect the presence of infectious … |
BHL PATENT HOLDINGS | 2022-10-27 | 2023-04-27 | |
| 590 | COMPOSITIONS AND METHODS FOR ENHANCING EFFICACY AND REDUCING ADVERSE EFFECTS FROM COVID VACCINATION Summary Related Patents View Save Abstract: Probiotic compositions and methods for enhancing efficacy of COVID-19 vaccination or for reducing adverse effects of COVID-19 vaccination. … |
CHINESE UNIVERSITY OF HONG KONG et. al. | 2022-10-27 | 2024-12-19 | |
| 591 | A RECOMBINANT CONSTRUCT FOR SCREENING DRUGS AGAINST SARS-COV-2 SPIKE PROTEIN Summary Related Patents View Save Abstract: Trypsin/trypsin-like proteases have been reported to be facilitating SARS-COV-2 entry into host cells. Spike has protease cleavage sites between the S1 and S2 domains. Cleavage … |
COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2022-10-27 | 2025-01-02 | |
| 592 | Antiviral Agent Comprising a Cellular Entry Receptor and Fc Region Component Summary Related Patents View Save Abstract: An immunotherapeutic protein and methods of use and production thereof are disclosed, wherein the immunotherapeutic protein comprises, for example, a cell surface receptor … |
MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH | 2022-10-26 | 2025-01-09 | |
| 593 | POINT-OF-CARE SARS-COV-2 VIRUS DIAGNOSTIC DEVICE AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: The present invention provides compositions comprising primers for loop-mediated isothermal amplification of a target nucleotide sequence of SARS-CoV-2, as well as point-of-care … |
GODX | 2022-10-25 | 2023-05-25 | |
| 594 | Anti-viral agents and methods for administration thereof Summary Related Patents View Save Abstract: This invention relates to the use of anti-viral drugs with different mechanisms of action for the treating or preventing of viral infections such as COVID-19 (also known as … |
JOHN M.H. GREGG | 2022-10-25 | 2025-04-29 | |
| 595 | MONOCLONAL ANTIBODIES SPECIFIC FOR SARS-COV-2 RBD Summary Related Patents View Save Abstract: The present invention relates to monoclonal antibodies binding to the Receptor Binding Domain of the Spike protein of SARS-CoV-2 virus, nucleic acids encoding said antibody, host … |
ROCHE DIAGNOSTICS OPERATIONS | 2022-10-25 | 2025-02-06 | |
| 596 | SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN Summary Related Patents View Save Abstract: Single-domain monoclonal antibodies (“nanobodies”) that specifically bind the S2 subunit of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein are … |
U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2022-10-25 | 2024-12-19 | |
| 597 | CHIMERIC BETACORONAVIRUS SPIKE POLYPEPTIDES Summary Related Patents View Save Abstract: The present invention relates to chimeric coronavirus spike polypeptides and uses thereof, including in vaccines. … |
UNIVERSITY OF MELBOURNE | 2022-10-21 | 2025-01-23 | |
| 598 | METHODS OF DETECTING ANTIBODIES TO SARS-COV-2 Summary Related Patents View Save Abstract: The present disclosure provides solution based assays for detecting antibodies induced by SARS-CoV-2 (anti-SARS-CoV-2) in a biological sample. … |
PROCISEDX | 2022-10-21 | 2023-04-27 | |
| 599 | VIRAL DETECTION SYSTEM AND METHODS OF USING SAME Summary Related Patents View Save Abstract: A biosensing device and methods for detecting the SARS-CoV-2 virus sequence in a biological fluid. The device includes an interdigitated electrode, a supporting flexible membrane … |
PURDUE RESEARCH FOUNDATION | 2022-10-21 | 2023-11-09 | |
| 600 | Method and combination for the suppression of COVID-19 virus Summary Related Patents View Save Abstract: Provided is a method for treating a SARS-CoV2 3CL -related disease in a subject in need thereof by blocking dimerization of 3C-like main protease (3CL ) of the SARS-CoV2, … |
NATIONAL TSING HUA UNIVERSITY; PRAEXISIO TAIWAN | 2022-10-20 | 2025-07-29 | |
| 601 | TREATMENT OF VIRUSES WITH ANTIVIRAL NUCLEOSIDES Summary Related Patents View Save Abstract: Therapies comprising administering at least one antiviral nucleoside, and the use of such therapies in the treatment of viral infections, such as infection by Eastern equine … |
MERCK SHARP & DOHME; EMORY UNIVERSITY | 2022-10-20 | 2025-06-26 | |
| 602 | DNA ORIGAMI SUBUNIT VACCINE FOR PREVENTION OF SARS-CoV-2 VARIANT INFECTION Summary Related Patents View Save Abstract: The present disclosure relates to DNA nanocarriers and methods of use for stimulating an immune response in a host. In some embodiments, the DNA nanocarriers comprise SARS-CoV-2 … |
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-10-20 | 2024-12-12 | |
| 603 | HIGH SENSITIVITY DNA LINKED IMMUNOSORBENT SIGNAL AMPLIFICATION ASSAY (DLISA) FOR DETECTION OF INFECTIOUS SARS-COV-2 VIRUS AND VARIANTS Summary Related Patents View Save Abstract: The present disclosure relates to the use of DNA-peptide hybrid molecules to detect target molecules in a sample. In some embodiments, the DNA-peptide hybrid molecules comprise … |
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-10-20 | 2025-09-11 | |
| 604 | ANTIBODIES TO CORONAVIRUS SARS-COV-2 Summary Related Patents View Save Abstract: Described herein are antibodies or variants thereof that specifically bind to coronavirus antigens, such as SARS-CoV-2 antigens. The antibodies can be neutralizing antibodies. … |
UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE; ATRECA | 2022-10-20 | 2024-10-03 | |
| 605 | USE OF PLANT COMPOSITION, TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARING MEDICINE FOR TREATING COVID-19 Summary Related Patents View Save Abstract: The present invention relates to a method of treating moderate or severe symptoms of COVID-19 using a plant composition. The plant composition comprises Prepared Monkshood … |
NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE MINISTRY OF HEALTH AND WELFARE | 2022-10-19 | 2023-04-20 | |
| 606 | MULTI-EPITOPE MRNA SARS-COV-2 VACCINE FOR BOOSTING IMMUNITY THROUGH THE ACTIVATION OF CD4 AND CD8 T CELLS AS WELL AS B LYMPHOCYTES Summary Related Patents View Save Abstract: In various embodiments immunogenic nanoparticles are provided that are capable of raising an immune response directed against SARS-CoV-2. In certain embodiments the immunogenic … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-10-19 | 2025-06-19 | |
| 607 | USES OF TAXIFOLIN FOR RESPIRATORY HEALTH Summary Related Patents View Save Abstract: The present disclosure provides methods for treating or preventing an infectious disease or condition, such as the COVID-19 virus (SARS-CoV-2), by administering a therapeutically … |
PHYTO TECH | 2022-10-19 | 2023-04-20 | |
| 608 | IMMUNOGENIC FUSION PROTEINS AGAINST CORONAVIRUS Summary Related Patents View Save Abstract: Immunogenic fusion proteins against coronavirus. A fusion protein is disclosed, which comprises a CD40-binding domain; an antigen of SARS-CoV2; a translocation domain located … |
NAVICURE BIOPHARMACEUTICALS | 2022-10-18 | 2024-12-05 | |
| 609 | Compositions Containing Coronavirus Proteins and Epitopes Summary Related Patents View Save Abstract: The present application relates to compositions of matter, processes and uses of compositions of matter relating to Coronavirus proteins, peptides and epitopes, for example, for … |
LA JOLLA INSTITUTE FOR IMMUNOLOGY | 2022-10-14 | 2024-12-05 | |
| 610 | MULTI-EPITOPE PAN-CORONAVIRUS VACCINE COMPOSITIONS Summary Related Patents View Save Abstract: Multi-epitope, pan-coronavirus recombinant vaccine compositions featuring a combination of highly conserved B cell epitopes, highly conserved CD4+ T cell epitopes, and highly … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-10-14 | 2023-05-11 | |
| 611 | COMPOSITIONS AND METHODS FOR VACCINATION AGAINST PATHOGENIC CORONAVIRUS SPECIES AND VARIANTS Summary Related Patents View Save Abstract: The current disclosure includes coronavirus vaccines that protect against pathogenic coronavirus species, as well as their variants. In certain embodiments, SARS-CoV-2 variant … |
YALE UNIVERSITY | 2022-10-14 | 2025-05-01 | |
| 612 | MODIFIED MULTABODY CONSTRUCTS, COMPOSITIONS, AND METHODS TARGETING SARS-COV-2 Summary Related Patents View Save Abstract: A self-assembled polypeptide complex comprises: (a) one or more fusion proteins comprising a nanocage monomer or subunit thereof linked to an Fc polypeptide, and (b) one or more … |
HOSPITAL FOR SICK CHILDREN | 2022-10-14 | 2025-01-09 | |
| 613 | GENE CONSTRUCT FOR EXPRESSING MRNA Summary Related Patents View Save Abstract: The present invention relates to a gene construct for expressing an mRNA, and a pharmaceutical composition, a vaccine composition, and a gene therapy composition, each comprising … |
GENOMICTREE | 2022-10-14 | 2024-12-12 | |
| 614 | LARGE SEQUENCE PAN-CORONAVIRUS VACCINE COMPOSITIONS Citation: 5 Summary Related Patents View Save Abstract: Pan-coronavirus vaccines for inducing efficient, powerful and long-lasting protection against all Coronaviruses infections and diseases, comprising multiple highly conserved large … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-10-14 | 2023-06-08 | |
| 615 | METHODS AND COMPOSITIONS FOR TREATING SUBJECTS WITH METABOLIC DISORDERS AND CORONAVIRUS INFECTIONS Summary Related Patents View Save Abstract: Provided herein are thiazolidinedione analogues that are useful for treating metabolic disorders and/or coronavirus infections. In some embodiments, the metabolic disorder … |
CIRIUS THERAPEUTICS | 2022-10-14 | 2023-07-06 | |
| 616 | PAN-CORONAVIRUS VACCINE COMPOSITIONS Summary Related Patents View Save Abstract: Pan-coronavirus recombinant vaccine compositions featuring whole proteins or sequences of proteins encompassing all mutations in variants of human and animal Coronaviruses (e.g., … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-10-13 | 2023-07-20 | |
| 617 | USE OF METABOLIC REGULATORS FOR THE TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: Methods of treating coronavirus infection, or decreasing the risk of symptomatic infection, by administering a peroxisome proliferator-activated receptor alpha (PPARA) agonist or … |
YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM | 2022-10-13 | 2023-06-22 | |
| 618 | ANTIBODIES FOR USE AGAINST SARS-COV-2 Summary Related Patents View Save Abstract: Disclosed herein are antibodies to SARS-COV-2 antigens and recombinant nucleic acid sequences that encode the SARS-COV-2 antibodies. The disclosure also provides a method of … |
DAVID WEINER et. al. | 2022-10-13 | 2024-12-12 | |
| 619 | METHODS AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF AN ANTI-B-CORONAVIRUS ANTIBODY IN A SAMPLE Summary Related Patents View Save Abstract: Disclosed herein are methods, kits, systems, algorithms and improvements for detecting the presence of or determining an amount, quantity, concentration and/or level of an … |
ABBOTT LABORATORIES | 2022-10-12 | 2023-08-17 | |
| 620 | NOVEL RHODANINE DERIVATIVES AND USES THEREOF Summary Related Patents View Save Abstract: Novel rhodanine derivatives and methods for their use are provided herein. The rhodanine derivatives are useful in treating or preventing viral infections, including coronavirus … |
GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION | 2022-10-12 | 2025-01-09 | |
| 621 | DEVICES AND METHODS FOR TREATING A VIRAL INFECTION AND SYMPTOMS THEREOF Summary Related Patents View Save Abstract: The devices and methods of the present invention can be used to capture and remove COVID-19 mediating nanoparticles and/or exosomes associated with COVID-19 or similar disease … |
AETHLON MEDICAL | 2022-10-11 | 2024-12-05 | |
| 622 | ACE2-Targeted Compositions and Methods for Treating COVID-19 Summary Related Patents View Save Abstract: This invention provides a monoclonal antibody that (i) specifically binds to the extracellular portion of human angiotensin converting enzyme 2 (hACE2); (ii) specifically inhibits … |
MADDON ADVISORE | 2022-10-11 | 2024-12-12 | |
| 623 | COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIOUS DISEASE-19 (COVID-19) Summary Related Patents View Save Abstract: Compositions and methods for treating and/or diagnosing a subject having COVID-19. The treatment composition includes an inhibitor of at least one of doublecortin-like kinase 1 … |
BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA | 2022-10-11 | 2025-04-24 | |
| 624 | COMPOSITION, KIT AND METHOD FOR DETECTING AND CLASSIFYING PATHOGENS CAUSING RESPIRATORY TRACT INFECTION, AND APPLICATION Citation: 1 Summary Related Patents View Save Abstract: Provided is a composition for detecting novel coronavirus 2019-nCoV, influenza A virus, influenza B virus, respiratory adenovirus, respiratory syncytial virus, and . Also … |
SANSURE BIOTECH | 2022-10-11 | 2023-09-14 | |
| 625 | DRY FORMULATIONS OF ANTI-SARS-COV-2 VIRUS ANTIBODIES AND COMPOSITIONS AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: The invention generally encompasses a human-derived monoclonal antibody compositions and methods comprising a dry powder formulation for neutralizing SARS-CoV-2 and known variants … |
AUGMENTA BIOWORKS et. al. | 2022-10-11 | 2023-08-31 | |
| 626 | MULTIEPITOPE SELF-ASSEMBLED NANOPARTICLE VACCINE PLATFORM (MSN-VACCINE PLATFORM) AND USES THERE OF Summary Related Patents View Save Abstract: The present invention is drawn to a next generation nano vaccine platform by using structure-based design to utilize the conserved or less variable or highly immunogenic domains … |
TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE | 2022-10-11 | 2024-12-26 | |
| 627 | Effect of YEL002 on Conditions and Diseases Summary Related Patents View Save Abstract: A preparation comprising the YEL002 compound as an active ingredient for the prevention or treatment of one or more diseases, and methods of using such preparations. The … |
RADMIT | 2022-10-08 | 2024-04-18 | |
| 628 | ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF I Summary Related Patents View Save Abstract: The present disclosure relates to proteins which bind to severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) and uses thereof. … |
SEQIRUS | 2022-10-07 | 2024-12-05 | |
| 629 | PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST AN INFECTION BY SARS-COV-2 (COVID-19) Summary Related Patents View Save Abstract: SARS-CoV2-associated T-cell peptide epitopes as active pharmaceutical ingredients of vaccine compositions to stimulate anti-SARS-CoV2 immune responses, or to stimulate T cells ex … |
EBERHARD KARLS UNIVERSITÄT TÜBINGEN MEDIZINISCHE FAKULTÄT | 2022-10-07 | 2023-12-21 | |
| 630 | ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF II Summary Related Patents View Save Abstract: The present disclosure relates to anti-SARS-COV-2 antibodies and uses thereof in detecting intact multimeric and/or intact trimeric severe acute respiratory syndrome coronavirus 2 … |
SEQIRUS | 2022-10-07 | 2025-07-31 | |
| 631 | PHARMACEUTICAL FORMULATIONS COMPRISING ANTI-CORONAVIRUS S PROTEIN ANTIBODIES AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure is directed to pharmaceutical formulations comprising antibodies, and antigen binding fragments thereof, having binding specificity for the S protein of … |
INVIVYD | 2022-10-07 | 2024-12-26 | |
| 632 | METHODS FOR ASSESSING THE SEVERITY OF, AND FOR INHIBITING, PRO-INFLAMMATORY RESPONSES WITH TOTAL CELL-FREE DNA Summary Related Patents View Save Abstract: This invention relates to methods and compositions for assessing an amount of total cell-free DNA, such as from a subject having a pro-inflammatory response, such as a … |
MEDICAL COLLEGE OF WISCONSIN | 2022-10-06 | 2023-05-04 | |
| 633 | CORONAVIRUS VACCINES Summary Related Patents View Save Abstract: Designed coronavirus polypeptide sequences are described, and their use as vaccines against viruses of the coronavirus family. The designed sequences include designed coronavirus … |
DIOSYNVAX et. al. | 2022-10-06 | 2025-10-09 | |
| 634 | Air filter with pathogen monitoring and inactivation Summary Related Patents View Save Abstract: An improved technology for inactivation of viruses, for example the SARS-CoV-2 virus that is causing the Covid-19 pandemic, is described. The technology can include a device that … |
INDUSTRIAL POLYMERS AND CHEMICALS | 2022-10-05 | 2023-09-26 | |
| 635 | Antibody specific to spike protein of SARS-CoV-2 and uses thereof Citation: 7 Summary Related Patents View Save Abstract: The present disclosure relates to an antibody or antigen-binding fragment thereof that specifically binds to a spike protein of SARS-CoV-2. The present disclosure also relates to … |
ACADEMIA SINICA | 2022-10-03 | 2024-01-09 | |
| 636 | DIAGNOSTIC SYSTEM AND METHODS OF USING AND MANUFACTURING THE SAME Summary Related Patents View Save Abstract: Provided are a diagnostic system and methods for detecting the presence or absence of one or more targets that represent virus infection, inflammatory diseases and/or respiratory … |
TINTORIA PIANA et. al. | 2022-10-03 | 2023-04-06 | |
| 637 | SARS-CORONAVIRUS 2 NEUTRALIZING ANTIBODY Summary Related Patents View Save Abstract: The present disclosure relates to a neutralizing antibody against SARS-coronavirus 2 (SARS-CoV2) or a variant virus thereof, or an antigen-binding fragment thereof. Since the … |
SCRIPPS KOREA ANTIBODY INSTITUTE | 2022-09-30 | 2025-01-02 | |
| 638 | COLOR READING FOR DIAGNOSTIC TESTS Summary Related Patents View Save Abstract: Provided herein, in some embodiments, are rapid diagnostic tests to detect one or more target nucleic acid sequences (e.g., a nucleic acid sequence of one or more pathogens). In … |
DETECT | 2022-09-30 | 2023-04-06 | |
| 639 | USE OF HUANGQI EXTRACT FOR SUPPRESSING SARS-COV-2 ENTRY AND TREATING COVID-19 RELATED CYTOKINE STORM Summary Related Patents View Save Abstract: The extract of Huangqi ( ) is a drug or composition with multiple effects. It is not only acting as an inhibitor of viral infection of host cells, but also has the emerging … |
PHYTOHEALTH | 2022-09-30 | 2023-06-22 | |
| 640 | RECOMBINANT NEWCASTLE DISEASE VIRUS EXPRESSING SPIKE PROTEIN OF SARS-COV-2 DELTA VARIANT AND USES THEREOF Summary Related Patents View Save Abstract: Described herein are recombinant Newcastle disease viruses (“NDVs”) comprising a packaged genome, wherein the packaged genome comprises a transgene comprising a nucleotide … |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2022-09-29 | 2025-02-06 | |
| 641 | VIRUCIDAL COMPOSITIONS AND USE THEREOF Citation: 1 Summary Related Patents View Save Abstract: The invention relates to virucidal compositions comprising a sialic acid (SA) moiety, pharmaceutical compositions and disinfection and/or sterilization compositions comprising … |
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE | 2022-09-29 | 2023-03-30 | |
| 642 | POLYMERS OBTAINED BY THE REACTION OF A PHENOLIC COMPOUND AND A CARBONYL COMPOUND AS ANTI-SARS-COV-2 AGENTS Summary Related Patents View Save Abstract: The present invention relates to a condensation product, obtained or obtainable by the reaction of phenol, formaldehyde, sulfuric acid and urea, or a pharmaceutical composition … |
BASF et. al. | 2022-09-29 | 2024-11-28 | |
| 643 | METHOD OF TREATING A PERSON AFFLICTED WITH COVID-19 AND PHARMACEUTICAL FORMULATION INCLUDING DAPSONE Summary Related Patents View Save Abstract: A method for treating patients with COVID-19 and/or other respiratory conditions includes administering eighty-five milligrams of dapsone twice daily for twenty-one days. A … |
PULMONEM | 2022-09-28 | 2023-02-02 | |
| 644 | Rapid diagnostic test for lamp Summary Related Patents View Save Abstract: Compositions and methods are described that are directed to specific and sensitive methods of target nucleic acid detection and more specifically detecting target nucleic acids … |
NEW ENGLAND BIOLABS | 2022-09-28 | 2023-08-22 | |
| 645 | 23-O-ACETYLALISOL B AS A NOVEL THERAPEUTIC AGENT FOR CORONAVIRUS INDUCED SEVERE ACUTE RESPIRATORY SYNDROME Summary Related Patents View Save Abstract: The subject invention pertains to a potent therapeutic agent, 23-O-Acetylalisol B, as an antiviral drug to treat COVID-19. 23-O-Acetylalisol B can broadly and dose-dependently … |
UNIVERSITY OF HONG KONG | 2022-09-28 | 2023-04-06 | |
| 646 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING CORONAVIRUSES Summary Related Patents View Save Abstract: Disclosed herein are immunogenic compositions or product combinations of engineered SARS-CoV nucleic acids, genes, peptides, or proteins that can be used to elicit an immune … |
SVENSKA VACCINFABRIKEN PRODUKTION | 2022-09-28 | 2023-09-21 | |
| 647 | Methods and compositions for treatment of COVID-19 Summary Related Patents View Save Abstract: A method of treatment for coronavirus disease 2019 (COVID-19) is disclosed herein. The method comprises administering a therapeutically effective dose of a combination of … |
ESRAIL MEDICAL | 2022-09-28 | 2023-11-28 | |
| 648 | METHODS, DEVICES, AND RELATED ASPECTS FOR DETECTING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 Summary Related Patents View Save Abstract: Provided herein are methods of detecting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in a sample. The methods include contacting the sample with a plurality of … |
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY; UNIVERSITY OF WASHINGTON | 2022-09-27 | 2025-04-24 | |
| 649 | NOVEL REOVIRUS-BASED VACCINE PLATFORM AND USE THEREOF Summary Related Patents View Save Abstract: The present invention relates to a novel reovirus-based vaccine platform, and confirmed that a part of the S1 gene of reovirus can be replaced with various exogenous … |
VIROCURE | 2022-09-26 | 2025-05-15 | |
| 650 | Monoclonal antibody for spike protein of middle east respiratory syndrome coronavirus, and use thereof Summary Related Patents View Save Abstract: The present invention relates to monoclonal antibodies for a spike protein of the Middle East respiratory syndrome coronavirus (MERS-CoV), and a use thereof. Particularly, … |
UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES; KOREA | 2022-09-25 | 2024-09-03 | |
| 651 | A VACCINE FOR CORONAVIRUS AND INFLUENZA VIRUS, AND METHOD FOR PREPARATION THEREOF Summary Related Patents View Save Abstract: The invention discloses vaccine for coronavirus and influenza virus and method for preparation thereof. More specifically, the invention discloses seasonal viral vaccine i. e. … |
BHARAT BIOTECH INTERNATIONAL | 2022-09-24 | 2024-12-05 | |
| 652 | ALDOSE REDUCTASE INHIBITORS FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME, ACUTE LUNG INFLAMMATION/INJURY, CARDIAC INJURY AND ANTI-VIRAL THERAPY Citation: 1 Summary Related Patents View Save Abstract: The disclosure relates to methods for treating acute respiratory distress syndrome (ARDS), acute lung inflammation (ALI), acute lung injury and/or cardiac injury (e.g., acute … |
APPLIED THERAPEUTICS | 2022-09-23 | 2023-02-23 | |
| 653 | ANTI-SARS-COV-2 ANTIBODIES DERIVED FROM 2DD8 Summary Related Patents View Save Abstract: This disclosure provides antibodies and antigen-binding fragments that can be administered to an individual that is infected or suspected of being infected with a virus. … |
CENTIVAX | 2022-09-23 | 2023-08-31 | |
| 654 | METHODS, COMPLEXES AND KITS FOR DETECTING OR DETERMINING AN AMOUNT OF A ß CORONAVIRUS ANTIBODY IN A SAMPLE Summary Related Patents View Save Abstract: Disclosed herein are methods, complexes, kits, systems and algorithms for detecting or determining an amount, quantity, concentration and/or level of at least one type of … |
ABBOTT LABORATORIES | 2022-09-23 | 2023-03-16 | |
| 655 | Ribonucleoside Analogues Against -Sars-Cov-2 Summary Related Patents View Save Abstract: The invention relates to nucleoside derivatives of formula (I), wherein R has the same meaning as that defined in the claims and the description. The present invention also … |
KATHOLIEKE UNIVERSITEIT LEUVEN | 2022-09-23 | 2025-02-27 | |
| 656 | RAPID-TESTING MASK Summary Related Patents View Save Abstract: A rapid-testing mask is worn by a user, and includes a covering portion, a strap portion and a rapid-testing portion. The covering portion is provided to cover the mouth and the … |
CHIH-CHENG CHIANG et. al. | 2022-09-21 | 2023-03-30 | |
| 657 | RECOMBINANT VACCINE AGAINST COVID-19 TO PRODUCE CELLULAR RESPONSE IN INDIVIDUALS WITH PRE-EXISTING IMMUNITY Summary Related Patents View Save Abstract: A recombinant vaccine is described, which comprises an active Newcastle disease viral vector (NDV) having inserted an exogenous nucleotide sequence of severe acute respiratory … |
LABORATORIO AVI-MEX S.A. DE et. al. | 2022-09-20 | 2025-12-11 | |
| 658 | METHODS FOR CONTROL OF AN INFECTIVE DISEASE WITH A VACCINE Summary Related Patents View Save Abstract: The COVID-19 pandemic has led to a worldwide health crisis and devastating economic and social issues. The present invention provides a method enhancing the effectiveness of the … |
RUSSELLVILLE CARDIOLOGY CONSULTANTS P.A. | 2022-09-20 | 2023-11-23 | |
| 659 | Detection of SARS-CoV-2 Summary Related Patents View Save Abstract: A molecularly imprinted polymer comprises at least one recognition site that is complementary to a template molecule consisting of an amino acid sequence corresponding to a … |
MIP DISCOVERY | 2022-09-20 | 2024-12-26 | |
| 660 | PIV5-BASED CORONAVIRUS VACCINES AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: The present invention provides constructs of the parainfluenza virus type-5 (PIV5) virus expressing the SARS-CoV-2 envelope spike (S) and nucleocapsid (N) proteins of SARS-CoV-2 … |
CYANVAC | 2022-09-20 | 2023-04-06 | |
| 661 | COMPOSITION, KIT AND METHOD FOR DETECTING AND TYPING VIRUSES CAUSING RESPIRATORY TRACT INFECTION AND APPLICATION OF COMPOSITION, KIT AND METHOD Summary Related Patents View Save Abstract: Provided is a composition for detecting a novel coronavirus, influenza A virus and influenza B virus; moreover, also provided are a kit including the composition, an application … |
SANSURE BIOTECH | 2022-09-19 | 2023-06-15 | |
| 662 | ENGINEERED RECEPTORS AND MONOCLONAL ANTIBODIES FOR CRONAVIRUSES AND USES THEREOF Summary Related Patents View Save Abstract: This disclosure relates generally to human ACE2 polypeptides that exhibit enhanced binding to the S protein of SARS-CoV-2, or increased affinity, that can be used as therapeutic … |
BOARD OF THE TRUSTEES OF THE UNIVERSITY OF ILLINOIS et. al. | 2022-09-15 | 2024-12-05 | |
| 663 | COMPOSITION FOR TREATING CORONAVIRUS DISEASE 2019 (COVID-19) CONTAINING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND ANTIVIRAL AGENT AS ACTIVE INGREDIENTS Summary Related Patents View Save Abstract: The present invention relates to a composition for treating coronavirus infection-19 (COVID-19), comprising taurodeoxycholic acid (TDCA) or a pharmaceutically acceptable salt … |
SHAPERON | 2022-09-15 | 2025-05-01 | |
| 664 | TREATMENT OF COVID-19 WITH REVERSE MICELLE SYSTEM COMPRISING UNMODIFIED OLIGONUCLEOTIDES Summary Related Patents View Save Abstract: The present disclosure relates to specific reverse micelle system that allows for the administration and intracellular delivery of unmodified oligonucleotide, such as siRNA, … |
MEDESIS PHARMA et. al. | 2022-09-15 | 2023-04-27 | |
| 665 | USE OF DOXYCYCLINE, RESVERATROL, IVERMECTIN, AND RELATED CHEMICALLY MODIFIED COMPOUNDS TO TREAT OR PREVENT VIRAL INFECTIONS Summary Related Patents View Save Abstract: In accordance with the purpose(s) of the present disclosure, as embodied and broadly described herein, the disclosure, in one aspect, relates to a therapeutic treatment or … |
ARDESTAT BIOLOGICS | 2022-09-15 | 2023-03-23 | |
| 666 | ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF IN THE MEDICAL FIELD Summary Related Patents View Save Abstract: The present invention relates to antibodies against SARS-CoV-2 and uses thereof in the medical field for the prevention and treatment of SARS-CoV-2 infection and COVID-19 disease. … |
TAKIS | 2022-09-15 | 2024-11-21 | |
| 667 | SYNTHETIC MODIFIED VACCINIA ANKARA (sMVA) BASED CORONAVIRUS VACCINES Summary Related Patents View Save Abstract: Disclosed are synthetic MVA-based vaccines for preventing or treating infections caused by a coronavirus or variants thereof. … |
CITY OF HOPE | 2022-09-14 | 2023-07-27 | |
| 668 | ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME Summary Related Patents View Save Abstract: The instant disclosure provides antibodies and antigen-binding fragments thereof that can bind to a SARS-CoV-2 antigen and, in certain embodiments, are capable of neutralizing a … |
VIR BIOTECHNOLOGY | 2022-09-14 | 2023-10-19 | |
| 669 | GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE Summary Related Patents View Save Abstract: This disclosure is based, at least in part, on an unexpected discovery that the novel nanobodies and variants thereof are able to specifically bind afucosylated or sialylated IgG … |
ROCKEFELLER UNIVERSITY | 2022-09-14 | 2025-06-12 | |
| 670 | VIRUS-LIKE PARTICLE STABLY EXPRESSED BY ANIMAL CELLS AS VACCINE ANTIGEN AGAINST COVID-19 AND INFLUENZA VIRUS Summary Related Patents View Save Abstract: The disclosure provides an animal cell stably expressing a virus-like particle (VLP). The disclosure also provides a method for manufacturing a virus-like particle, a virus-like … |
ACADEMIA SINICA | 2022-09-14 | 2025-07-31 | |
| 671 | Nitrile-Containing Antiviral Compounds Summary Related Patents View Save Abstract: The invention relates to compounds of Formula I″ wherein R, R , R , R , p, q and q′ are as defined herein, pharmaceutical compositions comprising the compounds, methods of … |
PFIZER | 2022-09-14 | 2023-04-20 | |
| 672 | Systems and methods for treating blood clots with nerve stimulation Summary Related Patents View Save Abstract: Systems and methods are provided for treating blood clots associated with a replicating pathogen, such as a virus in the coronaviridae family. The methods include emitting an … |
ELECTROCORE | 2022-09-13 | 2025-11-11 | |
| 673 | IVERMECTIN COMPOSITIONS FOR TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: Disclosed are novel mechanisms of action of ivermectin therapy as related to treatment of COVID-19 and means of augmenting therapeutic activities by co-administration with one or … |
THERAPEUTIC SOLUTIONS INTERNATIONAL | 2022-09-13 | 2023-03-16 | |
| 674 | N4-ISOBUTYRYLOXYCYTIDINE ANALOG SYNTHESIS AND COMPOSITION FOR TREATING VIRAL INFECTION COMPRISING ANTI-VIRAL USE THEREOF Summary Related Patents View Save Abstract: The present disclosure relates to N -isobutyryloxycytidine analog synthesis and to the anti-viral use thereof against dengue virus, influenza virus, and SARS-COV-2 virus. … |
DONG-A UNIVERSITY RESEARCH FOUNDATION FOR INDUSTRY-ACADEMY COOPERATION | 2022-09-13 | 2025-05-29 | |
| 675 | EXOSOMAL NUCLEIC ACID VACCINE COMPOSITION FOR PROTECTION AGAINST SARS-COV-2 INFECTION AND DISEASE Summary Related Patents View Save Abstract: The present invention relates to an extracellular vesicle (EV)-based nucleic acid composition or vaccine (EV-NAV), comprising EVs loaded with polynucleotides each encoding, e.g., … |
JOHNS HOPKINS UNIVERSITY et. al. | 2022-09-12 | 2025-01-02 | |
| 676 | BIOLOGICALLY PRODUCED NUCLEIC ACID FOR VACCINE PRODUCTION Summary Related Patents View Save Abstract: The invention relates to a biologically produced nucleic acid sequence comprising two or three primary nucleic acid sequence parts of SARS-COV-2 and not more than three secondary … |
UNIVERSITÄT BASEL | 2022-09-09 | 2025-06-12 | |
| 677 | SYNTHETIC HUMANIZED LLAMA NANOBODY LIBRARY AND USE THEREOF TO IDENTIFY SARS-COV-2 NEUTRALIZING ANTIBODIES Summary Related Patents View Save Abstract: Methods for producing synthetic single-domain monoclonal antibody libraries using humanized llama nanobody framework sequences, libraries obtainable by the method, as well as … |
U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2022-09-09 | 2024-12-05 | |
| 678 | COMPOSITIONS AND METHODS FOR DETERMINING HUMORAL IMMUNE RESPONSES AGAINST SEASONAL CORONAVIRUSES AND PREDICTING EFFICIENCY OF SARS-COV-2 SPIKE TARGETING, COVID-19 DISEASE SEVERITY, AND PROVIDING INTERVENTIONS Summary Related Patents View Save Abstract: Provided are compositions and methods for use in determining antibody profiles from individuals who have been infected, vaccinated, or both infected and vaccinated with a one or … |
JACOBS TECHNION-CORNELL INSTITUTE | 2022-09-09 | 2024-11-21 | |
| 679 | ANTIVIRAL STRUCTURALLY-STAPLED SARS-CoV-2 PEPTIDE-CHOLESTEROL CONJUGATES AND USES THEREOF Summary Related Patents View Save Abstract: Disclosed herein are cross-linked peptides either alone or conjugated to PEG(n)-cholesterol (or thiocholesterol) moieties useful for interfering with and inhibiting or preventing … |
DANA-FARBER CANCER INSTITUTE | 2022-09-08 | 2025-03-13 | |
| 680 | FREEZE-DRIED VIRAL COMBINATION VACCINE COMPOSITIONS AND PROCESS FOR PREPARATION THEREOF Summary Related Patents View Save Abstract: The present disclosure relates to field of lyophilized/freeze-dried viral combination composition/formulation and methods for manufacturing and obtaining the composition … |
SERUM INSTITUTE OF INDIA PRIVATE et. al. | 2022-09-08 | 2025-02-20 | |
| 681 | CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: Compositions and methods for the prevention and/or treatment of SARS-CoV-2 infection and/or COVID-19 are described. … |
AFFINIVAX | 2022-09-08 | 2023-07-27 | |
| 682 | CORONAVIRUS FUSION PROTEIN Summary Related Patents View Save Abstract: A fusion protein including fragments of the spike protein and of the nucleoprotein of a coronavirus. Also a vaccine, a composition, a pharmaceutical composition, or a diagnostic … |
UNIVERSITE DE TOURS; INSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE L’ALIMENTATION ET L’ENVIRONNEMENT; UNIVERSITÉ DE LILLE; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE; CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE | 2022-09-07 | 2024-12-26 | |
| 683 | HUMAN NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 SPIKE S2 DOMAIN AND USES THEREOF Summary Related Patents View Save Abstract: The disclosure is based, at least in part, on certain human monoclonal antibodies, or antigen binding fragments thereof, having unexpected broad neutralizing activities against … |
UAB RESEARCH FOUNDATION et. al. | 2022-09-06 | 2024-08-15 | |
| 684 | Digital Healthcare Capture Intake Data for COVID-19 And Other Significant Events Summary Related Patents View Save Abstract: Gateways for patient-responsibility portions of medical bills (PRPMB) transactions, regardless of healthcare provider or merchant services (Credit card processing) provider are … |
MICHAEL DERSHEM | 2022-09-06 | 2022-12-29 | |
| 685 | Peptide Therapeutics Against SARS-COV-2 Spike Protein Summary Related Patents View Save Abstract: Proteinaceous therapeutics, such as antibodies and fusion proteins, for preventing, reducing the occurrence of, and/or treating a SARS-CoV-2 infection in a subject are provided … |
NANTCELL | 2022-09-06 | 2023-07-13 | |
| 686 | COVID-19 THERAPEUTICS AND METHODS OF TREATMENT Summary Related Patents View Save Abstract: Therapeutics and methods of treating COVID-19 in a patient in need thereof comprising administering a pharmaceutically effective dose of a therapeutic, wherein the therapeutic … |
BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2022-09-06 | 2022-12-29 | |
| 687 | Method for predicting risk of unfavorable outcomes, e.g., in COVID-19 hospitalization, from clinical characteristics and basic laboratory findings Summary Related Patents View Save Abstract: A method for predicting an unfavorable outcome for a patient admitted to a hospital, e.g., with a COVID-19 infection is described. Attributes from an electronic health record for … |
BIODESIX | 2022-09-02 | 2024-02-06 | |
| 688 | NEW CORONAVIRUS VACCINE AND METHOD FOR DESIGNING AND OBTAINING A VIRUS VACCINE Summary Related Patents View Save Abstract: The present invention relates to a mutant receptor-binding domain (mRBD) of a coronavirus (mRBD-CORONA) or a fragment thereof and mutant spike protein of the coronavirus … |
MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT; ETH ZURICH | 2022-08-31 | 2024-11-21 | |
| 689 | ANTIBODY THERAPIES FOR SARS-COV-2 INFECTION IN PEDIATRIC SUBJECTS Summary Related Patents View Save Abstract: The instant disclosure provides methods of treating or preventing a SARS-CoV-2 infection in a pediatric subject, e.g., in a pediatric subject having or at risk for developing … |
VIR BIOTECHNOLOGY et. al. | 2022-08-31 | 2024-12-05 | |
| 690 | TREATING LONG COVID-19 WITH UROLITHINS Summary Related Patents View Save Abstract: The invention provides methods useful for treating post-viral illness, including long COVID-19, in a subject afflicted therewith comprising administering to the subject an … |
AMAZENTIS | 2022-08-30 | 2024-11-07 | |
| 691 | PHOSPHATE-REGULATED EXPRESSION OF BIOLOGICALLY ACTIVE RECOMBINANT CORONAVIRUS GLYCOPROTEINS AND OTHER RECOMBINANT PROTEINS IN PHAEODACTYLUM TRICORNUTUM Summary Related Patents View Save Abstract: Phosphate-regulated expression of recombinant glycoprotein antigens and other recombinant proteins in diatoms is described herein. More specifically, described herein is the … |
SUNCOR ENERGY | 2022-08-30 | 2023-10-12 | |
| 692 | EXTRACELLULAR VESICLE COMPOSITIONS AND THE USE THEREOF IN THE TREATMENT OF SKIN CONDITIONS AND IN IMMUNE MODULATION Citation: 2 Summary Related Patents View Save Abstract: Extracellular vesicle (EV) compositions, specifically exosomes and microvesicles are disclosed together with the use of such EV compositions, exosomes and microvesicles, in … |
MVEX JAPAN | 2022-08-30 | 2023-06-08 | |
| 693 | VACCINE COMPOSITION FOR PREVENTION AGAINST COVID-19 Summary Related Patents View Save Abstract: The present invention relates to a vaccine composition for preventing or treating coronavirus disease (COVID-19) comprising a recombinant adenovirus as an active ingredient. The … |
KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY | 2022-08-29 | 2024-11-07 | |
| 694 | Catalysis deactivated angiotensin-converting enzyme 2 (ACE2) variants and their uses Citation: 5 Summary Related Patents View Save Abstract: Angiotensin-converting enzyme 2 (ACE2) has been confirmed as a specific receptor for several β group coronaviruses include severe respiratory syndrome (SARS) coronavirus … |
AVIRMAX | 2022-08-29 | 2024-02-13 | |
| 695 | COMPOSITION, KIT AND METHOD FOR DETECTING SARS-COV-2 AND USE THEREOF Summary Related Patents View Save Abstract: A composition for detecting SARS-CoV-2 is provided; moreover, a kit including the composition, the use of the kit, and a method for detecting SARS-CoV-2 are also provided. … |
SANSURE BIOTECH | 2022-08-26 | 2023-03-23 | |
| 696 | Irak Inhibitor for Treating Cytokine Release-Related Conditions Associated With Infection by a Respiratory Virus Summary Related Patents View Save Abstract: Disclosed herein is method for treating and/or preventing a cytokine release-related condition associated with infection by a respiratory virus, e.g., COVID-19 or influenza. In … |
RIGEL PHARMACEUTICALS | 2022-08-26 | 2024-11-21 | |
| 697 | METHODS FOR DETECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 Summary Related Patents View Save Abstract: Methods and reagents for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) are described. Also described are methods and reagents for multiplexed detection … |
AVELLINO LAB | 2022-08-25 | 2023-04-27 | |
| 698 | ALVEOLAR ORGANOIDS, METHODS OF MAKING AND USES THEREOF Summary Related Patents View Save Abstract: Methods for obtaining a population of differentiated alveolar cells, differentiated alveolar cells in the form of alveolar organoids generated by the methods and uses for the … |
VERSITECH et. al. | 2022-08-25 | 2025-04-17 | |
| 699 | DETECTION OF SARS-COV-2 USING RNA MULTI-ARM JUNCTION LOGIC GATES Summary Related Patents View Save Abstract: The present invention provides loop-mediated riboregulators for the detection of SARS-CoV-2. Also provided are DNA constructs encoding the loop-mediated riboregulators and methods … |
ALEXANDER GREEN et. al. | 2022-08-25 | 2023-05-11 | |
| 700 | LATERAL FLOW ASSAY BY USING CARBOXYL LATEX BEADS AND BIOTIN-POLYSTREPTAVIDIN FOR THE DETECTION OF COVID-19 INFECTION AND DIAGNOSTIC KIT USING THE LATERAL FLOW ASSAY Summary Related Patents View Save Abstract: The systems and methods herein are directed to carboxylated latex beads and biotin-polysterptavidin as a label material for fluorescence lateral flow assay (LFA) for the diagnosis … |
JUNG JOO MOON et. al. | 2022-08-25 | 2025-03-13 | |
| 701 | GLP-1R AGONISTS FOR USE IN A TREATMENT OF NEUROLOGIAL IMPAIRMENT ASSOCIATED WITH VIRAL INFECTION Summary Related Patents View Save Abstract: Long-acting glucagon like peptide 1 receptor agonists (GLP-1R agonists) reduce and inhibit pathological processes caused by activated microglia that give rise to long-term … |
NEURALY | 2022-08-25 | 2024-11-14 | |
| 702 | Mammalian Hybrid Pre-Autophagosomal Structure HyPAS and Compositions and Methods for the Treatment of Coronavirus Infections and Related Disease States Summary Related Patents View Save Abstract: The present invention is directed to elucidating the mechanism of formation of autophagosomal membranes that emerge via convergence of secretory and endosomal pathways and … |
UNM RAINFOREST INNOVATIONS | 2022-08-25 | 2023-08-24 | |
| 703 | POTENTLY NEUTRALIZING NOVEL HUMAN MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 (COVID-19) Summary Related Patents View Save Abstract: The present invention relates to seven novel neutralizing human monoclonal antibodies (mAbs) THSC20.HVTR04, THSC20.HVTR06, THSC20.HVTR11, THSC20.HVTR26 THSC20.HVTR39, … |
TRANSLATIONAL HEALTH SCIENCE AND TECHNOLOGY INSTITUTE et. al. | 2022-08-24 | 2025-09-25 | |
| 704 | TREATMENT OF LOWER RESPIRATORY TRACT INFECTION WITH TRADIPITANT Summary Related Patents View Save Abstract: Disclosed herein is a method of treatment of a lower respiratory tract infection caused by. e.g., coronavirus disease (COVID-19), influenza, or other virus. comprising treatment … |
VANDA PHARMACEUTICALS | 2022-08-24 | 2024-10-24 | |
| 705 | IDENTIFICATION OF BIOMIMETIC VIRAL PEPTIDES AND USES THEREOF Summary Related Patents View Save Abstract: Disclosed are small peptides derived from the binding interface of each of SARS-CoV-2 spike protein and ACE2 receptor, compositions comprising the same, and prophylactic and … |
LIGANDAL | 2022-08-24 | 2023-08-03 | |
| 706 | SARS-CoV-2 Rapid Detection Device Summary Related Patents View Save Abstract: An integrated device for rapid detection of SARS-CoV-2 is disclosed. The integrated device includes a front-end system, a back-end system, and a microfluidic channel. The … |
CITY UNIVERSITY OF HONG KONG | 2022-08-23 | 2024-02-29 | |
| 707 | FUSION POLYPEPTIDE Summary Related Patents View Save Abstract: Disclosed herein are fusion polypeptides comprising at least one peptide domain from a severe acute respiratory syndrome coronavirus (SARS CoV-2) spike protein (S-protein), … |
VICTORIA LINK | 2022-08-23 | 2025-04-24 | |
| 708 | COMPOSITIONS AND METHODS FOR TREATING POST-COVID CONDITIONS OF FATIGUE Summary Related Patents View Save Abstract: Disclosed is a method for treating a subject that has previously been infected with SARS-COV-2 and exhibiting at least one Post COVID-19 Conditions of fatigue (PCC of fatigue) … |
AIM IMMUNOTECH | 2022-08-22 | 2024-10-24 | |
| 709 | TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: Provided herein are compositions useful for the treatment of COVID-19. … |
OXYGEN BIOTECH | 2022-08-22 | 2024-10-24 | |
| 710 | Use of Interferon in Preparing Drug for Preventing Coronavirus Infection or Preventing Disease Caused by Coronavirus Infection Summary Related Patents View Save Abstract: Disclosed are a use of an interferon in preparing a drug for preventing novel coronavirus SARS-CoV-2 infection or a disease COVID-19 caused by the novel coronavirus infection, and … |
ZHONGJI MENG et. al. | 2022-08-21 | 2022-12-22 | |
| 711 | COMPOSITION, KIT, AND METHOD FOR DETECTING AND TYPING CORONAVIRUSES Summary Related Patents View Save Abstract: Provided in the present invention is a composition capable of detecting and typing novel coronavirus 2019-nCoV, coronavirus 229E, coronavirus NL63, coronavirus OC43, coronavirus … |
SANSURE BIOTECH | 2022-08-19 | 2023-06-22 | |
| 712 | QUINACRINE AND DERIVATIVES THEREOF FOR TREATMENT OF VIRAL INFECTIONS Summary Related Patents View Save Abstract: Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). The present invention reveals that quinacrine directly binds to G4 … |
ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2022-08-19 | 2024-11-28 | |
| 713 | ENHANCEMENT OF UMBILICAL CORD MESENCHYMAL STEM CELL THERAPEUTIC ACTIVITY BY STIMULATORS OF T REGULATORY CELLS AND/OR CELLS EXPRESSING CD73 Summary Related Patents View Save Abstract: Disclosed are means, compositions of matter and protocols useful for treatment of COVID-19 and/or other inflammatory pathologies through stimulation of T regulatory cells and/or T … |
THERAPEUTIC SOLUTIONS INTERNATIONAL | 2022-08-18 | 2023-02-23 | |
| 714 | PRODRUGS, ANALOGS OR DERIVATIVES OF KAEMPFEROL AS ANTIVIRAL AGENTS Summary Related Patents View Save Abstract: The present invention relates to compounds which can inhibit host cell ACE2 receptor, viral spike S protein, Spike protein-ACE2 receptor interface, RNA-dependent RNA polymerase … |
SANCTUM THERAPEUTICS | 2022-08-18 | 2023-03-02 | |
| 715 | COMPOSITION, KIT FOR DETECTING MUTATIONS OF 2019 NOVELCORONAVIRUS AND USE THEREOF Summary Related Patents View Save Abstract: Provided is a composition for detecting mutations of 2019 novel coronavirus mutation. Also provided are a kit containing the composition, the use of the composition, and a method … |
SANSURE BIOTECH | 2022-08-18 | 2023-07-13 | |
| 716 | SINGLE DOMAIN ANTIBODIES FOR SARS-COV-2 Citation: 3 Summary Related Patents View Save Abstract: Provided herein are methods and compositions relating to libraries of optimized antibodies having nucleic acids encoding for an antibody comprising modified sequences. Libraries … |
TWIST BIOSCIENCE | 2022-08-17 | 2023-06-22 | |
| 717 | COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS BY NEUROTROPIC VIRUS Summary Related Patents View Save Abstract: Activators of hypoxia-inducible factor 1-alpha for treatment and prophylaxis of viral infections caused by neurotropic viruses are provided. The compounds are broad-spectrum … |
MICHAEL HANS WILLI LAPPE | 2022-08-17 | 2024-10-24 | |
| 718 | VACCINE COMPOSITIONS Summary Related Patents View Save Abstract: The invention relates to vaccine compositions for inducing an immune response to a coronavirus in a subject, and uses thereof. In particular, the vaccine comprises of a chimeric … |
MONASH UNIVERSITY | 2022-08-17 | 2025-03-27 | |
| 719 | SARS-COV-2 ANTIBODIES AND RELATED COMPOSITIONS AND METHODS OF USE Citation: 4 Summary Related Patents View Save Abstract: Provided herein are methods and compositions relating to libraries of optimized antibodies having nucleic acids encoding for an antibody comprising modified sequences. Libraries … |
TWIST BIOSCIENCE | 2022-08-17 | 2023-06-22 | |
| 720 | MEMBRANE FUSION AND IMMUNE EVASION BY THE SPIKE PROTEIN OF SARS-COV-2 DELTA VARIANT Summary Related Patents View Save Abstract: Provided herein, in some aspects, are methods for using the receptor-binidng domain (RBD) of the SARS-COV-2 S protein, including the the RBD-1, RBD-2, and/or RBD-3 regions, to … |
CHILDREN’S MEDICAL CENTER | 2022-08-16 | 2025-05-01 | |
| 721 | Methods and compositions for collection and preservation of biologicals Summary Related Patents View Save Abstract: Provided herein are compositions and methods of use thereof for collection, preservation and/or extraction of biologicals from a subject. For example, a solution that enables … |
CONVERGENT GENOMICS | 2022-08-15 | 2024-09-24 | |
| 722 | Inhibitors for coronavirus Summary Related Patents View Save Abstract: Inhibitors against SARS-COV-1, SARS-CoV-2 (Covid-19), MERS-CoV, and variants within each, including methods of treating a subject suffering from such respiratory disease. … |
SOUTHWEST RESEARCH INSTITUTE; GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE ARMY; HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE | 2022-08-12 | 2024-04-23 | |
| 723 | Disinfectants with iodine and copper complexes for use against coronavirus Summary Related Patents View Save Abstract: Liquid antimicrobial disinfectant compositions for treatment of coronaviruses and specifically the Covid-19 virus (SARS-CoV-2) on skin and surfaces such as PPE (personal … |
CLYRA MEDICAL TECHNOLOGIES | 2022-08-12 | 2023-09-05 | |
| 724 | SYSTEMS AND METHODS FOR A DEEP NEURAL NETWORK WITH COMBINED CROSS-ENTROPY AND FOCAL LOSS FOR COVID-19 DETECTION IN AUDIO SAMPLES Summary Related Patents View Save Abstract: Various embodiments of a system and associated method for detection of COVID-19 and other respiratory diseases through classification of audio samples are disclosed herein. The … |
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-08-12 | 2023-03-02 | |
| 725 | Vaccine Antigen Summary Related Patents View Save Abstract: The field of the specification relates broadly to SARS-CoV-2 vaccine spike protein antigens and methods of using and manufacturing these antigens. The invention also relates to … |
MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH | 2022-08-11 | 2024-10-24 | |
| 726 | Nucleic acid vaccine against the SARS-CoV-2 coronavirus Citation: 13 Summary Related Patents View Save Abstract: The invention relates to an immunogenic or vaccine composition against the 2019 novel coronavirus (SARS-CoV-2), comprising a nucleic acid construct encoding a SARS-CoV-2 … |
INSTITUT PASTEUR | 2022-08-11 | 2023-09-19 | |
| 727 | Coronavirus vaccine Citation: 19 Summary Related Patents View Save Abstract: The present invention is directed to a nucleic acid suitable for use in treatment or prophylaxis of an infection with a coronavirus, preferably with a Coronavirus SARS-CoV-2, or a … |
CUREVAC | 2022-08-09 | 2023-03-07 | |
| 728 | Rapid detection test for SARS-CoV-2 Summary Related Patents View Save Abstract: The present invention is directed towards methods, compositions and kits for testing SARS-CO-V2 virus in a sample. The methods determine the presence of a viral 3CL protease by … |
NLC PHARMA | 2022-08-09 | 2024-01-23 | |
| 729 | PHARMACEUTICAL COMBINATION HAVING POTENT ANTIVIRAL ACTIVITY AGAINST SINGLE-STRANDED RNA VIRUSES INCLUDING CORONAVIRUSES AND MONKEYPOX Summary Related Patents View Save Abstract: A pharmaceutical composition for treating viral infections, including treatments for treatments for viral and non-viral infections, such as Monkeypox virus (MPV, MPXV, or hMPXV)) … |
FEYNMAN LABS FZ-LLC | 2022-08-05 | 2023-07-06 | |
| 730 | NEW METHOD TO DIAGNOSE INFLAMMATORY DISEASES Summary Related Patents View Save Abstract: The present invention relates to the diagnostic of inflammatory diseases. The inventors described methods using NET biomarkers as diagnostic biomarkers for inflammatory diseases. … |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE et. al. | 2022-08-05 | 2025-07-24 | |
| 731 | Coronavirus disease (COVID-19) vaccine Summary Related Patents View Save Abstract: The present invention includes a vaccine comprising a SARS-CoV-2 spike protein (S) or portion thereof, and methods of use thereof. … |
THOMAS JEFFERSON UNIVERSITY | 2022-08-05 | 2023-05-30 | |
| 732 | DETECTION OF PEPTIDE STRUCTURES FOR DIAGNOSING AND TREATING SEPSIS AND COVID Summary Related Patents View Save Abstract: Embodiments disclosed herein generally relate to technologies for evaluating a biological sample obtained from a subject with respect to a sepsis state or coronavirus disease … |
VENN BIOSCIENCES | 2022-08-05 | 2025-05-08 | |
| 733 | COMPOSITIONS AND METHODS FOR DETECTION OF CORONAVIRUS Summary Related Patents View Save Abstract: Described herein, in certain embodiments, are methods of assaying for a segment of a coronavirus target nucleic acid in a sample. In some embodiments, the target nucleic acid is … |
MAMMOTH BIOSCIENCES | 2022-08-05 | 2023-10-19 | |
| 734 | DRUG AND DIAGNOSTIC COMBINATION SYSTEM TO IDENTIFY AND TREAT SINGLE-STRANDED RNA VIRUSES INCLUDING CORONAVIRUSES AND MONKEYPOX Summary Related Patents View Save Abstract: A method for treating an early-stage microbial infection comprising determining whether a subject exposed to SARS-CoV-2, Monkeypox virus (MPV, MPXV, or hMPXV) or suspected of … |
FEYNMAN LABS FZ-LLC | 2022-08-05 | 2023-07-06 | |
| 735 | ANTIBODY-FREE RAPID DETECTION OF SARS-COV-2 PROTEINS USING CORONA PHASE MOLECULAR RECOGNITION (COPHMORE) Summary Related Patents View Save Abstract: Corona phase molecular recognition (CoPhMoRe) that enables the molecular recognition of SARS-CoV-2 viral proteins without the need for antibody or enzymatic receptor incorporation. … |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2022-08-05 | 2023-04-06 | |
| 736 | SARS-COV-2 MUCOSAL VACCINE COMPOSITION, PREPARATION AND USE THEREOF Summary Related Patents View Save Abstract: The invention provides a SARS-CoV-2 mucosal vaccine composition, preparation, and use thereof. The SARS-CoV-2 mucosal vaccine composition comprises an antigen fusion protein which … |
NATIONAL TSING HUA UNIVERSITY | 2022-08-05 | 2023-05-18 | |
| 737 | ADENOVIRAL VECTOR-BASED VACCINE FOR EMERGING VIRUSES Summary Related Patents View Save Abstract: Provided herein is an adenoviral vector-based vaccine for inducing immune responses against viruses, such as coronaviruses. The adenoviral vector comprises a hybrid promoter, a … |
THERAVAX et. al. | 2022-08-05 | 2025-11-13 | |
| 738 | SARS-CoV-2 Virus-Like Particles Summary Related Patents View Save Abstract: Provided herein are SARS-CoV-2 virus-like particles as well as methods and compositions for generating SARS-CoV-2 virus-like particles. The SARS-CoV-2 virus-like particles can … |
J. DAVID GLADSTONE INTITUTES A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID et. al. | 2022-08-04 | 2025-09-25 | |
| 739 | COMPOSITIONS AND METHODS FOR RAPID DETECTION OF SARS-CoV-2 Summary Related Patents View Save Abstract: Disclosed here are compositions and methods for the detection of at least one virus viruses using a one-step assay. The viruses to be detected include at least SARS-CoV-2 and … |
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-08-04 | 2023-10-19 | |
| 740 | VACCINE CONSTRUCT AND USES THEREOF Summary Related Patents View Save Abstract: Disclosed herein are nucleic acid constructs for producing a virus-like particle (VLP) capable of raising an immune response against severe acute respiratory syndrome coronavirus … |
UNIVERSITY OF MELBOURNE | 2022-08-04 | 2025-06-12 | |
| 741 | FULLY HUMAN SINGLE DOMAIN ANTIBODY-BASED ANTI-SARS-COV-2 BISPECIFIC NEUTRALIZING ANTIBODY AND USE THEREOF Summary Related Patents View Save Abstract: Disclosed are a fully human bispecific antibody against SARS-COV-2 and a use thereof. Specifically, the present disclosure also relates to a vector and host cell expressing same, … |
SHANGHAI BIOMISSILE BIOTECH | 2022-08-03 | 2024-11-14 | |
| 742 | SYNERGISM OF IMMUNOGENICITY VIA COMBINED PARENTERAL AND MUCOSAL IMMUNIZATION AGAINST COVID-19 Summary Related Patents View Save Abstract: The present invention discloses a system and method of generating robust immune response in mammals against SARS-CoV-2 antigen by administering two or more doses of same or … |
BHARAT BIOTECH INTERNATIONAL | 2022-08-02 | 2024-10-17 | |
| 743 | SARS-COV-2 CHIMERIC VLP VACCINE COMPOSITION, EXPRESSING VECTOR AND USE THEREOF Summary Related Patents View Save Abstract: The present invention provides a SARS-CoV-2 chimeric VLP vaccine composition and an expressing vector and use thereof. The chimeric SARS-CoV-2 VLP comprises a VLP skeleton formed … |
NATIONAL TSING HUA UNIVERSITY | 2022-08-01 | 2023-02-23 | |
| 744 | Engineered Alum-binding SARS-CoV-2 Immunogens Summary Related Patents View Save Abstract: Compositions are disclosed that include alum and a SARS-CoV-2 Spike (S) glycoprotein variant covalently bound to the alum via at least one linker having 2-12 phosphoserine … |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2022-07-29 | 2023-04-06 | |
| 745 | METHODS FOR DEVELOPING CD3+CD8+ CELLS AGAINST MULTIPLE VIRAL EPITOPES FOR TREATMENT OF VIRAL INFECTIONS INCLUDING VARIANTS EVOLVING TO ESCAPE PREVIOUS IMMUNITY Summary Related Patents View Save Abstract: Disclosed herein are methods of preparing peptide specific cytotoxic T cells (CTLs) against an emerged strain of a virus. The methods include providing an initial peptide … |
TEVOGEN BIO | 2022-07-29 | 2024-10-31 | |
| 746 | BICYCLIC FUSED PYRAZOLE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY INFECTIONS INCLUDING RSV Summary Related Patents View Save Abstract: Disclosed herein are compounds and compositions for inhibiting, treating or preventing respiratory infections, illnesses, diseases, and other respiratory conditions such as those … |
GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION | 2022-07-29 | 2024-10-24 | |
| 747 | USE OF NICOLSAMIDE FORMULATIONS FOR ANTIVIRAL THERAPY Summary Related Patents View Save Abstract: Disclosed are niclosamide formulations for use as antiviral therapy. The formulations disclosed herein may be used for treating a sexually-transmitted virus or a respiratory virus … |
YOURCHOICE THERAPEUTICS | 2022-07-29 | 2023-02-09 | |
| 748 | Nutraceutical formulations to prevent, treat, and inhibit excess cytokines, SARS-CoV-2 spike proteins, and mRNA vaccine spike proteins Summary Related Patents View Save Abstract: Combinations of cannabinoids, vitamins, trace elements, bioactive components, bioflavonoid polyphenols, proteolytic enzymes, amino acids, and antioxidants which work independently … |
PONO LIFESTYLE | 2022-07-28 | 2025-07-15 | |
| 749 | THERAPEUTIC AGENT FOR COVID-19 Summary Related Patents View Save Abstract: The present invention provides a therapeutic agent for novel coronavirus infection comprising 6-fluoro-3-hydroxy-2-pyrazinecarboxamide or a salt thereof as an active ingredient, … |
FUJIFILM TOYAMA CHEMICAL | 2022-07-28 | 2024-10-03 | |
| 750 | APTAMER-BASED ELECTROCHEMICAL VIRUS DETECTOR AND METHODS THEREOF Summary Related Patents View Save Abstract: A method for virus detection is disclosed, including introducing a biological media to an aptamer functionalized electrochemical sensor, generating an electrochemical signal from … |
JOHNS HOPKINS UNIVERSITY | 2022-07-27 | 2024-11-07 | |
| 751 | COVID-19 IMMUNE RESPONSE ASSAY METHOD Summary Related Patents View Save Abstract: Disclosed herein are assay methods and kits for assessing the strength of the immune response to SARS-CoV-2 virus in a subject by allowing for rapid and efficient detection of … |
ORASURE TECHNOLOGIES | 2022-07-25 | 2024-10-31 | |
| 752 | ENGINEERED CRISPR-CAS SYSTEMS AND METHODS FOR SENSITIVE AND SPECIFIC DIAGNOSTICS Summary Related Patents View Save Abstract: The disclosure relates to an engineered type III CRISPR-Cas system for sensitive and sequence specific detection of nucleic acid in a sample. For example, the engineered type III … |
MONTANA STATE UNIVERSITY | 2022-07-25 | 2023-02-23 | |
| 753 | Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19 Summary Related Patents View Save Abstract: This disclosure provides pharmaceutical compositions comprising amino acid entities and uses thereof. Methods for treating post-acute sequelae of COVID-19 comprising administering … |
AXCELLA HEALTH | 2022-07-25 | 2023-08-29 | |
| 754 | COMPOSITIONS AND METHODS FOR USING PURIFIED HUMAN RNA EDITING ENZYMES Summary Related Patents View Save Abstract: In alternative embodiments, provided are methods for eradicating or reducing the in vivo numbers of cancer stem cells comprising administering to an individual in need thereof an … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-22 | 2025-03-27 | |
| 755 | CHARACTERIZATION OF POTENT AND BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SARS-COV-2, ITS VARIANTS, AND RELATED CORONAVIRUSES AND METHODS OF USE Summary Related Patents View Save Abstract: The subject matter described herein relates to engineered monoclonal antibodies, derived from antibodies isolated from human patients, neutralizing a SARS-CoV-2 virus, its … |
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-07-22 | 2024-10-17 | |
| 756 | Use of bromophenol-pyrazoline compounds for the treatment of feline coronavirus diseases Summary Related Patents View Save Abstract: The present invention belongs to the field of medical technology, and specifically relates to use of bromophenol-pyrazoline compounds for the treatment of feline coronavirus … |
SHANDONG LINGHAI BIOTECHNOLOGY | 2022-07-21 | 2023-12-12 | |
| 757 | POXVIRAL-BASED VACCINE AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 AND METHODS USING THE SAME Summary Related Patents View Save Abstract: The present invention relates to a recombinant poxviral vector for use in vaccinating a subject against SARS-CoV-2. The present invention also provides vaccination regimens using … |
ACADEMIA SINICA | 2022-07-21 | 2023-03-02 | |
| 758 | COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING CORONAVIRUS VARIANT INFECTIONS AND METHODS OF USING THE SAME Citation: 2 Summary Related Patents View Save Abstract: The present disclosure is directed to compositions and methods useful for treating, as well as vaccinating against, SARS-CoV-2 viral infections, including SARS-CoV-2 variant viral … |
ENGENEIC MOLECULAR DELIVERY | 2022-07-21 | 2023-02-09 | |
| 759 | METHODS AND SYSTEMS FOR RAPID DETECTION OF COVID-19 Summary Related Patents View Save Abstract: Methods for diagnosing a subject for a COVID-19 infection state include collecting an alveolar air breath sample from a subject; passing the breath sample into contact with a … |
TRUSTEES OF INDIANA UNIVERSITY | 2022-07-21 | 2025-04-03 | |
| 760 | HCoV immunogenic booster composition for improving immunityagainst SARS-COV-2 infection Summary Related Patents View Save Abstract: Embodiments include a method of using inactivated human cold coronaviruses (HCoVs) particularly HCoV-299E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 as a booster, for the immunization … |
TIMOTHY S. MOORE et. al. | 2022-07-20 | 2024-12-24 | |
| 761 | METHODS AND REAGENTS FOR THE DETECTION OF ANALYTES Summary Related Patents View Save Abstract: The present invention relates to a high throughput targeted proteomics-based method for identifying and quantifying one or more binding molecules in a biological fluid of an … |
UCL BUSINESS | 2022-07-20 | 2024-10-17 | |
| 762 | PLANT-BASED COVID-19 VARIANT RECOMBINANT SPIKE PROTEIN EXPRESSION VECTOR AND RECOMBINANT PROTEIN USING SAME Summary Related Patents View Save Abstract: The present invention relates to a plant-based COVID-19 variant recombinant spike protein expression vector, and a recombinant protein using the expression vector, wherein a plant … |
BIOAPPLICATIONS | 2022-07-19 | 2024-09-26 | |
| 763 | CORONAVIRUS MAIN PROTEASE INHIBITORS AND METHODS USING SAME Summary Related Patents View Save Abstract: In one aspect, the present disclosure provides compounds which inhibit a coronavirus main protease. In another aspect, the present disclosure provides a method of treating, … |
BAYLOR COLLEGE OF MEDICINE | 2022-07-18 | 2025-09-04 | |
| 764 | MULTIMERIC CORONAVIRUS BINDING MOLECULES AND USES THEREOF Citation: 5 Summary Related Patents View Save Abstract: This disclosure provides multimeric binding molecules that bind to a human coronavirus, e.g., MERS-CoV, SARS-CoV or SARS-CoV-2. This disclosure also provides compositions … |
IGM BIOSCIENCES | 2022-07-14 | 2022-12-22 | |
| 765 | METHODS FOR TREATING AND EVALUATING COVID-19 PATIENTS Summary Related Patents View Save Abstract: This application relates to methods for assessing patients suffering from coronavirus infection as responders or a non-responders to an immunomodulating therapy, and methods of … |
NFERENCE | 2022-07-13 | 2023-03-09 | |
| 766 | BIOSENSOR FOR DETECTION OF SARS-COV-2 SPIKE GLYCOPROTEIN AND RELATED METHODS Summary Related Patents View Save Abstract: An example biosensor includes a substrate, a graphene layer disposed on the substrate, and a binding site bonded to the graphene. The binding site includes an antibody configured … |
CARBON HOLDINGS INTELLECTUAL PROPERTIES | 2022-07-13 | 2023-01-19 | |
| 767 | Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments Summary Related Patents View Save Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and … |
REGENERON PHARMACEUTICALS | 2022-07-13 | 2025-12-16 | |
| 768 | COMPOSITIONS AND TREATMENTS FOR CORONAVIRUS INFECTIONS Summary Related Patents View Save Abstract: Disclosed are methods for assessing the severity of a coronavirus infection through the measurement of caspase 4 and methods of treating a coronavirus infection comprising … |
OHIO STATE INNOVATION FOUNDATION | 2022-07-12 | 2024-10-10 | |
| 769 | Rapid assay for detection of SARS-CoV-2 antibodies Summary Related Patents View Save Abstract: Described herein are diagnostic and control fusion protein reagents and methods for use thereof in simple rapid and inexpensive hemagglutinin assays for the detection of subject … |
UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2022-07-12 | 2025-04-08 | |
| 770 | NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF Summary Related Patents View Save Abstract: The present application discloses neutralizing anti-SARS-COV-2 antibodies or antigen-binding fragments thereof that are effective against several SARS-COV-2 variants. … |
VAL-CHUM LTD. PARTNERSHIP et. al. | 2022-07-09 | 2025-10-16 | |
| 771 | PAN-HUMAN CORONAVIRUS VACCINES Citation: 4 Summary Related Patents View Save Abstract: The disclosure relates to pan human coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. … |
MODERNATX | 2022-07-08 | 2024-11-21 | |
| 772 | METHOD FOR SURFACE EXPRESSION OF MEMBRANE PROTEINS THAT HAVE A CYTOPLASMIC C-TERMINAL TAIL Summary Related Patents View Save Abstract: Coronavirus egress is mediated by lysosomal exocytosis. It is demonstrated herein that the D614G mutation enhances Spike trafficking to lysosomes and the lysosomal accumulation of … |
JOHNS HOPKINS UNIVERSITY et. al. | 2022-07-08 | 2024-10-10 | |
| 773 | METHODS RELATED TO AN ALTERNATIVE CONFORMATION OF THE SARS-COV-2 SPIKE PROTEIN Summary Related Patents View Save Abstract: Described are methods related to a newly discovered alternative conformation of the SARS COV 2 Spike protein. … |
CZ BIOHUB SF; REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-08 | 2024-08-15 | |
| 774 | COMPOSITIONS AND METHODS TO INCREASE CORONAVIRUS IMMUNE RESPONSE Summary Related Patents View Save Abstract: A composition for increasing an immune response to a coronavirus may contain a coronavirus ORF8 protein, an immunogenic fragment of a coronavirus ORF8 protein, a nucleic acid … |
ATOSSA THERAPEUTICS | 2022-07-08 | 2024-08-08 | |
| 775 | CRISPR-based programmable RNA editing Summary Related Patents View Save Abstract: CRISPR RNA-guided nucleases are routinely used for sequence-specific manipulation of DNA. While CRISPR-based DNA editing has become routine, analogous methods for editing RNA have … |
NATIONAL INSTITUTES OF HEALTH U.S. GOVERNMENT | 2022-07-08 | 2024-11-12 | |
| 776 | BLOCKING ELISA KIT FOR DETECTING ANTIBODY TO SWINE ACUTE DIARRHEA SYNDROME CORONAVIRUS N PROTEIN Summary Related Patents View Save Abstract: The disclosure belongs to the field of biotechnology, and in particular to a blocking ELISA kit for detecting an antibody to swine acute diarrhea syndrome coronavirus (SADS-CoV) N … |
INSTITUTE OF URBAN AGRICULTURE CHINESE ACADEMY OF AGRICULTURAL SCIENCES | 2022-07-08 | 2023-06-22 | |
| 777 | PAN-HUMAN CORONAVIRUS DOMAIN VACCINES Citation: 5 Summary Related Patents View Save Abstract: The disclosure relates to pan human coronavirus ribonucleic acid (RNA) vaccines as well as methods of using the vaccines and compositions comprising the vaccines. … |
MODERNATX | 2022-07-08 | 2024-10-31 | |
| 778 | NON-COVALENT INHIBITORS OF THE MAIN PROTEASE OF SARS-COV-2 AND METHODS OF USE Summary Related Patents View Save Abstract: Provided herein are compounds of formula (I) or (I-A), which act as non-covalent inhibitors of SARS-CoV2 main protease (M ). In certain embodiments, the compounds of formula (I) … |
YALE UNIVERSITY | 2022-07-07 | 2025-10-09 | |
| 779 | CORONAVIRUS VACCINES Summary Related Patents View Save Abstract: The present invention provides multimeric protein complex comprising three polypeptides each comprising N- to C-terminally: (i) a receptor-binding domain (RBD) of an S1 subunit of … |
LUXEMBOURG INSTITUTE OF HEALTH | 2022-07-07 | 2024-09-19 | |
| 780 | USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED SYMPTOMS Summary Related Patents View Save Abstract: The claimed invention relates to treatment of virus-related neurological symptoms, particularly methods for treating such symptoms by administering a complement inhibitor. The … |
PHARMING | 2022-07-07 | 2024-10-17 | |
| 781 | PEPTIDE HAVING ANTI-VIRAL ACTIVITY, ANTI-VIRAL AGENT COMPRISING SAID PEPTIDE, AND METHOD FOR PRODUCING SAID ANTI-VIRAL AGENT Summary Related Patents View Save Abstract: Provided is a peptide capable of binding to a receptor binding domain (RBD) in SARS-CoV-2. chemically synthesized easily, having extremely high solubility to ultra-pure water or a … |
NATIONAL UNIVERSITY CORP. TOKYO MEDICAL AND DENTAL UNIVERSITY; CESPIA | 2022-07-06 | 2024-09-19 | |
| 782 | USE OF GAMMA PRIME FIBRINOGEN AS A BIOMARKER IN THE ASSESSMENT OF COVID-19 INFECTIONS AND PROGNOSIS OF SEVERE DISEASE Summary Related Patents View Save Abstract: A method of assessing a COVID-19 infection in a person, the method comprising analysing the concentration or levels of one or more biomarkers in a biological sample from a person, … |
GAMMA DIAGNOSTICS | 2022-07-05 | 2025-05-22 | |
| 783 | COMPOSITIONS COMPRISING ENDOSIDIN 2 FOR REDUCING SARS-COV-2 INFECTION Summary Related Patents View Save Abstract: A composition comprising ES2 prevents ACE2 translocation to the cell surface and susceptibility to SARS-CoV-2 infection. Treating a subject with a composition comprising the … |
HENRY FORD HEALTH SYSTEM | 2022-07-02 | 2025-08-28 | |
| 784 | CANNABICHROMENE AS A THERAPEUTIC MODALITY FOR COVID-19 Summary Related Patents View Save Abstract: Compositions and methods for treating or reducing symptoms of acute respiratory distress syndrome (ARDS) generally and COVID-19 infection in particular are provided herein. An … |
AUGUSTA UNIVERSITY RESEARCH INSTITUTE | 2022-07-01 | 2023-01-05 | |
| 785 | DEVELOPMENT AND VALIDATION OF A 2-GENE HOST-VIRAL TRANSCRIPTOMIC CLASSIFIER FOR ENHANCED COVID-19 DIAGNOSIS Summary Related Patents View Save Abstract: Provided herein are lists of combined host-viral gene markers that can be used for identifying COVID-19 in a subject and/or determining severity of disease. The host-viral … |
CZ BIOHUB SF et. al. | 2022-07-01 | 2024-08-08 | |
| 786 | DEOPTIMIZED SARS-COV-2 VARIANTS AND METHODS AND USES THEREOF Summary Related Patents View Save Abstract: Described herein are modified SARS-CoV-2 variants. These viruses have been recoded, for example, codon deoptimized or codon pair bias deoptimized and are useful for reducing the … |
CODAGENIX; SERUM INSTITUTE OF INDIA PRIVATE | 2022-06-30 | 2024-09-12 | |
| 787 | ANTIBODY AGAINST NUCLEOCAPSID PROTEIN OF SARS-COV-2 Summary Related Patents View Save Abstract: The purpose of the present invention is to provide an antibody that enables simple, rapid and sensitive detection of SARS-COV- , i.e., the causative virus of COVID-19 while … |
TAUNS LABORATORIES | 2022-06-30 | 2024-08-29 | |
| 788 | Methods for treating COVID-19 Summary Related Patents View Save Abstract: The invention relates to methods for treating COVID-19 by targeting the inflammasome/caspase1/pyroptosis axis as a key inflammatory pathway. In particular, the invention relates … |
MEDSTAR HEALTH | 2022-06-29 | 2023-05-23 | |
| 789 | METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19 Summary Related Patents View Save Abstract: A drug scaffold, MIND-4 and MIND4-17, and derivatives thereof, can be used to treat and prevent infection by SARS-CoV-2 that causes COVID-19, other coronavirus infections, and the … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-06-29 | 2024-09-05 | |
| 790 | CXC CHEMOKINE AGONISTS AND ANTAGONISTS IN COVID-19 DISEASE AND DIAGNOSTIC ASSAYS Summary Related Patents View Save Abstract: Methods of treating a disease, disorder or syndrome associated with a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (such as COVID-19) in a subject by … |
UNIVERSITY OF PITTSBURGH – OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION; TRUSTEES OF INDIANA UNIVERSITY | 2022-06-28 | 2024-10-03 | |
| 791 | Dual-Action Recombinant Vesicular Stomatitis Virus (RVSV)-Based Vaccine (DAV) Against COVID-19 and Influenza Viruses Summary Related Patents View Save Abstract: Described herein is a replicative Vesicular stomatitis virus (rVSV) comprising: a first Filoviridae glycoprotein comprising one or more influenza virus matrix 2 ectodomain peptide … |
UNIVERSITY OF MANITOBA | 2022-06-28 | 2025-10-23 | |
| 792 | Fusion peptide inhibitors of human coronavirus 229E Citation: 1 Summary Related Patents View Save Abstract: Fusion peptide inhibitors of human coronavirus 229E are provided. The fusion peptide inhibitors of HCoV-229E include peptide #1 (SEQ ID NO: 1: … |
KING FAISAL UNIVERSITY | 2022-06-27 | 2023-07-25 | |
| 793 | SARS-CoV-2 variant nanobodies and constructs comprising such nanobodies Summary Related Patents View Save Abstract: A large and highly diverse nanobody library was constructed and screened against multiple variants of SARS-COV-2 to find nanobodies with high sensitivity and specificity for the … |
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | 2022-06-27 | 2024-09-17 | |
| 794 | Colorimetric system for detection of COVID-19 using salivary metabolites Summary Related Patents View Save Abstract: A system for detecting COVID-19 infection, including a colorimetric sensor, an image-capturing device, and a processing unit connected to the image-capturing device. The … |
FARIN BEHBOOD TASHKHIS | 2022-06-27 | 2023-10-24 | |
| 795 | ANTIBODY-INDUCING POLYPEPTIDE AND VACCINE Summary Related Patents View Save Abstract: An antibody-inducing polypeptide useful for treatment or prevention of SARS-COV-2 infection and a vaccine including the same are disclosed. The polypeptide can be (a) one having 7 … |
YOSHIHIRO WATANABE | 2022-06-24 | 2024-10-31 | |
| 796 | EXPRESSION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) SPIKE PROTEIN SEQUENCES IN PLANTS AND PLANT PRODUCED VACCINE FOR SAME Summary Related Patents View Save Abstract: A plant produced vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is provided where the Spike protein of the virus is expressed in a plant by introducing … |
APPLIED BIOTECHNOLOGY INSTITUTE | 2022-06-24 | 2023-01-05 | |
| 797 | VIRAL VARIANT DETECTION Summary Related Patents View Save Abstract: The invention provides compositions and methods allowing for rapid detection of SARS-CoV-2 variants. … |
TRANSFORMATIVE BIOTECH et. al. | 2022-06-24 | 2025-09-18 | |
| 798 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR FOR TREATMENT OR TREATMENT OF RNA VIRAL INFECTIONS Summary Related Patents View Save Abstract: The present invention relates to a therapeutic agent of a lipase inhibitor for a wide spectrum of RNA viral infections in humans and animals. More specifically, the lipase … |
INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY et. al. | 2022-06-24 | 2024-08-29 | |
| 799 | SARS-COV-2 ANTIGEN NANOPARTICLES AND USES THERE OF Summary Related Patents View Save Abstract: Provided herein are nanoparticles which enhance the immunogenicity of antigens for use in Beta coronavirus (e.g., MERS-CoV, SARS-CoV-1, or SARS-CoV-2) vaccines, as well as … |
CHILDREN’S MEDICAL CENTER; DANA-FARBER CANCER INSTITUTE | 2022-06-23 | 2024-04-11 | |
| 800 | TREATMENT OF DISEASES CAUSED BY RNA VIRUSES Summary Related Patents View Save Abstract: Up-regulation of caspase has been found in COVID-19 patients, and also occurs in patients suffering from diabetes, hypertension, metabolic syndrome, and other conditions. Such … |
AMERIMMUNE | 2022-06-22 | 2025-09-18 | |
| 801 | TREATMENT FOR DISEASES CAUSED BY RNA VIRUSES Summary Related Patents View Save Abstract: Up-regulation of caspase has been found in COVID-19 patients, and also occurs in patients suffering from diabetes, hypertension, metabolic syndrome, and other conditions. Such … |
AMERIMMUNE | 2022-06-22 | 2023-02-09 | |
| 802 | Methods and compositions relating to covid antibody epitopes Citation: 7 Summary Related Patents View Save Abstract: Provided herein are methods and compositions relating to libraries of optimized antibodies having nucleic acids encoding for an antibody comprising modified sequences. Libraries … |
TWIST BIOSCIENCE | 2022-06-22 | 2025-01-21 | |
| 803 | SPATIAL DETECTION OF SARS-COV-2 USING TEMPLATED LIGATION Citation: 24 Summary Related Patents View Save Abstract: Provided herein are methods, compositions and kits for detecting SARS-CoV-2 and host nucleic acids in a tissue sample. … |
10X GENOMICS | 2022-06-22 | 2024-11-07 | |
| 804 | Methods and devices for COVID-19 testing using urine samples Citation: 2 Summary Related Patents View Save Abstract: The present invention generally includes methods, devices and/or kits for the detection of a COVID-19 infection in an individual by measuring the level or concentration or one or … |
UCHENNA CHUKWU | 2022-06-21 | 2023-04-18 | |
| 805 | Methods and Systems for Detection of Covid Variants Summary Related Patents View Save Abstract: Disclosed are methods and systems for the detection of variants of the SARS-CoV-2 virus that cause COVID-19. For example, disclosed are methods for identifying and/or tracking … |
LABORATORY CORP. OF AMERICA HOLDINGS | 2022-06-21 | 2022-12-29 | |
| 806 | ASSAYS FOR SARS-COV-2 BY LESION INDUCED DNA AMPLIFICATION (LIDA) Summary Related Patents View Save Abstract: Assays for SARS-CoV-2 are described, together with lesion induced DNA amplification (LIDA)-based methods for amplifying RNA or DNA. … |
READYGO DIAGNOSTICS | 2022-06-20 | 2024-08-22 | |
| 807 | MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF POST-ACUTE COVID-19 Citation: 1 Summary Related Patents View Save Abstract: Provided herein are methods of using modified caveolin-1 (Cav-1) peptides to treat or prevent pathogen-induced lung injury and disrepair caused by a coronavirus such as … |
LUNG THERAPEUTICS | 2022-06-17 | 2025-02-06 | |
| 808 | TEMPERATURE-CONTROLLABLE, SELF-REPLICATING RNA VACCINES FOR VIRAL DISEASES Summary Related Patents View Save Abstract: The present disclosure relates to mRNA, self-replicating RNA, and temperature-sensitive, self-replicating RNA encoding a coronavirus nucleocapsid protein or an influenza virus … |
ELIXIRGEN THERAPEUTICS | 2022-06-17 | 2024-08-15 | |
| 809 | Primers, Probes and Kits for Multiplex Detection of Respiratory Pathogen Target Nucleic Acids, and Methods of Use Thereof Summary Related Patents View Save Abstract: Disclosed in the present application are primers, probes and kits for multiplex detection of respiratory pathogen target nucleic acids, and methods of use thereof. The primers, … |
BOE TECHNOLOGY GROUP | 2022-06-17 | 2024-10-31 | |
| 810 | FULLERENE GALLIUM PHOSPHONATE AND METHODS Summary Related Patents View Save Abstract: An antimicrobial composition of buckminsterfullerene with gallium phosphonate functional groups is provided to disassemble or make virus particles inert, and to inhibit viral and … |
EXOTHULE | 2022-06-17 | 2022-10-27 | |
| 811 | SARS-COV-2 IMMUNOASSAY METHOD AND IMMUNOASSAY KIT, AND MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT THEREOF Summary Related Patents View Save Abstract: The present invention provides an immunoassay method for assaying SARS-CoV-2, including a step of contacting a biological sample with a monoclonal antibody or an antibody fragment … |
SEKISUI MEDICAL | 2022-06-16 | 2024-07-18 | |
| 812 | SARS-COV-2 IMMUNOASSAY METHOD AND IMMUNOASSAY KIT Summary Related Patents View Save Abstract: The present invention provides an immunoassay method for assaying SARS-CoV-2 in a biological sample, including using two types of monoclonal antibodies or antibody fragments … |
SEKISUI MEDICAL | 2022-06-16 | 2024-08-01 | |
| 813 | Protease Inhibitors for Treatment of Coronavirus Infections Summary Related Patents View Save Abstract: Provided herein are compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions: wherein R , R , R , R , R , R , and A are defined in … |
SCRIPPS RESEARCH INSTITUTE | 2022-06-16 | 2023-02-02 | |
| 814 | Methods of assigning a COVID pathological type based on a cytokine/chemokine panel Summary Related Patents View Save Abstract: Methods of assigning a COVID pathological type for a subject suffering from COVID-19 are provided. Aspects of the methods include assigning a COVID pathological type for the … |
INCELLDX | 2022-06-16 | 2025-02-18 | |
| 815 | Anti-BAFF Antibodies for use in a Method of Treatment of Long Covid and/or Post-Acute Sequelae SARS-CoV-2 Infection (PASC) Summary Related Patents View Save Abstract: The present disclosure relates to a B lymphocyte Stimulator (BlyS; B-cell activating factor; BAFF) antagonist for use in the treatment of Long Covid and/or post-acute sequelae … |
GLAXOSMITHKLINE; GLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT | 2022-06-15 | 2024-08-01 | |
| 816 | Transcription Mediated Amplification Methods for RNA Detection Citation: 1 Summary Related Patents View Save Abstract: Provided herein is a method for detecting the presence of a COVID-19 virus RNA or other pathogenic respiratory viruses, such as an influenza virus, or other RNA of interest in a … |
PATHOGENDX | 2022-06-15 | 2022-12-22 | |
| 817 | PRODRUGS, ANALOGS OR DERIVATIVES OF ANTHOCYANIDIN AS ANTIVIRAL AGENTS Summary Related Patents View Save Abstract: The present invention relates to compounds which can inhibit host cell ACE2 receptor, viral spike S protein, Spike protein-ACE2 receptor interface, RNA-dependent RNA polymerase … |
SANCTUM THERAPEUTICS | 2022-06-15 | 2022-12-29 | |
| 818 | Xylitol Topical Ocular Solution Summary Related Patents View Save Abstract: A solution for ocular application containing xylitol. Topically applied to the eye, the solution improves the quality of the ocular tear film, and reduces the incidence of … |
GSX PHARMA | 2022-06-14 | 2024-06-13 | |
| 819 | MRNA VACCINES ENCODING FLEXIBLE CORONAVIRUS SPIKE PROTEINS Citation: 7 Summary Related Patents View Save Abstract: The disclosure provides mRNA vaccines which encode for coronavirus spike proteins exhibiting increased flexibility in the crown of the helix turn region. This increased … |
MODERNATX | 2022-06-13 | 2024-08-29 | |
| 820 | CORONAVIRUS GLYCOSYLATION VARIANT VACCINES Citation: 7 Summary Related Patents View Save Abstract: The disclosure provides SARS-CoV-2 mRNA vaccines, comprising a double proline mutation at positions K986 and V987, and an additional substitution D428N that introduces an … |
MODERNATX | 2022-06-13 | 2024-09-05 | |
| 821 | STRAINS OF PROBIOTIC BACTERIA FOR USE IN A PREVENTIVE METHOD OF TREATMENT OR IN AN ADJUVANT METHOD OF TREATMENT OF VIRAL RESPIRATORY INFECTIONS Citation: 1 Summary Related Patents View Save Abstract: The present invention relates to specific and selected strains of bacteria and compositions thereof for use in the treatment of viral respiratory tract infections, preferably … |
PROBIOTICAL | 2022-06-13 | 2024-07-04 | |
| 822 | Protease inhibitors for treatment of coronavirus infections Citation: 2 Summary Related Patents View Save Abstract: Provided herein are compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions: wherein R , R , R , R , R , R , and A are defined in … |
SCRIPPS RESEARCH INSTITUTE | 2022-06-10 | 2023-07-25 | |
| 823 | Self-Amplifying RNA-Based VLP Vaccines Summary Related Patents View Save Abstract: The present disclosure provides compositions comprising an sa-RNA VLP vaccine (e.g. the VLP vaccine) that is capable of delivering a self-amplifying RNA to a target cell in a … |
CHIMERON BIO | 2022-06-09 | 2024-08-22 | |
| 824 | GENE COMBINATION AS A BROAD SPECTRUM ANTIVIRAL Summary Related Patents View Save Abstract: Provided herein are methods for treating a virus (e.g, an RNA virus, such as a SARS-COV-2) infection or a disease associated therewith (e.g., COVID-19) comprising administering to … |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2022-06-08 | 2024-11-07 | |
| 825 | COMPOSITIONS AND METHODS FOR TREATING COVID-19 AND SYMPTOMS THEREOF Summary Related Patents View Save Abstract: Methods for treating or preventing viral infection-induced symptoms are disclosed. Methods for treating or preventing a viral infection are disclosed. Methods for treating or … |
YUVA BIOSCIENCES | 2022-06-08 | 2023-05-18 | |
| 826 | 2019 NOVEL CORONAVIRUS ANTIBODY-CONTAINING PHARMACEUTICAL FORMULATIONS Summary Related Patents View Save Abstract: A pharmaceutical formulation is provided that includes a 2019 novel coronavirus (2019-nCOV) antibody and agents that provide commercially acceptable shelf-life stability, in-use … |
ELI LILLY AND | 2022-06-08 | 2024-06-27 | |
| 827 | Method and composition for preventing and treating COVID-19 and long COVID Summary Related Patents View Save Abstract: Coronavirus Disease 2019 (COVID-19) remains a threat with the emergence of new variants, especially Delta and Omicron, without specific effective therapeutic drugs. The present … |
GLOBAL PREVENTIVE MEDICINE BIOTECH | 2022-06-07 | 2023-11-07 | |
| 828 | Coronavirus vaccine compositions, methods, and uses thereof Summary Related Patents View Save Abstract: The present disclosure relates in some aspects to immunogenic compositions including recombinant peptides and proteins comprising coronavirus viral antigens and immunogens, e.g., … |
SICHUAN CLOVER BIOPHARMACEUTICALS | 2022-06-05 | 2025-04-22 | |
| 829 | ORAL ADMINISTRATION OF CORONAVIRUS SPIKE PROTEIN FOR ALTERING CYTOKINE LEVELS AND PROVIDING PASSIVE IMMUNITY TO NEWBORN PIGS Summary Related Patents View Save Abstract: Plants and plant produced compositions which include Coronavirus S proteins are disclosed. These may be used as vaccines, boosters or immune modulators. The compositions have been … |
MAZEN ANIMAL HEALTH | 2022-06-03 | 2022-12-08 | |
| 830 | A DEVICE FOR DETECTING HEALTH DISORDERS FROM BIOLOGICAL SAMPLES AND A DETECTION PROCESS Summary Related Patents View Save Abstract: The present invention relates to instruments and processes for detecting compounds in gas samples. In particular, for detecting health disorders from biological samples, more … |
RICARDO DANIEL DE SIMONE | 2022-06-03 | 2024-08-08 | |
| 831 | VIRUS-LIKE PARTICLE VACCINE FOR CORONAVIRUS Summary Related Patents View Save Abstract: The present disclosure relates to targeting SARS-CoV-2, in particular, prevalent strains of SARS-CoV-2, and methods of using such vaccines to induce neutralizing antibody levels … |
ICOSAVAX | 2022-06-03 | 2024-08-01 | |
| 832 | MINERALOCORTICOID RECEPTOR ANTAGONISTS FOR THE PREVENTION AND/OR TREATMENT OF A CORONAVIRUS INFECTION Summary Related Patents View Save Abstract: The present invention relates to a novel therapy for preventing viral spread and/or reducing viral load in a patient and, in particular, a novel therapy for preventing viral … |
IMAGINATIVES GROUP | 2022-06-01 | 2024-08-01 | |
| 833 | COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS Summary Related Patents View Save Abstract: Provided are compositions and methods of treating Coronavirus disease 2019 (COVID-19) in a subject, the method including administering to the subject a therapeutically effective … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-06-01 | 2025-08-21 | |
| 834 | HUMAN CORONAVIRUS 229E DERIVED PEPTIDES Summary Related Patents View Save Abstract: The invention relates to common cold coronavirus peptides derived from HcoV-229E, and related polynucleotides, complexes pharmaceutical compositions, methods of treatment, and … |
EMERGEX VACCINES HOLDING | 2022-06-01 | 2024-08-15 | |
| 835 | LIDOCAINE OR ARTICAINE FOR TREATING COVID-19, AUTOIMMUNE DISEASE OR CYTOKINE STORM RESPONSE Summary Related Patents View Save Abstract: A composition including lidocaine or a salt thereof, or articaine or a salt thereof, is disclosed for use in the treatment of COVID-19 or an autoimmune disease or a condition in … |
STICHTING MEDISCHE KLINIEK VELSEN | 2022-06-01 | 2024-08-15 | |
| 836 | Protease inhibitors as antivirals Citation: 1 Summary Related Patents View Save Abstract: Provided herein, inter alia, are compounds, pharmaceutical compositions and methods related to the treatment of viral infections caused by coronavirus or enterovirus. Provided … |
ACEA THERAPEUTICS | 2022-06-01 | 2023-09-12 | |
| 837 | Immunogenic and vaccine compositions against SARS-CoV-2 Summary Related Patents View Save Abstract: Disclosed herein are immunogenic and/or vaccine compositions and methods for treating or preventing Severe Acute Respiratory Syndrome (SARS). The compositions and methods include … |
LOWA STATE UNIVERSITY RESEARCH FOUNDATION | 2022-06-01 | 2024-11-26 | |
| 838 | RNA vaccine against SARS-CoV-2 variants Citation: 6 Summary Related Patents View Save Abstract: The present invention is directed to a nucleic acid suitable for use in treatment or prophylaxis of an infection with a coronavirus, preferably with a Coronavirus SARS-CoV-2, or a … |
CUREVAC; GLAXOSMITHKLINE BIOLOGICALS | 2022-05-31 | 2024-01-16 | |
| 839 | ADJUVANTED INACTIVATED RECOMBINANT RABIES VIRUS VECTORED CORONAVIRUS VACCINE FORMULATIONS Summary Related Patents View Save Abstract: The invention discloses an adjuvanted inactivated recombinant rabies virus vectored coronavirus vaccine formulation comprising SEPIVAC SWE or MemVax as adjuvant/s. The invention … |
BHARAT BIOTECH INTERNATIONAL | 2022-05-31 | 2024-07-18 | |
| 840 | APPLICATION OF NOVEL CORONAVIRUS VACCINE PEPTIDE AND NANOEMULSION PREPARATION THEREOF IN PREVENTION OF NOVEL CORONAVIRUS WILD AND MUTANT STRAINS Summary Related Patents View Save Abstract: Disclosed are an application of a coronavirus SARS-CoV-2 vaccine polypeptide, a polypeptide composition and a nanoemulsion preparation thereof in the prevention of coronavirus … |
SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES et. al. | 2022-05-30 | 2025-01-09 | |
| 841 | COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS RELATING TO CORONAVIRUS INFECTIONS Summary Related Patents View Save Abstract: Use of GABA-receptor agonists, either alone or with one or more positive PAMs, anti-inflammatory compounds, and/or antiviral treatments, e.g., one that limits viral replication or … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-05-30 | 2024-11-28 | |
| 842 | TLR7 AGONIST CONJUGATED PEPTIDE-BASED NOVEL CORONAVIRUS NANOEMULSION VACCINE AND PREPARATION THEREOF Summary Related Patents View Save Abstract: The present invention relates to a novel coronavirus vaccine using a TLR7 agonist conjugated peptide as an antigen and an emulsion as an adjuvant. An antigen polypeptide of the … |
SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES et. al. | 2022-05-30 | 2024-08-08 | |
| 843 | Antigens of β-coronaviruses, preparation methods and uses thereof Summary Related Patents View Save Abstract: The embodiments of the present disclosure relate to antigens of β-coronaviruses, preparation methods and uses thereof. The amino acid sequence of the antigen of the β-coronavirus … |
INSTITUTE OF MICROBIOLOGY CHINESE ACADEMY OF SCIENCES | 2022-05-27 | 2023-02-28 | |
| 844 | MODELLING FRAMEWORK FOR EMBEDDING-BASED PREDICTIONS FOR COMPOUND-VIRAL PROTEIN ACTIVITY Summary Related Patents View Save Abstract: A global effort is underway to identify compounds to treat emerging virus infections, such as COVID-19. Since de novo compound design is an extremely long, time-consuming, and … |
QATAR FOUNDATION FOR EDUCATION SCIENCE AND COMMUNITY DEVELOPMENT | 2022-05-27 | 2022-12-08 | |
| 845 | NEW SALIVA-BASED LATERAL-FLOW ANTIBODY TEST PLATFORM FOR ASSESSING INFECTIONS AND VACCINATION EFFICACY Summary Related Patents View Save Abstract: Sensitive detection of IgG antibodies against SARS-CoV-2 is important to assessing immune responses to viral infection or vaccination and immunity duration. Antibody assays using … |
NIRMIDAS BIOTECH | 2022-05-27 | 2023-01-26 | |
| 846 | INHIBITORS OF SARS-COV-2 VIRAL REPLICATION AND USES THEREOF Summary Related Patents View Save Abstract: This invention is in the field of medicinal pharmacology. In particular, the present invention relates to pharmaceutical agents which function as inhibitors of severe acute … |
ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2022-05-27 | 2024-08-08 | |
| 847 | COMBINED AGONIST ADJUVANT FOR CORONAVIRUS VACCINE Summary Related Patents View Save Abstract: The disclosure is directed to compositions and methods for inducing an immune response against a coronavirus, which involve a coronavirus vaccine and an adjuvant composition. The … |
REGENTS OF THE UNIVERSITY OF MICHIGAN et. al. | 2022-05-26 | 2024-08-01 | |
| 848 | Compounds for the treatment of SARS Citation: 9 Summary Related Patents View Save Abstract: Inhibitors of SARS-CoV-2 (COVID), pharmaceutical compositions comprising same; and methods of treating a severe acute respiratory syndrome. … |
PURDUE RESEARCH FOUNDATION | 2022-05-26 | 2023-12-05 | |
| 849 | METHOD OF BREATH SCREENING OF VIRAL INFECTION Summary Related Patents View Save Abstract: An apparatus for detecting Covid-19 infection in a subject, the apparatus comprising (a) a sampling apparatus for collecting a breath sample from a subject (b) An analyzer, … |
TEKNOSCAN SYSTEMS | 2022-05-25 | 2022-12-08 | |
| 850 | NOVEL POVIDONE-IODINE PHARMACEUTICAL PREPARATION AND USES THEREOF Summary Related Patents View Save Abstract: This disclosure provides novel aqueous povidone-iodine (PVP-I) pharmaceutical preparations, which demonstrate strong antimicrobial activity and also strong virucidal activities. … |
PURDUE PHARMA | 2022-05-25 | 2022-12-08 | |
| 851 | BODY CAVITY GEL Summary Related Patents View Save Abstract: The present invention relates to non-psychoactive cannabinoid-comprising compositions, said compositions comprising cannabidiol (CBD) formulated for application in a body cavity, … |
CS MEDICA | 2022-05-25 | 2025-09-11 | |
| 852 | COMPOSITIONS AND METHODS RELATED TO SURGE-ASSOCIATED SARS-COV-2 MUTANTS Summary Related Patents View Save Abstract: Compositions for use as a vaccine against SARS-CoV-2 infection are disclosed, which comprise either a polypeptide that comprises at least one surge-associated mutation (e.g., … |
VENKATARAMANAN SOUNDARARAJAN et. al. | 2022-05-23 | 2023-02-09 | |
| 853 | Methods and compositions for a universal and long-lasting vaccine Summary Related Patents View Save Abstract: To develop a universal and long-lasting influenza or other pathogens vaccine has been a mission impossible goal in the life science and health field. Applicants disclose, herein, … |
GONGYI ZHANG | 2022-05-23 | 2023-07-04 | |
| 854 | Compounds for the treatment of SARS Citation: 7 Summary Related Patents View Save Abstract: Bis-amide inhibitors of SARS-CoV-2 (COVID); pharmaceutical compositions comprising same; and methods of treating a severe acute respiratory syndrome. … |
PURDUE RESEARCH FOUNDATION | 2022-05-23 | 2023-10-24 | |
| 855 | VIRAL STRAIN SEROLOGY ASSAYS Citation: 1 Summary Related Patents View Save Abstract: The invention relates to methods and kits for determining a SARS-CoV-2 strain in a sample. The invention further provides methods and kits for detecting a single nucleotide … |
MESO SCALE TECHNOLOGIES et. al. | 2022-05-20 | 2022-12-01 | |
| 856 | Coronavirus Constructs and Vaccines Citation: 1 Summary Related Patents View Save Abstract: Disclosed herein are nucleic acid constructs comprising a replication defective Zika virus vector and one or more coronavirus sequences and compositions thereof. The constructs … |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-05-20 | 2024-08-01 | |
| 857 | ASSAYS FOR VIRAL STRAIN DETERMINATION Summary Related Patents View Save Abstract: The invention relates to methods and kits for determining a SARS-CoV-2 strain in a sample. The invention also provides methods and kits for detecting a single nucleotide … |
MESO SCALE TECHNOLOGIES | 2022-05-20 | 2022-12-22 | |
| 858 | Method for optimizing virus membrane fusion inhibitor, broad-spectrum anti-coronavirus lipopeptide and use thereof Summary Related Patents View Save Abstract: The present disclosure relates to a method for optimizing a virus membrane fusion inhibitor, a broad-spectrum anti-coronavirus lipopeptide and use thereof. The present disclosure … |
YOUCARE PHARMACEUTICAL GROUP | 2022-05-19 | 2025-12-09 | |
| 859 | SARS-CoV-2 POLYPEPTIDES Summary Related Patents View Save Abstract: This document provides methods and materials related to selected severe acute respiratory distress coronavirus 2 (SARS-CoV-2) polypeptides. For example, this document provides … |
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH | 2022-05-19 | 2022-11-24 | |
| 860 | Compositions and methods for inhibition of SARS-CoV-2 viral infections Summary Related Patents View Save Abstract: The present disclosure provides methods of treating COVID-19 by administering a pharmaceutical composition providing inhibition of severe acute respiratory syndrome-coronavirus 2 … |
TEXAS A&M UNIVERSITY SYSTEM | 2022-05-19 | 2023-11-07 | |
| 861 | ANTIBODY CONJUGATED NANOPARTICLE ASSAY AND TREATMENT FOR SARS-CoV-2 Summary Related Patents View Save Abstract: An embodiment provides a method for treatment of a viral antigen for the COVID-19 virus, including: obtaining a body fluid from a patient; introducing the body fluid to at least … |
ARIZONA BOARD OF REGENTS ON BEHALF A ARIZONA STATE UNIVERSITY et. al. | 2022-05-18 | 2022-11-24 | |
| 862 | MULTIGENIC MVA-SARS-COV-2 VACCINE Summary Related Patents View Save Abstract: The present invention includes compositions and methods of making and using an immunogenic protein for mucosal delivery comprising at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, … |
BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM | 2022-05-18 | 2022-11-24 | |
| 863 | COMPOSITION FOR TREATMENT OF COVID-19 COMPRISING TAURODEOXYCHOLIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT Summary Related Patents View Save Abstract: The present invention relates to a composition for treatment of coronavirus disease 2019 (COVID-19) containing taurodeoxycholic acid (TDCA) or a pharmaceutically acceptable salt … |
SHAPERON | 2022-05-17 | 2025-08-21 | |
| 864 | SARS-COV-2 SPIKE PROTEIN ANTIBODIES Summary Related Patents View Save Abstract: The present disclosure provides antibodies that bind to the SARS-CoV-2 spike protein, as well as compositions containing the same, and methods of making and using such a … |
CURIA IP HOLDINGS | 2022-05-17 | 2024-07-18 | |
| 865 | SARS-COV-2 SPIKE PROTEIN ANTIBODIES Summary Related Patents View Save Abstract: Embodiments include monoclonal antibodies (mAbs) that recognize SARS-Cov-2 spike protein. The mAbs are capable of distinguishing among variants of the virus. The present … |
CURIA IP HOLDINGS | 2022-05-17 | 2023-04-13 | |
| 866 | SARS-COV-2 SPIKE PROTEIN ANTIBODIES Summary Related Patents View Save Abstract: The present disclosure provides antibodies that bind to the SARS-CoV-2 spike protein, as well as compositions containing the same, and methods of making and using such a … |
CURIA IP HOLDINGS | 2022-05-17 | 2022-11-24 | |
| 867 | NOVEL PROTEIN AND NUCLEIC ACID SEQUENCES FOR COVID-19 VACCINES Summary Related Patents View Save Abstract: The present invention relates to a mutated SARS-COV-2 spike protein, a variant or fragment thereof or an mRNA or DNA encoding them for use in the prevention of COVID-19. … |
DOMPE’ FARMACEUTICI | 2022-05-16 | 2025-09-11 | |
| 868 | Viral inactivation spray and gargling formulation Summary Related Patents View Save Abstract: A viral inactivation composition includes an aqueous solution of citric acid and L-arginine hydrochloride with a pH below 3.5. The citric acid and L-arginine hydrochloride are … |
RENE DUMALAOG JAVIER | 2022-05-16 | 2025-09-16 | |
| 869 | METHOD FOR TREATING INFECTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) Summary Related Patents View Save Abstract: The disclosure provides a method for treating an infection of SARS-CoV-2 infection in a subject, comprising administering to said subject a therapeutically effective amount of a … |
JIU-YAO WANG | 2022-05-16 | 2023-01-05 | |
| 870 | REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION Summary Related Patents View Save Abstract: Provided are methods for treating subjects with coronavirus infections. The methods include providing a subject infected with a coronavirus resulting in a prothrombotic condition … |
UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2022-05-16 | 2025-03-13 | |
| 871 | PROTEIN ANTIGEN-BINDING MOLECULES Summary Related Patents View Save Abstract: The present disclosure provides antigen-binding molecule capable of binding to a sarbecovirus spike protein from two or more different sarbecovirus. Nucleic acids, expression 5 … |
NATIONAL UNIVERSITY OF SINGAPORE | 2022-05-15 | 2024-08-01 | |
| 872 | PAN-SPECIFIC CORONA VIRUS BINDERS Summary Related Patents View Save Abstract: Compositions and binding agents specifically binding the Spike protein of Corona viruses via at least two different binding sites and potently neutralizing coronaviruses, in … |
VIB VZW et. al. | 2022-05-12 | 2024-07-11 | |
| 873 | COMPOSITIONS AND METHODS FOR DEBULKING VIRUS OR MICROORGANISM LOAD IN THE ORAL CAVITY Summary Related Patents View Save Abstract: Compositions and methods for reducing viral load in the oral cavity, particularly Coronavirus such as SARS-CoV-2 and Influenza viral loads are disclosed. Also disclosed are … |
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2022-05-11 | 2024-08-22 | |
| 874 | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN CORONAVIRUS DISEASE (COVID-19) Summary Related Patents View Save Abstract: A pharmaceutical composition for treating acute respiratory distress syndrome (ARDS), multiple end organ failure and survival in serious and life-threatening condition in patients … |
PHARMAZZ | 2022-05-11 | 2022-11-17 | |
| 875 | Composite-type nano-vaccine particle Citation: 1 Summary Related Patents View Save Abstract: The present invention discloses a composite-type nano-vaccine particle, which comprises an active ingredient selected from spike RBD protein of COVID-19, two adjuvants as … |
NUECOLOGY BIOMEDICAL | 2022-05-11 | 2025-03-04 | |
| 876 | BINDING POLYPEPTIDES AGAINST SARS COV-2 AND USES THEREOF Summary Related Patents View Save Abstract: Provided herein are binding polypeptides, such as binding peptides and antibodies, against a SARS CoV-2. The binding polypeptides relate to or are based on bovine antibodies, … |
APPLIED BIOMEDICAL SCIENCE INSTITUTE; KANSAS STATE UNIVERSITY RESEARCH FOUNDATION | 2022-05-11 | 2024-08-08 | |
| 877 | ANTIMICROBIAL NANO-DELIVERANT AND METHODS Summary Related Patents View Save Abstract: An antimicrobial composition of buckminsterfullerene with saponified phosphorus acid functional groups is provided to disassemble or make virus particles inert, and to inhibit … |
EXOTHULE | 2022-05-11 | 2022-08-25 | |
| 878 | ANTIMICROBIAL NANO-SURFACTANT AND METHODS Summary Related Patents View Save Abstract: An antimicrobial composition of buckminsterfullerene with saponified phosphorus acid functional groups is provided to disassemble or make virus particles inert, and to inhibit … |
EXOTHULE | 2022-05-11 | 2022-08-25 | |
| 879 | Methods for Monoclonal Antibody Generation Summary Related Patents View Save Abstract: The present disclosure provides a set of high-throughput methods for rapid and efficient identification and generation of monoclonal antibodies. Also provided are highly potent … |
YALE UNIVERSITY | 2022-05-10 | 2024-07-11 | |
| 880 | ETHACRYNIC ACID DERIVATIVES AS INHIBITORS OF MPRO PROTEASE AND SARS-COV-2 REPLICATION Summary Related Patents View Save Abstract: A novel compound of formulae (I) or (II), to the use thereof as a drug, particularly for the treatment of SARS-COV-2, for the treatment of COVID-19 disease and any diseases … |
UNIVERSITE EUROMEDITERRANEENNE DE FES | 2022-05-10 | 2024-08-29 | |
| 881 | VACCINES AND COMPOSITIONS BASED ON SARS-COV-2 S PROTEIN Summary Related Patents View Save Abstract: This disclosure provides vaccines and compositions based on SARS-COV-2 S protein, and specifically relates to recombinant SARS-COV-2 spike protein (Sprotein) and mRNA and DNA … |
GUANGZHOU RIBOBIO et. al. | 2022-05-10 | 2024-10-24 | |
| 882 | METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT Summary Related Patents View Save Abstract: In alternative embodiments, provided are methods for treating, ameliorating, decreasing the chances of having any adverse effects from, decreasing the severity of adverse effects … |
TOPELIA AUST | 2022-05-10 | 2025-08-28 | |
| 883 | METHODS FOR THE IDENTIFICATION AND TREATMENT OF SEVERE FORMS OF COVID-19 Summary Related Patents View Save Abstract: Provided herein are method for treating or preventing severe coronavirus disease 2019 (COVID-19) in a subject, comprising administering to the subject a composition comprising a … |
GENUITY SCIENCE | 2022-05-09 | 2025-08-21 | |
| 884 | TAPENTADOL FOR TREATING NEUROPATHIC PAIN IN COVID-19 PATIENTS Summary Related Patents View Save Abstract: The invention relates to a pharmaceutical dosage form comprising Tapentadol or a physiologically acceptable salt thereof for use in the treatment of pain in a patient who is or … |
GRÜNENTHAL | 2022-05-06 | 2024-07-18 | |
| 885 | SARS-COV-2 MULTI-EPITOPE VACCINES Summary Related Patents View Save Abstract: The present invention provides multi-epitope vaccines comprising or capable of expressing one or more concatemers of epitopes from a viral pathogen, namely, SARS-COV-2. wherein at … |
UNIVERSITY OF BRITISH COLUMBIA et. al. | 2022-05-05 | 2024-07-18 | |
| 886 | USE OF A COMPOUND SUCH AS PLERIXAFOR FOR TREATING A VIRAL PULMONARY DISEASE Summary Related Patents View Save Abstract: A compound of formula (I) or a pharmaceutically acceptable salt and/or hydrate thereof, for use in the treatment of a viral pulmonary disease or a chronic respiratory distress … |
4LIVING BIOTECH; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; INSTITUT PASTEUR DE LILLE; UNIVERSITE DE LILLE; CENTRE HOSPITALIER UNIVERSITAIRE DE LILLE; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE | 2022-05-05 | 2024-07-18 | |
| 887 | Vaccines Against Coronavirus and Methods of Use Summary Related Patents View Save Abstract: Provided herein are methods of inducing an immune response against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) in a subject in need thereof by administering an … |
INOVIO PHARMACEUTICALS et. al. | 2022-05-05 | 2022-11-24 | |
| 888 | NEUTRALIZING ANTI- SARS-COV-2 ANTIBODIES AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: This disclosure provides novel neutralizing anti-SARS-COV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-COV-2 antibodies constitute a novel … |
ROCKEFELLER UNIVERSITY | 2022-05-05 | 2024-07-04 | |
| 889 | Use of Chlorophyll Derivatives for the Treatment of SARS-CoV-2 Infection Summary Related Patents View Save Abstract: The present application relates to the use of pheophorbide A, pheophorbide A analog, or pharmaceutically acceptable salt thereof for blocking the entry of SARS-CoV-2 in an … |
AFFINITYIMMUNO | 2022-05-04 | 2024-11-07 | |
| 890 | CORONAVIRUS AND INFLUENZA COMPOSITIONS AND METHODS FOR USING THEM Citation: 3 Summary Related Patents View Save Abstract: Disclosed herein are compositions and methods for inducing immune responses against both influenza and coronaviruses. Provided herein are compositions and methods of using the … |
NOVAVAX | 2022-05-04 | 2022-11-10 | |
| 891 | IMMUOGENIC COMPOSITIONS OF MUTANT SARS-COV-2 N PROTEIN AND GENE AND METHODS OF USE THEREOF Summary Related Patents View Save Abstract: Compositions and methods for generating an immune response to fight against viral infections such as SARS-CoV- are provided. The disclosed compositions and methods are based on … |
KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY | 2022-05-04 | 2024-07-11 | |
| 892 | COMPOSITIONS AND METHODS FOR SARS CoV-2 RNA DETECTION Summary Related Patents View Save Abstract: Compositions and methods for enriching, isolating, and/or detecting SARS-CoV-2 RNA in a sample are provided. The compositions include the nucleocapsid (N) protein derived from … |
KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY | 2022-05-04 | 2024-11-14 | |
| 893 | HUMAN ANTI-CORONAVIRUS PEPTIDE VACCINES AND METHODS OF THEIR USE Summary Related Patents View Save Abstract: Disclosed are compositions related to modified coronavirus S protein peptides, synthetic coronavirus S protein peptides, chimeric coronavirus S protein peptides, anti-coronavirus … |
OHIO STATE INNOVATION FOUNDATION | 2022-05-03 | 2024-07-11 | |
| 894 | PEPTIDES INHIBITING COVID-19 Summary Related Patents View Save Abstract: Provided are novel peptides which can block the binding interaction of novel coronavirus SARS-CoV-2 in mammals, specifically by inhibiting the interaction between the Spike SI … |
QUANTBIORES | 2022-05-03 | 2024-07-04 | |
| 895 | A NANOFLUIDIC DEVICE FOR RAPID AND MULTIPLEXED SEROLOGICAL ANTIBODY DETECTION Summary Related Patents View Save Abstract: The planetary outbreak of COVID-19 has led to a substantial death toll and has hindered the functioning of modern society. This underlines the importance of accurate, … |
PAUL SCHERRER INSTITUT | 2022-05-02 | 2024-05-02 | |
| 896 | MESSENGER RNA THERAPEUTICS AND COMPOSITIONS Citation: 1 Summary Related Patents View Save Abstract: In the various aspects and embodiments, this disclosure provides messenger RNA (mRNA) constructs for therapeutic delivery, as well as methods for making such mRNA constructs and … |
GREENLIGHT BIOSCIENCES | 2022-05-02 | 2022-11-24 | |
| 897 | SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASE Summary Related Patents View Save Abstract: The present disclosure provides a compound of Formula II, wherein R is an optionally substituted mono or bicyclic saturated, partly unsaturated or aromatic heterocyclyl comprising … |
JENS CARLSSON, et. al. | 2022-04-29 | 2024-11-21 | |
| 898 | SARS-CoV-2 mRNA vaccine and preparation method and use thereof Summary Related Patents View Save Abstract: Provided is a SARS-CoV-2 mRNA vaccine, and the preparation method and use thereof. The present invention provides an mRNA molecule capable of encoding a target polypeptide, … |
SHENZHEN RHEGEN BIOTECHNOLOGY | 2022-04-29 | 2024-03-19 | |
| 899 | SUBSTITUTED HYDANTOIN COMPOUNDS, METHODS FOR PREPARATION THEREOF AND USE THEREOF IN THE TREATMENT AND/OR PREVENTION OF A CORONA VIRUS DISEASE Summary Related Patents View Save Abstract: Described is a compound of Formula II, wherein R is an optionally substituted mono or bicyclic saturated, partly unsaturated or aromatic heterocyclyl having at least one nitrogen … |
JENS CARLSSON et. al. | 2022-04-29 | 2024-06-27 | |
| 900 | PEPTIDE BASED PROBES FOR THE DETECTION OF SARS-COV-2 Summary Related Patents View Save Abstract: A highly specific molecular diagnostic for the detection of an intended target protein within a matter of minutes employing a peptide beacon, the peptide beacon having a stem … |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2022-04-29 | 2023-06-22 | |
| 901 | MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF Summary Related Patents View Save Abstract: In various embodiments, provided are immune response signatures that can be used for the diagnosis, monitoring, and treatment of long-term diseases and inflammatory disorders … |
ALLEN INSTITUTE; FRED HUTCHINSON CANCER CENTER | 2022-04-28 | 2024-07-04 | |
| 902 | Benzimidazoles and Methods of Using Same Summary Related Patents View Save Abstract: The present disclosure is concerned with benzimidazole compounds and methods of using these compounds for the treatment of hepatitis (e.g., hepatitis C), RNA virus infections … |
UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2022-04-28 | 2022-09-01 | |
| 903 | VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS Summary Related Patents View Save Abstract: The invention relates to vaccination of human subjects, in particular elderly, against bacterial infections, wherein the bacterial infection is not pneumococcal, and COVID-19 … |
PFIZER | 2022-04-28 | 2025-09-11 | |
| 904 | ANTIVIRAL NUCLEIC ACID Summary Related Patents View Save Abstract: An object of the present invention is to provide an antiviral nucleic acid, etc. against SARS-COV-2 SARS-COV-2, SARS-COV-1, or MERS-COV and/or a method for treating and/or … |
NIPPON SHINYAKU; NATIONAL UNIVERSITY CORP. GUNMA UNIVERSITY | 2022-04-28 | 2024-07-11 | |
| 905 | ARTIFICIAL ADJUVANT VECTOR CELL CAPABLE OF INDUCING IMMUNE RESPONSE TO CORONAVIRUS, PHARMACEUTICAL COMPOSITION CONTAINING SAID CELL, AND USE APPLICATIONS OF SAID CELL AND SAID PHARMACEUTICAL COMPOSITION Summary Related Patents View Save Abstract: The present disclosure provides an artificial adjuvant vector cell inducing an immune response to a spike protein of a coronavirus, a pharmaceutical composition containing the … |
RIKEN | 2022-04-28 | 2024-07-11 | |
| 906 | ANTIBODIES FOR THE TREATMENT AND PREVENTION OF COVID-19 AND EMERGING VARIANTS Summary Related Patents View Save Abstract: The subject matter disclosed herein relates to a recombinant spike (S) protein from the B.1.351.2-7 variant of the SARS-CoV-2 virus, the DNA and RNA nucleotide sequences encoding … |
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2022-04-27 | 2024-07-11 | |
| 907 | Infectious disease screening system Summary Related Patents View Save Abstract: An infectious disease screening system ( ) for screening for infectious diseases, such as COVID-19 disease. The system comprises an ultrasonic transducer ( ) for generating … |
SHAHEEN INNOVATIONS HOLDING | 2022-04-27 | 2024-04-02 | |
| 908 | RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE Summary Related Patents View Save Abstract: Recombinant chimeric bovine/human parainfluenza virus 3 (rB/HPIV3) vectors expressing a recombinant Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike (S) protein … |
U.S.A. AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2022-04-27 | 2024-06-20 | |
| 909 | NON-VIRAL DNA VECTORS EXPRESSING ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF Summary Related Patents View Save Abstract: The application describes methods and compositions comprising ceDNA vectors useful for the expression of anti-CoV-2 S antibodies and antigen-binding fragments thereof in a cell, … |
GENERATION BIO et. al. | 2022-04-27 | 2024-07-04 | |
| 910 | ENGINEERED INFLUENZA VIRUSES EXPRESSING SARS-COV-2 ANTIGENS, VACCINES AND METHODS OF MAKING AND USING THE SAME Summary Related Patents View Save Abstract: The present invention provides engineered polynucleotides encoding both the receptor binding domain (RBD) of a SARS-CoV-2 spike protein and an influenza hemagglutinin (HA) … |
DUKE UNIVERSITY | 2022-04-27 | 2024-06-27 | |
| 911 | Vaccines for treating SARS infections in cancer patients Summary Related Patents View Save Abstract: Provided herein are, inter alia, compositions including recombinant oncolytic herpes simplex viruses that express SARS-CoV spike (S) protein and viral vectors including nucleic … |
CITY OF HOPE | 2022-04-26 | 2026-01-06 | |
| 912 | NEUTRALIZING ANTI-SARS-CoV-2 ANTIBODIES AND USE THEREOF Summary Related Patents View Save Abstract: The present invention relates to antibodies or antigen-binding fragments that are useful for treating coronavirus infections (e.g., COVID-19 caused by SARS-CoV-2). The present … |
WASHINGTON UNIVERSITY | 2022-04-26 | 2022-10-27 | |
| 913 | SARS-COV-2 SUBUNIT VACCINE Summary Related Patents View Save Abstract: The present invention relates to a protein subunit vaccine comprising at least one antigen characterized in that it comprises at least one monomer from at least one variant of … |
HIPRA SCIENTIFIC S.L.U. et. al. | 2022-04-25 | 2024-09-26 | |
| 914 | PHARMACEUTICAL COMPOSITION CONTAINING ARTESUNATE OR SALT THEREOF AND PYRONARIDINE OR SALT THEREOF, FOR ANTIPYRESIS, ANTI-INFLAMMATORY EFFICACY, ANTI-VIRAL EFFICACY AND TREATMENT OR PREVENTION OF COVID-19, AND METHOD USING SAME Summary Related Patents View Save Abstract: The present invention relates to: a pharmaceutical composition for antipyresis, anti-inflammatory efficacy, anti-viral efficacy and treatment or prevention of COVID-19 infection, … |
MIN BO SHIM | 2022-04-25 | 2024-06-27 | |
| 915 | SARS-COV-2 SUBUNIT VACCINE Summary Related Patents View Save Abstract: The present invention relates to a protein subunit vaccine comprising at least one antigen characterized in that it comprises at least one monomer from at least one variant of … |
HIPRA SCIENTIFIC S.L.U. et. al. | 2022-04-25 | 2025-06-12 | |
| 916 | Recombinant polypeptides containing at least one immunogenic fragment and uses thereof Summary Related Patents View Save Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike glycoprotein, and … |
BOOST BIOPHARMA | 2022-04-25 | 2025-09-09 | |
| 917 | THERAPEUTIC INTERFERING PARTICLES FOR CORONA VIRUS Summary Related Patents View Save Abstract: Described herein are compositions of recombinant SARS-CoV-2 constructs and particles that can interfere with or block infection of uninfected cells. The compositions and methods … |
J. DAVID GLADSTONE INSTITUTES A TESTAMENTARY TRUST ESTABLISHED UNDER THE WILL OF J. DAVID GLAD et. al. | 2022-04-25 | 2025-11-06 | |
| 918 | SARS-CoV-2 fusion protein vaccine/regimen Summary Related Patents View Save Abstract: A SARS-CoV-2 immunotherapeutic targeted fusion protein regimen or vaccine in which the extracellular domain (ecd) of the CD40L immunostimulatory protein, is attached individually … |
MICROVAX | 2022-04-22 | 2025-09-30 | |
| 919 | ANTIBODIES THAT BIND SARS-COV-2 SPIKE PROTEIN Summary Related Patents View Save Abstract: Described herein are antibodies that specifically recognize the SARS-CoV-2 spike (S) polypeptide, compositions comprising said antibodies, uses thereof, and methods employing said … |
NATIONAL RESEARCH COUNCIL OF CANADA | 2022-04-22 | 2024-08-15 | |
| 920 | PEPTIDE VACCINE FOR VIRUS INFECTION Summary Related Patents View Save Abstract: The present invention relates to an immunogenic composition against virus infection, especially to an immunogenic composition having peptides that are capable of binding to major … |
VACINO BIOTECH | 2022-04-22 | 2022-11-24 | |
| 921 | Nitrile-containing antiviral compounds Summary Related Patents View Save Abstract: The invention relates to compounds of Formula I″ wherein R, R , R , R , p, q and q′ are as defined herein, pharmaceutical compositions comprising the compounds, methods of … |
PFIZER | 2022-04-22 | 2022-09-27 | |
| 922 | GLYCOSYLATED RBD AND USE THEREOF Summary Related Patents View Save Abstract: As a technique for efficiently producing anti-coronavirus antibodies with cross-reactivity, provided is a polypeptide comprising an amino acid sequence having at least 60% or more … |
OSAKA UNIVERSITY | 2022-04-22 | 2025-09-04 | |
| 923 | Immunogenic Compositions Against SARS-COV-2 Variants and Their Methods of Use Summary Related Patents View Save Abstract: Disclosed herein are nucleic acid molecules encoding a Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) spike antigen, SARS-CoV-2 spike antigens, immunogenic … |
INOVIO PHARMACEUTICALS | 2022-04-22 | 2022-10-27 | |
| 924 | ANTIBODY ASSAY FOR SARS-CoV-2 Summary Related Patents View Save Abstract: An embodiment provides a method for detection of viral antigen for the COVID-19 virus, including: obtaining a body fluid from a patient; introducing the body fluid to at least one … |
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY et. al. | 2022-04-21 | 2022-10-27 | |
| 925 | EARLY MANAGEMENT, MITIGATION and PREVENTION OF SEPSIS and SEPSIS-LIKE SYNDROMES, INCLUDING NEO-NATAL ARDS DUE TO INFECTION, INJURY or IATROGENESIS Summary Related Patents View Save Abstract: The present invention relates to the early treatment, including pre-diagnosis treatment, of sepsis and acute inflammatory syndromes such as systemic inflammatory response syndrome … |
OPHIREX | 2022-04-21 | 2022-10-20 | |
| 926 | SARS-COV-2 SUBUNIT AND VARIANT VACCINES Summary Related Patents View Save Abstract: The present invention includes an immunogenic protein, constructs, vectors, and methods of making, comprising at least 90% amino acid identity to at least one antigenic peptide … |
IBIO | 2022-04-21 | 2022-11-24 | |
| 927 | NEUTRALIZING ANTIBODY TESTING AND TREATMENT Summary Related Patents View Save Abstract: A method for detection and measurement of neutralizing antibody levels to SARS-CoV-2 in a test-specimen, said method comprising obtaining a test-specimen from a subject, … |
SAPPHIRE BIOTECH | 2022-04-21 | 2022-08-11 | |
| 928 | GLYCAN MODIFIED SPIKE RECEPTOR BINDING DOMAIN NANOPARTICLES AND METHOD OF USE THEREOF AS A CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE Summary Related Patents View Save Abstract: Disclosed herein are glycan-coated RBD immunogens, engineered nanoparticle vaccines comprising glycan-coated RBD immunogens and methods of use thereof for SARS-COV-2 vaccines. … |
DANIEL KULP et. al. | 2022-04-20 | 2024-06-06 | |
| 929 | VIRUS VACCINE Summary Related Patents View Save Abstract: This disclosure relates to the field of preventing or treating virus infection, in particular, the disclosure relates to agents for vaccination against virus infection and … |
BIONTECH | 2022-04-20 | 2024-11-21 | |
| 930 | METHODS AND KITS FOR DIAGNOSING COVID-19 DISEASE Summary Related Patents View Save Abstract: This invention relates to methods of diagnosing COVID-19 disease, preferably post-acute COVID-19 syndrome, in a subject using a fluorescent or microscopy detection method to … |
STELLENBOSCH UNIVERSITY | 2022-04-20 | 2023-11-16 | |
| 931 | A VACCINE ADJUVANT FOR INFECTIOUS DISEASES Summary Related Patents View Save Abstract: Provided herein is a vaccine adjuvant containing an N-terminal domain of osteopontin or a fragment thereof. Also provided are conjugates and fusion proteins containing the … |
UNIVERSITY OF CINCINNATI | 2022-04-20 | 2024-06-27 | |
| 932 | NOVEL COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS Summary Related Patents View Save Abstract: Disclosed are compositions and methods suitable for treating coronavirus infections. More particularly, disclosed is a proteinaceous agent that prevents or inhibits the … |
COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH | 2022-04-20 | 2024-10-24 | |
| 933 | Lung-targeted corticosteroid treatment in viral respiratory disease, COVID-19 and ARDS (acute respiratory distress syndrome) Summary Related Patents View Save Abstract: Provided herein are methods for treating, preventing, minimizing and/or substantially inhibiting inflammation associated with a respiratory virus such as COVID-19 and/or acute … |
BODOR LABORATORIES | 2022-04-19 | 2022-10-27 | |
| 934 | Compositions and methods for inhibiting M and PL protease activity and for preventing and treating SARS-CoV-2 infection Summary Related Patents View Save Abstract: This invention is in the field of medicinal chemistry and relates to a new class of small-molecules having a pyrrolidinone-acetamide (or similar) structure (e.g., Formula I) which … |
ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2022-04-19 | 2024-01-09 | |
| 935 | Colorimetric COVID-19 Rapid-Test and Methods of Using Same Summary Related Patents View Save Abstract: The present disclosure provides a method of testing a subject for COVID-19, the method comprising the steps of: obtaining a saliva sample from the subject; diluting the saliva … |
YALE UNIVERSITY | 2022-04-18 | 2024-06-06 | |
| 936 | COLOR: A LOW-COST OPTODIAGNOSTIC FOR SARS-COV-2 Summary Related Patents View Save Abstract: The COVID-19 pandemic has exacerbated society’s tremendous health equity gap. Disadvantaged populations have been disproportionally affected by COVID-19, lacking access to … |
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA et. al. | 2022-04-18 | 2024-06-13 | |
| 937 | KIT FOR TESTING COVID-19 ANTIGEN AND METHOD FOR TESTING SAME Summary Related Patents View Save Abstract: Disclosed is a kit for testing a COVID-19 antigen. The kit includes a test card, a conjugate pad and a reaction pad being arranged on the test card; wherein the conjugate pad is … |
DAAN GENE | 2022-04-15 | 2023-05-18 | |
| 938 | APPLICATIONS OF ANALOGS OR DERIVATIVES OF SIALIC ACIDS Summary Related Patents View Save Abstract: Provided are compositions or products comprising analogs or derivatives of N-acetylneuraminic acid with a particular pH range. The compositions or products are effective for … |
B & H BIOTECHNOLOGIES | 2022-04-15 | 2024-07-18 | |
| 939 | RECOMBINANT PROTEINS, COMPOSITIONS, VECTORS, KITS, AND METHODS FOR IMMUNIZING AGAINST, AND TESTING FOR EXPOSURE TO, SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 Summary Related Patents View Save Abstract: Disclosed are recombinant proteins, compositions, vectors, kits, data analyses, and methods for inducing an immune response against, or detecting exposure to, SARS-CoV-2. In … |
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2022-04-15 | 2022-10-27 | |
| 940 | USE OF THE AGENT FOR INDUCTION OF SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 FOR REVACCINATION OF POPULATION (VARIANTS) Summary Related Patents View Save Abstract: The disclosed invention relates to safe and efficacious methods of extending postvaccinal immunity against severe acute respiratory syndrome virus SARS-CoV-2 and revaccinating a … |
FEDERAL STATE BUDGETARY INSTITUTION NATIONAL RESEARCH CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAME | 2022-04-15 | 2022-08-25 | |
| 941 | METHOD FOR PREPARING ATOMIZING SARS-COV-2 NANOVACCINE Summary Related Patents View Save Abstract: A method for preparing an atomizing SARS-CoV-2 nanovaccine includes the followings steps: mimicking a structure of SARS-COV-2 with receptor binding domains (RBDs) of SARS-COV-2, … |
HEALTHINA STEM CELL INDUSTRY PLATFORM; TANGYI HOLDINGS(SHENZHEN) | 2022-04-14 | 2023-08-17 | |
| 942 | DETECTION OF SARS-COV-2 VARIANT Summary Related Patents View Save Abstract: Provided herein are compositions and methods for detecting novel SARS-COV-2 variants. Disclosed herein are nucleic acid constructs that can be used as primers in various molecular … |
BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2022-04-14 | 2024-06-20 | |
| 943 | CHIMERIC ANTI-SARS-COV2 NUCLEOPROTEIN ANTIBODIES Summary Related Patents View Save Abstract: Compositions and methods are disclosed for diagnosing, treating, and/or preventing coronavirus infection and related pathologies. The compositions include antibodies having … |
LA JOLLA INSTITUTE FOR IMMUNOLOGY | 2022-04-14 | 2025-10-16 | |
| 944 | SYSTEMS AND METHODS FOR DETECTING AND CHARACTERIZING COVID-19 Summary Related Patents View Save Abstract: A method includes receiving one or more radiological images of an anatomy of a patient. The method also includes identifying a boundary of different tissue types in the anatomy of … |
JOHNS HOPKINS UNIVERSITY | 2022-04-14 | 2024-11-07 | |
| 945 | HUMAN ANTIBODY TARGETING COVID-19 VIRUS Summary Related Patents View Save Abstract: The present invention relates to a human antibody against a novel coronavirus and a variant thereof, or an immunologically active fragment of the human antibody. The human … |
KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION | 2022-04-13 | 2024-06-20 | |
| 946 | Methods of Inducing Immune Response Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Summary Related Patents View Save Abstract: Disclosed herein are methods of administering and uses of a plasmid encoding residues 19-1279 of SEQ ID NO: 1, a plasmid comprising nucleotides 55-3837 of SEQ ID NO: 2, pGX9501, … |
INOVIO PHARMACEUTICALS | 2022-04-13 | 2022-10-20 | |
| 947 | INFLUENZA-CORONAVIRUS COMBINATION VACCINES Citation: 8 Summary Related Patents View Save Abstract: The disclosure provides combination miRNA vaccines for respiratory viruses, such as influenza and coronaviruses (e.g., SARS-CoV-2) as well as methods of using the vaccines. … |
MODERNATX. | 2022-04-13 | 2024-07-11 | |
| 948 | Wearable Collector for Noninvasive Sampling of Exhaled Breath Biomarkers, Pathogens or Viral Loads Summary Related Patents View Save Abstract: Airborne transmission of exhaled virus can rapidly spread by increasing disease progression from local incidents to pandemics. Due to the COVID-19 pandemic, states and local … |
BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY OFFICE OF THE GENERAL COUNSEL | 2022-04-13 | 2024-09-19 | |
| 949 | AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 IN LIQUID FORM (VARIANTS) Summary Related Patents View Save Abstract: The invention relates to a biomolecule agent for inducing specific immunity against severe acute respiratory syndrome virus SARS-CoV-2, in liquid form, which contains a single … |
FEDERAL STATE BUDGETARY INSTITUTION NATIONAL RESEARCH CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAME | 2022-04-12 | 2022-08-18 | |
| 950 | MESSENGER RNA VACCINES AGAINST WIDE SPECTRUM OF CORONAVIRUS VARIANTS Citation: 7 Summary Related Patents View Save Abstract: The present invention relates to the mRNA vaccine of coronavirus spike protein with deletion of glycosites in the receptor binding domain (RBD), the subunit 1 (S1) domain, or the … |
ACADEMIA SINICA | 2022-04-12 | 2024-02-29 | |
| 951 | Coronavirus vaccine Citation: 3 Summary Related Patents View Save Abstract: The present disclosure provides a glycoengineered SARS-CoV-2 spike protein which is capable of eliciting an enhanced immune response relative to a native spike protein of … |
ACADEMIA SINICA | 2022-04-12 | 2025-03-25 | |
| 952 | Biomarkers for predicting intensive care unit stay duration for mechanically ventilated covid-19 patients Summary Related Patents View Save Abstract: The disclosure provides methods that facilitate disease management by providing for early detection of metabolic changes that differentiate critically ill-COVID-19 patients under … |
QATAR UNIVERSITY | 2022-04-12 | 2026-01-06 | |
| 953 | HUMANIZED ANTIBODY FOR SARS-CoV-2 SPIKE PROTEIN INFUSION Summary Related Patents View Save Abstract: An embodiment provides a method for treatment of the COVID-19 virus, including: preparing an intravenous infusion, wherein the intravenous infusion comprises at least one … |
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY et. al. | 2022-04-11 | 2022-10-13 | |
| 954 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS Summary Related Patents View Save Abstract: Compounds, compositions and methods for preventing, treating or curing a coronavirus infection in human subjects or other animal hosts. In one embodiment, the compounds can be … |
EMORY UNIVERSITY | 2022-04-11 | 2024-07-04 | |
| 955 | ROTAVIRUS VECTORS FOR HETEROLOGOUS GENE DELIVERY Summary Related Patents View Save Abstract: Rotavirus vectors encoding in their genome a heterologous gene, and nucleic acid constructs encoding such rotavirus vectors. The rotavirus vector genome may include a rotavirus … |
MERCK SHARP & DOHME | 2022-04-11 | 2024-06-20 | |
| 956 | NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS Summary Related Patents View Save Abstract: Compounds, compositions and methods for preventing, treating or curing a coronavirus infection in human subjects or other animal hosts. In one embodiment, the compounds can be … |
EMORY UNIVERSITY | 2022-04-11 | 2025-04-10 | |
| 957 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES Summary Related Patents View Save Abstract: Compounds, compositions and methods for preventing, treating or curing a coronavirus infection in human subjects or other animal hosts. In one embodiment, the compounds can be … |
EMORY UNIVERSITY | 2022-04-11 | 2024-07-18 | |
| 958 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF VIRUS INFECTION, THE PHARMACEUTICAL COMPOSITION COMPRISING ROTTLERIN AS ACTIVE INGREDIENT Summary Related Patents View Save Abstract: The present disclosure relates to a pharmaceutical composition comprising rottlerin as an active ingredient for the prevention or treatment of a virus infection. The … |
QVET | 2022-04-08 | 2024-06-06 | |
| 959 | IMMUNOASSAY FOR SARS-COV-2 AND MATERIALS THEREFOR Summary Related Patents View Save Abstract: The present disclosure relates to the development of novel immunoassays for the detection of SARS-CoV-2 or secreted spike protein (or fragments thereof) in saliva, nasal mucosal … |
BIO-RAD LABORATORIES | 2022-04-08 | 2022-10-13 | |
| 960 | PHARMACEUTICLA COMPOSITION FOR PREVENTION OR TREATMENT OF VIRUS-INDUCED DISEASE Summary Related Patents View Save Abstract: A pharmaceutical composition for use in the treatment or prevention of SARS Covid 19, wherein the composition includes an extract of – and optionally pharmaceutically acceptable … |
QUR MEDICAL APS | 2022-04-08 | 2024-07-18 | |
| 961 | PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 Summary Related Patents View Save Abstract: The invention relates to biotechnology. The claimed agent can be used for the prevention of SARS-CoV-2. A pharmaceutical agent may contain component (1), and contains a … |
FEDERAL STATE BUDGETARY INSTITUTION ‘NATIONAL RESEARCH CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAME | 2022-04-07 | 2022-07-21 | |
| 962 | SARS-COV-2 POLYPEPTIDES AND USES THEREOF Summary Related Patents View Save Abstract: The present disclosure relates to a HR1-derived polypeptide comprising 10 or more consecutive amino acids of the polypeptide of SEQ ID NO. 8 as disclosed in the description, or a … |
IAMA FRANCE | 2022-04-07 | 2025-01-09 | |
| 963 | AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 IN LYOPHILIZED FORM (VARIANTS) Summary Related Patents View Save Abstract: The invention relates to a biomolecule agent for inducing specific immunity against severe acute respiratory syndrome virus SARS-CoV-2, in lyophilized (freeze-dried) form, which … |
FEDERAL STATE BUDGETARY INSTITUTION NATIONAL RESEARCH CENTRE FOR EPIDEMIOLOGY AND MICROBILOGY NAMED | 2022-04-07 | 2022-08-11 | |
| 964 | METHODS, KITS, AND APPROACHES FOR VIRAL VACCINES Summary Related Patents View Save Abstract: The invention provides methods of making vaccines against viruses, including against SARS-Cov-2. Such methods entail identifying areas of a viral genome that are highly conserved … |
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION | 2022-04-07 | 2024-08-15 | |
| 965 | NANOVACCINES FOR TREATMENT OF VIRAL DISEASES Summary Related Patents View Save Abstract: A polymeric nanoparticle is disclosed which comprises: (i) at least one SARS-CoV-2 derived antigen which is capable of producing a T-cell and/or B cell response: and (ii) an … |
RAMOT AT TEL-AVIV UNIVERSITY | 2022-04-07 | 2024-06-06 | |
| 966 | CAMELID ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES Summary Related Patents View Save Abstract: Anti-SARS-CoV-specific llama single domain antibodies, methods of making and characterizing those antibodies, and methods of using those antibodies are described herein. In some … |
ERNESTO RUBIN RESNIK et. al. | 2022-04-07 | 2025-05-29 | |
| 967 | TKTL1 INHIBITORS FOR ANTIVIRAL THERAPY Summary Related Patents View Save Abstract: At least one inhibitor of TKTL1 transketolase is used in patients to treat virus infections, in particular RNA virus infections and more particularly SARS-CoV-2 infections. … |
TAVARGENIX | 2022-04-07 | 2024-11-14 | |
| 968 | VACCINATION AGAINST CORONAVIRUS WITH POLIOMYELITIS VACCINE Summary Related Patents View Save Abstract: Provided herein is a method for preventing a person from an infection by a Coronaviridae virus with a poliomyelitis vaccine. Also provided herein is a method of inducing a … |
E-MO BIOLOGY | 2022-04-06 | 2022-07-21 | |
| 969 | CDI Rapid Test For COVID-19 Variants of Concern Summary Related Patents View Save Abstract: A method, detection assay, and kit for rapidly detecting mutations of the SARS-COV-2 virus includes preparing a detection assay, performing an asymmetric real time-polymerase … |
HACKENSACK MERIDIAN HEALTH | 2022-04-06 | 2024-06-13 | |
| 970 | LIPID NANOPARTICLES AND METHODS OF USE Summary Related Patents View Save Abstract: Provided herein are, inter alia, lipid nanoparticles, lipid nanoparticles comprising nucleic acids encapsulated therein, pharmaceutical compositions comprising lipid nanoparticles … |
CITY OF HOPE | 2022-04-06 | 2024-07-11 | |
| 971 | VACCINE COMPOSITION AGAINST CORONAVIRUS Summary Related Patents View Save Abstract: The present invention relates to: a conjugate in which a receptor-binding domain (RBD) of coronavirus and a hepatitis B surface antigen (HBsAg) are linked; virus-like particles … |
LG CHEM | 2022-04-05 | 2025-10-02 | |
| 972 | METHODS FOR TREATING COVID-19 BASED ON INDIVIDUAL GENOMIC PROFILES Summary Related Patents View Save Abstract: Disclosed are gene risk profiles that predict outcomes in COVID-19. Single-cell analysis reveals immune responses associated with COVID-19 mortality. … |
UNIVERSITY OF SOUTH FLORIDA | 2022-04-05 | 2022-10-13 | |
| 973 | ANTIVIRAL COMPOUNDS, METHODS FOR THE MANUFACTURING OF COMPOUNDS, ANTIVIRAL PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUNDS AND METHOD FOR THE ORAL TREATMENT OF CORONAVIRUS INFECTION AND RELATED DISEASES THEREOF Summary Related Patents View Save Abstract: The present invention relates to antiviral compounds selected from cytokinins, their nucleosides and nucleotide analogs, and their prodrugs as inhibitors of viral RNA synthesis, … |
JOÃO BATISTA CALIXTO et. al. | 2022-04-01 | 2024-06-27 | |
| 974 | HUMAN NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND USES THEREOF Summary Related Patents View Save Abstract: The invention relates to antibodies against Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2), in particular human neutralizing monoclonal antibodies against … |
INSTITUT PASTEUR | 2022-04-01 | 2024-10-10 | |
| 975 | SARS-COV-2 VACCINE COMPOSITION AND USE THEREOF Summary Related Patents View Save Abstract: The present disclosure provides a SARS-CoV-2 vaccine composition and use thereof. The SARS-CoV-2 vaccine composition includes a mutant SARS-CoV-2 spike protein with N-linked … |
NATIONAL TSING HUA UNIVERSITY et. al. | 2022-04-01 | 2024-06-06 | |
| 976 | Sleep quality using full spectrum hemp oil Summary Related Patents View Save Abstract: This disclosure provides cannabinoid preparations for human consumption that have proven clinical benefits in patients infected with SARS-CoV-2 (the virus that causes COVID-19). … |
CLINT SORENSEN et. al. | 2022-03-31 | 2023-02-09 | |
| 977 | EXPRESSION VECTOR AGAINST SEVERE ACUTE RESPIRATORY SYNDROME VIRUS SARS-COV-2 Summary Related Patents View Save Abstract: The invention relates to preparing and using recombinant expression vectors for inducing specific immunity against severe acute respiratory syndrome virus SARS-CoV-2. One … |
FEDERAL STATE BUDGETARY INSTITUTION NATIONAL RESEARCH CENTRE FOR EPIDEMIOLOGY AND MICROBIOLOGY NAME | 2022-03-31 | 2022-07-28 | |
| 978 | Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19 Summary Related Patents View Save Abstract: The present application relates to the new the pharmaceutical combination therapy and prevention of SARS-CoV-2 and/or disease associated with this infection, including viral and … |
ASAVI; NIKOLAY FILIPPOVICH SAVCHUK | 2022-03-31 | 2023-05-16 | |
| 979 | COMBINATION THERAPY FOR COVID-19 VACCINATION Summary Related Patents View Save Abstract: The present invention relates to the combination of a Selective Estrogen Receptor Modulator (SERM) and a COVID-19 vaccine. … |
DOMPE’ FARMACEUTICI | 2022-03-31 | 2024-06-06 | |
| 980 | EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING POST COVID-19 Summary Related Patents View Save Abstract: The present invention concerns Ezrin peptide 1 for use in a method of treating post COVID-19 syndrome. … |
PANTAPHARM | 2022-03-31 | 2024-06-06 | |
| 981 | Systems, devices and methods for treating post-infection symptoms of COVID-19 using vestibular nerve stimulation Summary Related Patents View Save Abstract: Methods, systems and devices are provided to stimulate the vestibular system in such a way as to alleviate post-infection symptoms of COVID-19. A device with one or more … |
NEUROVALENS | 2022-03-31 | 2025-12-30 | |
| 982 | VIRUS DETECTION VIA PROGRAMABLE TYPE III-A CRISPR-CAS SYSTEMS AND METHODS Summary Related Patents View Save Abstract: Methods and systems, which use a reconstituted Type III-A CRISPR-Cas system, MORIARTY ( ultipronged, ne-pot, NA nduced, ugmentable, apid, est s stem) for the detection of … |
FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION | 2022-03-31 | 2022-10-13 | |
| 983 | ANTI-RNA VIRAL PHARMACEUTICAL COMBINATION THERAPY WITH APROTININ + anti-RNA DRUG Summary Related Patents View Save Abstract: A pharmaceutical combination prevention and treatment of RNA virus infection and/or a disease associated with this infection, of acute respiratory viral infections (ARVI) and … |
ASAVI | 2022-03-31 | 2023-10-05 | |
| 984 | PEPTIDES AND ANTIBODY FUSIONS THAT BIND TO SARS-COV-2 AND METHODS OF USING SAME Summary Related Patents View Save Abstract: Described herein are peptides and peptide-antibody fusions that bind to the SARS-CoV-2 S protein and the receptor binding domain (RED), and methods for using the compositions … |
SACHDEV SIDHU et. al. | 2022-03-31 | 2024-06-06 | |
| 985 | COMPOSITIONS FOR PREVENTION AND TREATMENT OF RSV AND CORONAVIRUS INFECTION Summary Related Patents View Save Abstract: Compositions and methods are provided for the prevention or treatment of RSV infection and SARS-CoV2 virus related infections, such as COVID-19 (2019-nCoV), in a human. The … |
FRANK JOSEPH REED, III | 2022-03-31 | 2022-12-22 | |
| 986 | PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + REMDESIVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19 Summary Related Patents View Save Abstract: The application relates to pharmaceutical combinations, methods, and therapies for the treatment and prevention of SARS-CoV-2 infection and related diseases. The combinations … |
ASAVI | 2022-03-31 | 2023-10-05 | |
| 987 | PHARMACEUTICAL COMBINATION THERAPY AND PREVENTION WITH APROTININ + MOLNUPIRAVIR OF SARS-CoV-2 AND/OR DISEASE ASSOCIATED WITH THIS INFECTION, INCLUDI COVID-19 Summary Related Patents View Save Abstract: The application relates to pharmaceutical combinations, methods, and therapies for the treatment and prevention of SARS-CoV-2 infection and related diseases. The combinations … |
ASAVI | 2022-03-31 | 2023-10-05 | |
| 988 | Compositions and methods for treating SARS-CoV-2 infection Summary Related Patents View Save Abstract: The present disclosure provides small hairpin nucleic acid molecules capable of stimulating interferon production. The nucleic acid molecules of the present disclosure has a … |
YALE UNIVERSITY | 2022-03-30 | 2023-10-17 | |
| 989 | CHIMERIC NUCLEOTIDE SEQUENCE, VECTOR FOR EXPRESSION IN MAMMALS, RNA VACCINE, CHIMERIC FUSION PROTEIN, USE IN THE PRODUCTION OF A VACCINE AGAINST CORONAVIRUS Summary Related Patents View Save Abstract: A chimeric nucleotide sequence that corresponds to an encoded fusion protein comprising a polyepitope resulting from selecting and juxtaposing multiple epitopes from a coronavirus … |
IMUNOTERA SOLUÇÕES TERAPÊUTICAS LTDA. | 2022-03-30 | 2025-09-11 | |
| 990 | Methods for treating SARS-CoV-2 infection Summary Related Patents View Save Abstract: The present disclosure provides small hairpin nucleic acid molecules capable of stimulating interferon production. The nucleic acid molecules of the present disclosure has a … |
YALE UNIVERSITY | 2022-03-30 | 2023-05-16 | |
| 991 | PLANT-PRODUCED VLPS AND RIC VACCINES Summary Related Patents View Save Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 antigen virus-like particles (VLPs) and recombinant immune complexes (RICs) are described, along with methods of making said VLPs … |
QIANG CHEN | 2022-03-30 | 2022-10-13 | |
| 992 | COVID 19 memorial box Citation: 2 Related Patents View Save |
PAUL HUDON et. al. | 2022-03-30 | 2023-05-09 | |
| 993 | OPTIMAL PRODUCTION OF SARS-COV-2 VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN MAMMALIAN CELLS Summary Related Patents View Save Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus-like particles (VLP) are provided herein as well as methods of making and using the same. The methods of making … |
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-03-30 | 2024-05-16 | |
| 994 | Highly Attenuated Replication-Competent Recombinant Poxvirus As A Vaccine Platform And Methods Of Use Summary Related Patents View Save Abstract: Recombinant poxvirus expressing severe acute respiratory syndrome coronavirus 2 structural proteins and virus-like particles are described, along with methods of making and using … |
ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-03-30 | 2024-07-11 | |
| 995 | NANOSENSOR FOR DETECTING SARS-CoV-2 SPECIFIC ANTIBODIES Summary Related Patents View Save Abstract: The present invention relates to a nanosensor for detecting SARS-CoV-2 specific antibodies, wherein the nanosensor comprises a metal nanoparticle functionalised with one or more … |
AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH | 2022-03-29 | 2024-11-07 | |
| 996 | SARS-CoV-2 SPIKE ECTODOMAIN POLYPEPTIDES AND COMPOSITIONS AND METHODS THEREOF Summary Related Patents View Save Abstract: The present disclosure provides engineered SARS-CoV-2 spike ectodomain polypeptides and cells for producing such a polypeptide, as well as compositions and methods thereof. … |
REGENTS OF THE UNIVERSITY OF MINNESOTA | 2022-03-29 | 2022-10-13 | |
| 997 | SARS-COV-2 SUBUNIT VACCINE Summary Related Patents View Save Abstract: An immunogenic subunit vaccine antigen which comprises at least two receptor-binding domains (RBDs) of the spike (S) protein of SARS-CoV-2 which are fused to a heterologous … |
VIRAVAXX | 2022-03-29 | 2025-11-13 | |
| 998 | NONINVASIVE VACCINE TESTER Summary Related Patents View Save Abstract: This invention this invention is a device and method for validating the identity of a liquid in a container that is transparent to light, while the liquid is in the container, … |
HANNU HARJUNMAA | 2022-03-29 | 2022-09-15 | |
| 999 | PYRROLOPYRIMIDINE NUCLEOSIDES FOR TREATING OR PREVENTING A SARS-COV-2 INFECTION Summary Related Patents View Save Abstract: The present disclosure provides methods of treating or preventing a SARS-CoV-2 infection or a SARS-CoV-2-infection associated disease or disorder (e.g. COVID-19) comprising … |
CHIMERIX | 2022-03-29 | 2024-06-27 | |
| 1000 | Ether-Linked Antiviral Compounds Summary Related Patents View Save Abstract: The invention relates to compounds of Formula I and pharmaceutically acceptable salts thereof wherein R , R , R , p, q, q′ and Ring A are as defined herein, pharmaceutical … |
PFIZER | 2022-03-25 | 2025-10-02 |